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ABSTRACT 
This research belongs to the multi-disciplinary research community concerned with 
wearable medical technology and branches of sociology and psychology that study its 
impact. It addresses a real-life problem of Insulin Pump (IP) adoption by Children. This 
is important for Saudi Arabia, since it is among the top five countries in the world with 
the highest rate of diabetes. Theories of reasoned action (TRA), technology acceptance 
model (TAM) and health belief models (HBM) for some of the cases predict that the 
perception of benefits is the main motivator for the proper use of the technology. This is 
often not realised in practice, because the main theoretical focus is on the benefits of IP, 
specifically in the pre-adoption phase.  In contrast, this research project is focused on the 
reasons why some diabetic children patients misuse the IP in spite of the initial perception 
of its benefits.  To find answers to this research question, an empirical study of adoption 
of IP by children and young adults in Saudi Arabia was carried out. A novel analytical 
framework was developed in this study in order to unify different perspectives and 
expectations of the benefits of the IP for a diabetic child and young adult. The analytic 
framework is applied using empirical study of diabetic children struggling with the IP in 
the course of the adoption process, with main emphasis on the post-adoption phase. 
Research methods were predominantly qualitative, involving in-depth interviews and 
case studies. In the discovery phase, data was collected through interviews of medical 
personnel and case studies with children and their parents. The analysis was focused on 
different interactions between medical personnel, patients and their caregivers, the 
discourses among them in order to explicate the contradictions between them. The main 
findings are that contradictions show different expectations between the different actors. 
The medical personnel used medical reasons, whereas the caregiver focus on emotional 
aspects. However, the diabetic child was concerned with the life-style changes that the 
use of the IP caused. The different motivations create misunderstandings and result in 
resistance towards the IP. Age-related and culture-specific factors were also considered, 
but further research is needed to ensure that the findings can be generalised to other 
devices, age-groups, cultures and different social contexts. Such studies would also refine 
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the analytical framework and enrich research methodology to make generalisations 
possible.  
  
 -III- 
 
DECLARATION 
I declare that the work described in this thesis is original work undertaken by me for the 
degree of Doctor of Philosophy, at the software Technology Research Laboratory 
(STRL), at De Montfort University, United Kingdom. 
No part of the material described in this thesis has been submitted for any award of any 
other degree or qualification in this or any other university or college of advanced 
education.  
 
Abeer Ghazy A. Almakky 
  
 -IV- 
 
 ACKNOWLEDGMENT 
I would like to express my appreciations and acknowledgements for those who 
have supported me through my PhD journey. 
First and foremost, my deepest gratitude to ALLAH (SWT) the most Gracious and 
Merciful for His infinite blessings and guidance.  
I owe sincere appreciation to my supervisor, Professor Duska Rosenberg, without 
her continuous support this thesis would not have been possible. I have benefited 
greatly from her experience, wisdom and knowledge.  Special appreciation goes to 
Dr Antonio Cau for his technical suggestions and guidance through my PhD journey.   
I would also like to express heartfelt appreciation to my family.  To my parents, 
Professor Ghazy Almakky and my mother Mrs. Wafaa Daghustani, I am grateful to 
your constant, love and support - you both have made me the daughter, wife and 
mother I am today.  
Special appreciation goes to my mother in-law Mrs. Shadaya Kurdi, for her 
continuous prayers and moral support 
My biggest thanks to my husband and best friend Khaled Shaban, for his friendship and 
continuous support in our life together, and especially for the very useful debates we 
shared during our PhD studies; he was my trustworthy advisor during my PhD journey 
like he is in our daily lives. 
Special thanks go to my children, Rayan and Omar, I love you so much, thank you 
for being patient with me and letting me work on my thesis. I have devoted so 
much time from you during this research, thank you my dears. 
 -V- 
I would also like to thank my sisters Dr. Hana and Dr. Rawa, and my three brothers, 
Dr. Mohammed, Anas and Badr for their continuous and unremitting love and 
support. 
Finally, I would like to thank all my friends for all the encouragement they gave me 
during my PhD journey.  
 
Thank you all. 
 
  
 -VI- 
 
Table of Contents 
DEDICATION ....................................................................................................................... II 
ABSTRACT .......................................................................................................................... III 
DECLARATION .................................................................................................................... III 
ACKNOWLEDGMENT .......................................................................................................... IV 
CHAPTER 1 INTRODUCTION ......................................................................................... 13 
1.1 INTRODUCTION .............................................................................................................. 13 
1.2 RESEARCH PROBLEM....................................................................................................... 15 
1.3 RESEARCH MOTIVATION .................................................................................................. 17 
1.4 RESEARCH QUESTION ..................................................................................................... 21 
1.5 RESEARCH AIM .............................................................................................................. 21 
1.6 RESEARCH OBJECTIVES .................................................................................................... 21 
1.7 KEY DELIVERABLES ......................................................................................................... 22 
1.8 THESIS STRUCTURE ......................................................................................................... 23 
CHAPTER 2 LITERATURE REVIEW ................................................................................. 26 
2.1 INTRODUCTION .............................................................................................................. 26 
2.2 WEARABLE DEVICES ....................................................................................................... 26 
2.3 INSULIN PUMPS ............................................................................................................. 27 
2.3.1 Technical Specifications ........................................................................................ 28 
2.3.2 How it works ......................................................................................................... 30 
2.4 BENEFITS OF IP FOR CHILDREN .......................................................................................... 31 
2.4.1 Medical Benefits .................................................................................................... 33 
2.4.2 Non-Medical benefits ............................................................................................ 35 
2.5 DRAWBACKS OF IP ......................................................................................................... 37 
2.6 READINESS TO RECEIVE THE IP .......................................................................................... 47 
2.6.1 Patient Readiness .................................................................................................. 49 
2.6.2 Family Readiness .................................................................................................. 52 
2.6.3 Readiness improvement and education before using the IP .................................. 55 
2.7 CHAPTER SUMMERY........................................................................................................ 56 
 -VII- 
CHAPTER 3 THEORIES IN ADOPTION OF IP IN CHILDREN ............................................... 59 
3.1 INTRODUCTION .............................................................................................................. 59 
3.2 THEORIES OF ACCEPTING NEW MEDICAL TECHNOLOGIES ...................................................... 60 
3.2.1 Wearable Devices in Technology Acceptance Models (TAM) .............................. 63 
3.2.2 Technology Acceptance Framework in Medical Wearable Devices ..................... 64 
3.2.3 Health Belief Model .............................................................................................. 65 
3.3 BEHAVIOURAL MODELS IN ACCEPTING AND REJECTING ENFORCED BEHAVIOUR .......................... 67 
3.3.1 Patient adherence to medication / patient compliance ......................................... 68 
3.3.2 Cognitive dissonance and Psychological Reactance behaviours .......................... 70 
3.4 SOCIAL THEORETICAL FOUNDATIONS ................................................................................. 71 
3.4.1 Contradictions ....................................................................................................... 71 
3.4.2 Sociomateriality .................................................................................................... 73 
3.5 KNOWLEDGE GAP ANALYSIS ............................................................................................. 74 
3.6 CHAPTER SUMMARY ....................................................................................................... 77 
CHAPTER 4 RESEARCH METHODOLOGY ....................................................................... 80 
4.1 INTRODUCTION .............................................................................................................. 80 
4.2 RESEARCH STRATEGY ...................................................................................................... 81 
4.2.1 Phase 1: Interview Research ................................................................................. 82 
4.2.2 Phase 2: Case Study Research ............................................................................... 85 
4.2.3 Ethical Considerations ........................................................................................... 87 
4.3 RESEARCH QUALITY ........................................................................................................ 87 
4.3.1 Reliability .............................................................................................................. 89 
4.3.2 Validity .................................................................................................................. 90 
4.3.3 Credibility ............................................................................................................. 90 
4.3.4 Reflexivity .............................................................................................................. 91 
4.3.5 Transferability ....................................................................................................... 95 
4.4 CHAPTER SUMMARY ....................................................................................................... 96 
CHAPTER 5 TECHNOLOGY ADOPTION FRAMEWORK FOR IP (TAF IP FOR CHILDREN) ...... 98 
5.1 INTRODUCTION .............................................................................................................. 98 
5.2 DEVELOPING THE ANALYTIC FRAMEWORK .......................................................................... 98 
5.2.1 Research Perspective ............................................................................................ 99 
5.2.2 Level of Analysis ................................................................................................. 100 
5.2.3 The Analytic Constructs ...................................................................................... 102 
 -VIII- 
5.3 SUMMARY OF THE (TAF IP FOR CHILDREN) ....................................................................... 103 
5.4 APPROACH OF THE ANALYTICAL FRAMEWORK .................................................................... 104 
5.5 RESEARCH MODEL ....................................................................................................... 105 
5.6 CHANGE AGENT PERSPECTIVE ........................................................................................ 108 
5.6.1 Change Agent Motivations to prescribe the IP.................................................... 109 
5.6.2 Using change agent power to avoid improper use of the IP ............................... 110 
5.6.3 Reasons for improper use from change agent perspective ................................. 111 
5.7 BENEFICIARY PERSPECTIVE: DIABETIC CHILD AND FAMILY .................................................... 115 
5.7.1 Change agent perceptions .................................................................................. 118 
5.7.2 Caregivers’ perceptions, feelings, attitudes and behaviour ................................ 120 
5.7.3 Patient self-perception ........................................................................................ 126 
5.8 INTERPRETATIONS: CONTRADICTIONS .............................................................................. 133 
5.8.1 First contradiction: between change agent and the diabetic child ..................... 134 
5.8.2 Second contradiction: between caregiver and change agent ............................. 135 
5.8.3 Third contradiction: the relationship between patient and caregiver ................ 137 
5.9 SUMMARY .................................................................................................................. 141 
CHAPTER 6 DISCUSSION ............................................................................................ 143 
6.1 INTRODUCTION ............................................................................................................ 143 
6.2 LITERATURE REVIEW AND KNOWLEDGE GAP ..................................................................... 144 
6.3 THE RESEARCH ANALYTIC APPROACH: EVALUATING THE ANALYTIC APPROACH ........................ 145 
6.3.1 Summary of Analytic Framework ........................................................................ 145 
6.3.2 Analytic Framework Evaluation ......................................................................... 147 
6.4 AREAS OF IMPROVEMENT IN USING THE ANALYTIC FRAMEWORK TO OTHER DOMAIN ................ 150 
6.4.1 Sampling technique ............................................................................................. 150 
6.4.2 Evolving the level of contradictions among different actors through time ......... 150 
6.4.3 Generalisability of the analytical framework ...................................................... 151 
6.5 THE RESEARCH FRAMEWORK ......................................................................................... 153 
6.5.1 Change agent perspectives towards the IP ......................................................... 154 
6.5.2 Perceptions of the Caregivers towards IP .......................................................... 155 
6.5.3 Child perception towards the IP ......................................................................... 157 
6.5.4 Contradictions between different agents (the definition of contradiction) ......... 157 
6.6 CHAPTER SUMMARY ..................................................................................................... 159 
CHAPTER 7 CONCLUSION .......................................................................................... 161 
 -IX- 
7.1 PROBLEM DESCRIPTION ................................................................................................. 162 
7.2 RESEARCH QUESTION: HOW CONTRADICTIONS BETWEEN THE DIFFERENT ACTORS IN DEFINING AND 
UNDERSTANDING THE IP AFFECT THE MAIN BENEFICIARY (CHILD) UNDERSTAND, DEFINE AND BE MOTIVATED 
TO USE THE IP? ......................................................................................................................... 163 
7.3 UNIFORM ANALYTICAL FRAMEWORK ................................................................................ 165 
7.4 CONTRIBUTION TO KNOWLEDGE ..................................................................................... 165 
7.5 RESEARCH METHODS .................................................................................................... 166 
7.6 IMPLICATIONS FOR PRACTICE ......................................................................................... 167 
7.7 RESEARCH LIMITATION .................................................................................................. 169 
7.8 FUTURE RESEARCH ....................................................................................................... 170 
REFERENCES .................................................................................................................... 172 
APPENDIX ....................................................................................................................... 196 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 -X- 
 
 LIST OF FIGURES 
 
FIGURE 1-1: RESEARCH MOTIVATION ................................................................................................................. 20 
FIGURE 1-2: CONTRIBUTION STRUCTURE ............................................................................................................. 23 
FIGURE 1-3: THESIS STRUCTURE ........................................................................................................................ 25 
FIGURE 2-1: CHAPTER 2 STRUCTURE .......................................................................................................... 26 
FIGURE 2-2: SMART WEARABLE ......................................................................................................................... 27 
FIGURE 2-3: IP DEVICE ATTACHED TO THE BODY (ADAPTED FROM HYDERABAD ENDOCRINOLOGY, 
2016) ................................................................................................................................................. 29 
FIGURE 2-4: INSULIN PUMP AND INFUSION SET (ADAPTED FROM REECE & WILLIAMS, 2014) ..................... 30 
FIGURE 2-5: FACTORS AFFECTING THE ACCEPTANCE OF NEW TECHNOLOGY ............................................... 31 
FIGURE 2-6: BENEFITS OF IP ....................................................................................................................... 32 
FIGURE 2-7: DRAWBACK OF INSULIN PUMP THERAPY ................................................................................ 38 
FIGURE 2-8: SCHEINER ET AL., (2009) FACTORS RELATED TO SUCCESSFUL INITIATION OF INSULIN PUMP 
THERAPY ........................................................................................................................................... 48 
FIGURE 2-9: READINESS ELEMENTS ..................................................................................................................... 49 
FIGURE 2-10: FACTORS OF PATIENT TO BE ESSENTIAL FOR ACHIEVING SUCCESS IN USING THE IP ............... 49 
FIGURE 2-11: FACTORS OF FAMILY TO BE ESSENTIAL FOR ACHIEVING SUCCESS IN USING THE IP FOR CHILD ........................ 53 
FIGURE 3-1: CHAPTER 3 STRUCTURE .......................................................................................................... 60 
FIGURE 4-1: CHAPTER 4 STRUCTURE .................................................................................................................. 81 
FIGURE 4-2: RESEARCH STRATEGY ............................................................................................................. 82 
FIGURE 4-3: REFLEXIVITY ELEMENTS ................................................................................................................... 92 
FIGURE 4-4: CHAPTER SUMMARY ...................................................................................................................... 97 
FIGURE 5-1: CHAPTER 5 STRUCTURE .................................................................................................................. 98 
FIGURE 5-2: ANALYTIC FRAMEWORK ELEMENTS ....................................................................................... 99 
FIGURE 5-3: LEVEL OF KNOWLEDGE .................................................................................................................. 101 
FIGURE 5-4: THE ANALYTICAL FRAMEWORK ............................................................................................ 103 
FIGURE 5-5: MODEL TO UNDERSTAND DIABETIC CHILD BEHAVIOUR ......................................................................... 107 
FIGURE 5-6: CONTRADICTION FRAMEWORK ....................................................................................................... 117 
 
Chapter 1  Introduction 
 
 
 -13- 
CHAPTER 1 Introduction 
1.1 Introduction 
Wearable devices are now being used by a significant proportion of people in their daily 
lives to manage their health and wellbeing (Giani et al., 2016).  Wearable device releases, 
lower prices, and company rationalizations marked the first quarter of 2016 in the 
worldwide wearable market. According to data from the International Data Corporation 
Worldwide Quarterly Wearable Device Tracker, overall 19.7 million wearable device 
units have been sold in 2016, an increase of 67.2% from the 11.8 million components 
shipped in 2015 (Mass, 2016). 
 
In this thesis, the research focus is on the adoption and use of the Insulin Pump (IP) as a 
medical wearable device. The first connected devices, which help the user to take their 
therapy through convenience and the use of apps, are already on the market and in 
development.  For example, Insulet Corp. (Billerica, Mass.) market the stick-on OmniPod 
IP. However, rates of IP use appear to vary greatly world Wide (Maahs et al., 2010); 
(Beck et al., 2012). Moreover, Heinemann (2015) mentioned that the exact number of IP 
users worldwide is not known, because it is not reported by the manufacturers. However, 
it is estimated from financial reports, which suggest that the number may be between 0.75 
to 1.0 million. A recent Medtronic Mini Med Paradigm and 530G pump recall included 
444,374 units in the US and 293,000 patients elsewhere (close Concerns, 2014). 
Worldwide sales of medical devices are predicted to reach 27.8 billion Us dollars by 2022, 
as reported by Grand View Research, Inc. “Rising prevalence of conditions such as 
obesity and hypertension, as a result of sedentary lifestyle is anticipated to boost the 
demand for wearable medical devices”. 
 
Wearable devices in general, such as fitness and wellness monitors, are used in 
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monitoring activity and emotions. Healthcare and medical devices are used in monitoring 
vital signs, such as blood pressure monitors and glucose monitoring defibrillator. Another 
type of medical device are drug delivery products such as, IP. Thus, the IP is considered 
to be a wearable -health management that is self-managed device that is prescribed to 
deal with diabetes and is overseen by medical professionals. 
 
Diabetes is a global epidemic with 382 million people affected by the disease worldwide 
and with figures expected to rise to 582 million by 2035 (Guariguata et al., 2014).  In 
Saudi Arabia, diabetes remains a major public health problem affecting 24% of the 
population. Furthermore, the number of children and adolescents with type 1 diabetes has 
more than doubled in the past decade with average incidence rates reported at 
27.2/100,000 population (Al-Mendalawi and Al-Herbish, 2009; AlBuhairan et al., 2016). 
 
The number of diabetic patients is increasing in numerous regions of the world 
(Association, 2012; Aanstoot et al., 2007).  In many studies, it has been reported that the 
incidence of diabetes in Saudi Arabia are raised drastically over the last 25 years (Cherian 
et al., 2010). The rates of children and adolescents with diabetes in Saudi Arabia is almost 
109.5 per 100,000, which is higher than many developed countries (Al-Hayek et al., 2014; 
Al-Herbish et al., 2008).  Thus, the Saudi government subsidize the IP for those children 
who suffer from diabetes, as IP has several benefits for the children and many doctors 
advise it. However, as mentioned by Heinemann (2015) there are several reports of 
patients’ and doctors’ dissatisfaction with risks involved in misusing the IP and 
consequent withdrawal of the pump (de Vries et al., 2015, Hofer et al., 2010a) Hofer et 
al., 2010). As reported by Heinemann (2015), estimates of rates of IP discontinuation in 
children and adults range from 0–64%.  
 
There are number of advanced medical technologies such as monitoring, and delivery of 
medication since 1922 have transformed the lives of millions. However, the fact that 
“sophisticated technology can be added to deliver devices and accessories, does not mean 
it is always the best thing for the patient” (Fry, 2012, p. 947). Therefore, it is important 
to understand why the IP or a similar medical device that is expected to help and improve 
Chapter 1  Introduction 
 
 
 -15- 
the condition of diabetic children is failing to do so. For this reason, this research 
investigates the reasons for adoption and discontinuation among Saudi nationals, 
evaluating the views and attitudes of users, families and the healthcare sector specialists. 
These may affect the children patients, and their families, and encourage them to use it 
properly. Indeed, the misuse of IP, as is the case with any technology, would cause harm 
and dissatisfaction or even unintended results which in turn may lead to the 
discontinuation of IP.   
  
1.2 Research Problem 
 
Diabetes is one of chronic diseases that cause biological (Nelson et al., 2012) 
psychological (Wong et al., 2010) cultural and social challenges and that have strong 
impacts on quality of life. These factors have been studied focusing on medical condition 
(Moyse et al., 2009), psychosocial condition of the patients, their family members and 
caregivers (French et al., 2010).  The view of IP as a wearable device brings into focus 
the specific nature of the device as it becomes integrated with the patient's body (unlike 
more traditional wearable devices such as smart glasses, smart clothes, etc.) and this has 
consequences for the adoption, patients' attitudes, behaviour, in the way they respond to 
their condition in general and the IP. Thus, the study of IP adoption in this context 
requires a broader perspective on the people involved - not only the patient and the 
medical personnel, but also the patient's family, friends, social pressures. Thus, this 
research addresses a real-world problem - IP has the capability of improving the quality 
of life of diabetic patients, but its take-up is disappointing. In the literature, there is a 
research gap between the expectations of IP benefits that are based on the capability of 
the technology to maintain steady glucose levels and the reasons why these expectations 
are not met in the real-life practice. 
 
The use of IPs in Saudi Arabia is currently somewhat low, and there is limited indication 
regarding their effect on glycaemic control and diabetes treatment satisfaction (Hayek et 
al., 2015; Sharef et al., 2015).  Bin Abbas et al. (2005) mentioned that the number of IP 
Chapter 1  Introduction 
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users among Saudi children is still small. As he stated, the lack of patient/family 
motivation, health care team enthusiasm and proper technical support are among the 
contributing factors for that”  (Bin-Abbas et al., 2005)  A partial explanation for this may 
be related to the usability of modern technologies, where interest levels may be transient 
and adverse experiences common, for example occurring in over 40 % of users per year, 
with a minority, particularly in children, requiring hospital management. This research 
thus aims to generate insight into the range of potential IP-associated adverse events and 
their impact on adoption and ongoing usage of the technology, including the incidence, 
features, impacts, and contributory factors such as skills and knowledge of the pump user, 
their supporters and healthcare professionals. 
  
The use of IP by children presents unique issues and different problems not found in adult 
IP users and in older individuals (Giani et al., 2015).  Furthermore, it was mentioned that 
there is no guarantee that patients will achieve improved diabetes control with IP. 
(Gonder-Frederick et al., 2011). Moreover, problems of discontinuation of IP has been 
noted widely in literature (de Vries et al., 2015; Hofer et al., 2010).  Discontinued pump 
use has been, for variety of reasons noted, most commonly related to user comfort 
(Heinemann et al., 2015).  The reasons can be attributed to the IP design factors or human 
factors (FDA, 2014). The problem is not with the design only, since pump failures can be 
caused by insulin infusion or blockage on the insulin infusion set, as well as the site where 
the insulin infusion is attached to the body, issues with the insulin stability, as well as 
user error and or any combination of these issues. (Regittnig et al., 2013).   Self- 
management of the IP is essential (Educators, 2009, Comeaux and Jaser, 2010a, 
Tumminia et al., 2015). Thus, evidence from literature shows that the technology is not 
the main factor responsible for this discomfort with the IP; rather, the causes lie in people 
and technology. Thus, the research in this project is focused on their interaction with the 
IP. 
 
Human interaction with technology can be understood using different theoretical lenses 
such as socio-technological approach and technology acceptance models. Indeed, human 
behaviour is mainly driven by psychological factors such as attitudes, motivations and 
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perceptions. Thus, understanding these psychological factors is expected to be useful for 
understanding the relationship between the patient and her/his family (i.e. socio 
perspective) and the technology (i.e. techno perspective). If factors affecting this 
psychological relationship are discovered, human behaviour can be adapted to the proper 
use of IP in particular circumstances. 
 
Psychological factors are important, not only where there is psychopathology 
(pathological anxiety or fear, depression, eating disorder, and cognitive impairment) but 
more importantly as the factors that determine everyday “normal” behaviour (Harvey 
(2015). Because of the perception of obligation to use the IP forever, a higher rate of 
complications might occur in patients who are poorly motivated or non-adherent (Pickup 
et al, 2014).  
1.3 Research Motivation  
 
The main motivation is to increase knowledge about assistive technology so that genuine 
people needs for assistance can lead a better and safer life. The research in this project 
was centred on medical devices for diabetic patients, since medical technology is 
advancing, and diabetes is increasing.  
Understanding and minimising real life problems that arise when patients interact with a 
medical device is important.  Technology has delivered great benefits, and it can continue 
to do so. For diabetes (and other chronic conditions), the delivery device is the drug-to-
patient interface which is important. The ultimate objective is to help patients comply 
with their therapy and manage their condition (Fry et al., 2012). 
The IP is a medical device that is integrated to the diabetic patient body to improve and 
or control the diabetes, “expected to improve long-time metabolic outcome in patients 
using this treatment” (Giani et al., 2015). Although Pańkowska et al., (2009) mentioned 
that the systematic reviews of children in using IP showed only modest benefits between 
0% to 0.9% medical improvements compared with the normal insulin injections. (Giani 
et al., 2016). Indeed, this raises an interesting research question, why the IP does not have 
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a significant improvement on children health? The answer to this question can be sought 
in the improper use of the IP (Shulman et al., 2016). 
That’s why I am interested to see how technology can have an effect for patient health.  I 
was motivated to go and investigate the use of technology in Saudi Arabia why the IP is 
not used in the proper way. 
In this project, the effect of technology on patients’ health and well-being was centred on 
the adoption of IP by diabetic children and adolescents, with special emphasis on the 
misuse of IP. There are different schools of thought interpreting improper use of the IP. 
These include cultural (Al-Hayek et al. 2014), family (Alsaleh et al., 2012) and 
psychological factors (Müller-Godeffroy et al., 2009).  Culture is defined as the shared 
patterns of behaviours and interactions, cognitive constructs, and affective understanding 
that are learned through a process of socialization (Hofstede 1984). Culture has a 
significant effect on people’s behaviour, beliefs, and decisions. Thus, it is not surprising 
that culture influences an individual’s acceptance and use of wearable technology. 
Although there are studies in developed countries (Willi, et al., 2015) and developing 
countries (Daya et al, 2014), Arabic Gulf countries have a distinctive environment where 
the income is comparable to developed countries but the culture and behaviours are still, 
from technology adoption angle, in the range of developing countries.  Furthermore, the 
Arabs have a distinct lifestyle and culture that does not always work to their advantage 
with regards to diabetes care (Beshyah & Deeb, 2012). In developing countries, a 
perception of being weak or disabled is a source of shame (Hofstede, 2010). This can 
expose the unique perspective in understanding the patient behaviour in a country such 
as Saudi Arabia, taking into consideration the cultural factors. 
In particular, family members' and the surrounding' social group perceptions, attitudes 
and behaviours can be significant factors leading to discontinuation of the IP. Binek et al, 
(2016) mentioned that the caregiver’s lack of engagement and therefore lack of 
management of IP is an issue. Indeed, it is not clear from their study what the reasons 
behind this disengagement in managing the IP for their children regardless the obvious 
benefits of it may be. Such lack of proper management of IP would cause discomfort to 
Chapter 1  Introduction 
 
 
 -19- 
the child, discourage the parents, and eventually lead to the discontinuation of the IP. At 
the same time, many families have a negative perception towards the IP. They perceive 
it as uncomfortable or are apprehensive of the daily use of newer IP technologies in 
younger children (Cope et al., 2012). As the contribution of the caregiver is significant in 
children and young adults, their attitude and perceptions toward the IP for children is a 
cornerstone in understanding the patient behaviour (Kesavadev et al., 2010). 
Family members are not the only ones who can shape the diabetic children behaviour 
towards the IP, doctors and educators are also important. The ways the relationships 
between diabetic children and doctors and educators are developed are largely based on 
cultural factors. These relationships between the behaviour and culture in the adoption of 
medical devices have been discussed in different contexts. For instance, Compos (2007) 
mentioned that the Hispanic cultural values can affect the patient-provider relationship 
negatively, which can result in decreased satisfaction. Such behaviours include: Patients 
may be hesitant to ask questions because questioning an authority figure (e.g., a 
physician) is viewed as disrespectful.  Patients may nod in response to physician’s 
instructions as a sign of respect even when they do not understand the instructions. 
Indeed, this problem can be approached from another angle: the significance of doctors' 
role. If doctors and educators understand these cultural problems and appreciate how they 
might affect the patient behaviour, they can overcome potential misbehaviours. 
Thus, in this research the interaction between patient behaviour and culture is explored 
from a user-centric perspective in order to see how the patient and his/her parents are 
perceiving themselves, perceiving others perceiving them and how they respond to these 
perceptions. In Information Systems literature, perception affects the attitude and attitude 
affects motivations and behaviours (Montano and Kasprzyk, 2015). Thus, by 
understanding the different perceptions and the interactions between them, a new 
framework can be developed for understanding behaviour. 
Furthermore, from a psychological perspective, there are two main approaches to 
understanding behaviour. First, the acceptance of adherence to an "obligatory" device 
attached to the body in continuous use over a long period of time. In other words, long-
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term commitment and integration of an external body to human body may be 
psychologically rejected from the patient perspective. The psychological factor of the 
patient having the pump being attached to the body and feeling discomfort, 
embarrassment (de Vries et al., 2010) can lead to difficulties controlling the diabetes 
(Morris, 2015).  Meanwhile Binek et al., (2016 p.68) mentioned that “The individual 
psycho-emotional state of the child and appropriate education are important at the start 
and continuation of IP”.  As Wood et al., (2006 ) mentioned, IP discontinuation in adult 
populations may not be applicable to youth with type 1 diabetes given the unique 
physiological and psychosocial characteristics of children and adolescents, such as 
pubertal growth and development, reliance on family members for assistance, and the 
challenges of increasing autonomy during adolescence (Moreland et al., 2004; Palmer et 
al., 2004). 
Most of the studies regarding non-adherence to treatment were done in developed 
countries and with adults, where the culture from developing countries is different (Raza 
et al., 2014). It has not been studied how a different culture in a developing country with 
a different age group (i.e. children) can have different and unique results.   
 
Figure 1-1: Research Motivation 
Cultural Reasons (e.g Riaz et al., 2014; Compos, 2007; Khan et al., 
2016); 
Family Reasons (Hirose et al, 2012; Eilander et al., 
2015)
Psychological factors (Burdick, 
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2006; Sharef 2015)
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1.4 Research Question 
The main research question is “How contradictions between the different actors in 
defining and understanding the IP affect the main beneficiary (child) understand, define 
and be motivated to use the IP?” 
The research sub questions are: 
 Why some children use the IP improperly after its adoption?  
 What is the role of the family in preventing or facilitating improper use?  
 What are the motivations that lead to improper use? 
1.5 Research Aim  
By answering this research question, the research can achieve its aim which is  
To develop an analytic framework for understanding the contradiction between different 
actors' definitions and motivations towards the IP that influences beneficiaries’ 
motivation to use the IP. 
1.6 Research Objectives 
To fulfil this research, aim, this research has certain objectives. These objectives focus 
on understanding different perceptions: agent, parents, and child. By having such 
understandings, the contradictions between them can be shown and investigated in such 
a way the behaviour can be understood.  
1. To identify and to understand the change agent perspective towards the IP 
2. To understand the parents' perspective towards the IP 
3. To understand the main beneficiary (child) towards the IP 
4. To understand the interactions and contradictions between different actors 
5. To understand how these interactions are affecting the child perception, attitude 
and motivations towards the IP.  
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1.7 Key Deliverables 
There are two main key deliverables. First is the analytic framework to understand the 
reasons for improper use. The analytic framework serves to provide and derive an 
understanding of the facts, taking into consideration the various theories that can be 
partially or wholly utilised to explain those facts. As a consequence of this, the proposed 
analytic framework restricts the understanding into a limited number of main 
interpretations: understanding how different discourses and perceptions shape the 
perception of beneficiaries, using both contradictions and socio-materiality theory; and 
understanding how the produced perception creates a pattern of behaviour, using TRA 
(i.e. the belief that subjective norms affect attitude, which in turn affects behaviour).  
The second deliverable is applying the analytic framework on two case studies to 
understand the child motivations to misuse the Insulin Pump.  According to the analytic 
framework there are three level of analysis: facts, interpretations, and explanations. The 
facts are based on what the actor perceives while interpretation is how the researcher 
understands what is said based on the context and other actors’ perceptions (List of 
perceptions are included in  5). The explanation is based on deriving from the different 
interpretations of different actors towards a single object, the IP. Explanations are focused 
on understanding how these facts are influencing the child attitude towards the IP, which 
in turn affects the behaviour. The main finding is the contradictions in defining the IP 
between actors creates a unique perception by the child which in turn led to un-intended 
behaviour.   
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Figure 1-2: Contribution Structure 
Symbol Meaning 
Clouds Views toward the IP  
Circle Behaviours 
Red dotted arrow Relationship – Contradictions  
Tag Discourse used in understanding technology 
 
1.8 Thesis Structure  
The thesis is structured into 7 chapters Figure 1-3. The content of the 6 chapters is briefly 
outlined below:  
Chapter Two is a review which provide a coherent theoretical background of the insulin 
pump (IP), specifically for readers who do not know about the benefits and drawbacks of 
this device. The defining the concept of wearable devices. This is followed by a 
discussion of the underlying concept of IPs, as well as their technical and operational 
specifications. Given that this thesis aims to understand the reasons for the improper use 
of IPs, a discussion is provided of their main motivators (benefits) and de-motivators 
(drawbacks). Finally, as the proper and improper use of IPs is generally thought to be 
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largely dependent on whether they are ready to use before and after adoption. The chapter 
concludes with an examination of patient’s readiness to receive the IP.  
Chapter Three provides further literature sources to discover how the person perceives 
and defines the technology affects the attitude toward it and therefore the use of the IP.  
Will first highlight and explain the theories in adapting the IP (TAM, TRA, TPB and 
HBM). Secondly the behavioural models in accepting and rejecting medication by the 
patient the perception of benefits will be discussed. Thirdly the sociological themes to 
develop the theoretical foundations for understanding how the child logics are 
formulated. 
Chapter Four discusses the research approach and methods adopted and reflected in the 
way which data about the problem situation should be gathered. This research is an 
interpretive qualitative research. Its strategy is based on two phases; interview research 
and case study. Finally, the research issues are discussed. 
  
Chapter Five aims to develop the technology adoption framework (TAF) for IP for 
children. It includes 2 main stages. The first stage is developing the analytic framework, 
through understanding the research perspective, level of analysis, analytic constructs and 
application of this analytic framework. The second stage is the implementation of the 
analytical framework. It is based on empirical investigation in Saudi Arabia using 
qualitative methods including interviews, observation and case studies. Representative 
sample of the informants were chosen from medical personal (change agent) and child 
and adolescent diabetic patients together with their families and caregivers (beneficiaries) 
Chapter Six seeks to provide an explanation of the discovery results and the answer to 
the research question: How contradictions between the different actors in defining and 
understanding the IP affect the main beneficiary (child) understand, define and be 
motivated to use the IP)? In simple terms, the explanation seems to be found in the 
contradictions that exist between the differing expectations of the three types of agent 
involved in this context, namely the change agents, patients and caregivers 
Chapter 1  Introduction 
 
 
 -25- 
Chapter Seven summarises the problem description, research question, critical review 
of the contribution is given, research limitation and Future research. 
 
 
Figure 1-3: Thesis Structure 
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CHAPTER 2 Literature Review 
2.1 Introduction 
This chapter seeks to provide a coherent theoretical background of the insulin pump (IP), 
specifically for readers who do not know about the insulin pump specification, benefits, 
drawbacks and readiness of the device. The structure of the chapter can be found in 
Figure 2-1, and begins by defining the concept of wearable devices. This is followed by 
a discussion of the underlying concept of IPs, as well as their technical and operational 
specifications. A discussion is provided of their main motivators (benefits) and de-
motivators (drawbacks). It also provides the readiness to receive the IP, as the proper and 
improper use of IPs is generally thought to be largely dependent on whether they are 
ready to use before and after adoption (Cogen et al., 2002; Weissberg-Benchell et al., 
2003; Grunberger et al., 2014). That will include the patient readiness, family readiness 
and role of education.  
 
Figure 2-1: Chapter 2 Structure 
2.2 Wearable Devices 
The term ‘wearable technology’ is usually deemed to include a range of devices that are 
mounted on the bodies of users, “such as “wearable computers, smart clothing, and 
functional clothing” (Dunne, 2004). The term is used to describe devices that may or may 
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not “compute” and which have been constructed to perform set tasks, to fulfil the needs 
of a specific target group (Malmivaara, 2009; Dunne, 2004). In broad terms, wearable 
technology can be classified as smart, interactive or digital clothing, referring to devices 
that have been combined into garments to add new functionality, such as the ability for 
information to be processed (Dunne et al., 2005). These kinds of modifications impart the 
ability for ‘intelligent’ or ‘smart’ clothing to react to environmental circumstances by 
sensing and adapting to local stimuli (Baurley, 2004). These types of clothing therefore 
constitute the integration of science with fashion, with several computerised functions. 
This research focuses on one medical wearable device, namely, the Insulin Pump.  
 
 
 
 
2.3 Insulin Pumps 
The first insulin pump (IP) was designed in the 1960s, by Arnold Kadish. While the first 
version was the size of a large backpack, these devices have become much smaller and 
more sophisticated in the years since, with many now being approximately the size of a 
small mobile phone. The improved development and design of these devices makes 
Smart 
medical 
wearble 
technology
Medical 
Functional 
clothing
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Figure 2-2: Smart wearable 
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insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), a 
viable alternative to the use of multiple daily injections (MDIs) (Reece, 2014; Marcus 
and Fernandez, 1996) in the treatment of conditions such as insulin-dependent diabetes 
(Reece and Williams, 2014; Bray, 2012; Heinemann et al., 2015). 
Modern IPs are small devices that generally weigh around 400 grams and are worn 
outside the body, such as on a belt. They contain insulin-filled cartridges that deliver 
insulin continuously through a thin tube is inserted internally (Duffy, 2015). Effectively, 
an insulin pump can be understood as, “an electro-mechanical device that mimics the 
body’s natural insulin secretion from pancreatic beta-cells by subcutaneously delivering 
rapid-acting insulin both at pre-set continuous basal rates and in extra bolus doses at 
mealtimes on demand” (Reece and Williams, 2014). 
These devices are therefore used by people who require the regular delivery of insulin to 
their body, such as individuals with diabetes. Pumps are programmed to deliver or ejects 
insulin continuously through the day, as well as to release supplementary doses of insulin 
to handle rises in blood sugar (e.g. after eating) (Bruttomesso et al, 2009; Danne et al., 
2008; Phillip et al., 2007).   As is evident from this outline, the existing literature on IPs 
is technically oriented, describing the technological artefact without taking into 
consideration its human aspects. Therefore, this research defines an IP as a medical 
wearable device that shall be continuously attached to the body so as to, if properly used, 
improve the quality of life of diabetic persons.  
2.3.1 Technical Specifications  
The components of the insulin pump include a  tank or called reservoir, a pump, and an 
infusion set (Schaepelynck et al., 2011, Reznik and Cohen, 2013). The reservoir functions 
in a manner like a syringe. It typically has the capacity to hold the supply of the insulin 
for 2-3-days, which functions with the battery-powered pump (Reece et al., 2014). The 
infusion set consists of tubing that connects the reservoir to a cannula (i.e. a tiny tube that 
delivers insulin subcutaneously); this delivers the insulin from pump to patient’s body 
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(Schaepelynck et al., 2011; Reznik and Cohen, 2013). The design of a representative IP 
can be seen below Figure 2-3. 
 
Figure 2-3: IP device attached to the body (adapted from HYDERABAD ENDOCRINOLOGY, 2016) 
A small piece of adhesive holds the cannula in place at the insertion site (see 
Figure 2-4(Reece and Williams, 2014), which is typically the upper arm, the upper thigh, 
or the abdomen. The infusion set is generally changed every 2-3 days, which also 
corresponds to the aforementioned capacity of the reservoir (Reece and Williams, 2014). 
Pumps deliver insulin through small tubing called a cannula into a catheter that is inserted 
into the skin. Insulin is then absorbed from the subcutaneous tissue (Heinemann et al., 
2015). 
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Figure 2-4: Insulin pump and infusion set (adapted from Reece & Williams, 2014) 
  
2.3.2 How it works 
The insulin pump (IP) offers another way to provide intensive insulin therapy, as opposed 
to the more common approach of MDIs (multiple daily injections), either using insulin 
pens or syringes. As with these more traditional methods, IPs still require the patients to 
undertake certain manual tasks, like carb counting and blood glucose monitoring, refilling 
the insulin reservoir, changing the infusion sets etc. (Kamble et al., 2013). 
Pumps deliver insulin in two ways. The first method involves the continuous delivery of 
basal rate insulin (Morrison and Weston, 2013). This describes small increments of 
rapid/short-acting insulin being delivered at specific intervals throughout the day in 
accordance with the baseline requirements of the patient (Sherr and Tamborlane, 2008; 
McAdams and Rizvi, 2016b). The specific dose is calculated to the needs of the individual 
and can be changed if necessary. The second mode of delivery is bolus insulin, which 
describes the insulin given with meals and snacks containing carbohydrates. This can also 
be used to correct high blood-glucose values (Everett, 2004; Bray, 2012; Błazik and 
Pańkowska, 2012).  
The calculation of bolus doses requires the user to know the number of carbohydrates that 
will be consumed and their current blood glucose level, which is then used to calculate 
the dose based on a number of factors. These include: the insulin sensitivity factor of the 
user, meaning the expected effect that a single unit of insulin will have on their blood 
sugar; the specific insulin-to-carbohydrate ratio of the user; and the remaining insulin that 
is active from their last dose (Rubin and Peyrot, 2010). For the insulin pump to be 
effective, it must be used safely: carbohydrate consumption must be counted and tracked; 
the blood glucose of the user must be checked four or more times every day; and the 
insulin dosage must be continually adjusted in response to these values, plus overall level 
of physical activity (Pickup, 2012; Approaches to Glycaemic treatment, 2015). Pumps 
are also able to deliver boluses that provide additional insulin boosts to account for 
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ingested carbohydrates or hyperglycaemia (Boyd & Boyd, 2008), or deliver corrections 
to adjust pre-meal blood glucose values (Klobassa & Moreland, 2013). 
Due to the fact that the IP is a relatively new technological improvement, patient readiness 
may be a critical factor in accepting this new technology (Heinemann et al., 2015), which 
may be exacerbated by the perception of benefits (e.g. theory of planned behaviour and 
theory of reasoned action) and drawbacks (Judith et al., 2012). In the following sections, 
these key factors are discussed in reference to the literature, as illustrated in Figure 2-5.  
 
Figure 2-5: Factors affecting the acceptance of new technology 
2.4 Benefits of IP for children    
The insulin pump offers a number of benefits and drawback. This section will discuss the 
perception of the positive using IPs in the treatment of children. The following section 
will discuss the negatives of using the IP. 
 Insulin pumps can be perceived from the medical (i.e. physicians) angle and non-medical 
(i.e. patient) angle. In general terms, the medical benefits tend to be more concerned with 
the patient materialistic system, whereas non-medical benefits are individual or soft 
(psychological) benefits. However, the patient considers both the medical and non-
medical benefit of the IP during the post transition. While often closely related, these two 
benefits can often be perceived differently, because the medical benefit provided by the 
IP will be perceived from the professional perspective of the patients having to control 
the diabetes. In other words, the outcome of diabetes technology management in children 
and families with type 1 diabetes is likely to be a clear impact on the quality of life and 
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glycaemic control (Hirose et al., 2012a). Having said this; the management of the insulin 
pump can impact the outcome medically and non-medically.  
Having precise insulin dosages enables the IP to be programmed and administered 
(DeVries et al., 2002), giving the patient increased flexibility in daily living with regard 
to a range of activities, such as mealtimes, travel, or work schedule (Davidson et al., 
2008). As quality of life measures have shown improvement with Insulin pump compared 
with traditional injection (Hoogma et al., 2006, McAdams and Rizvi, 2016a). In simple 
terms, the IP offers the benefit of glycaemic control, enabling a reduction to be made in 
the occurrence and severity of the difficulties of diabetes, as well as improving the 
flexibility of meal times, carbohydrate quantities, and physical activities (Cummins et al., 
2010).  
This section will highlight how the medical benefits and the procedures involved in using 
the insulin pump will also impact upon the non-medical benefits, as illustrated in 
Figure 2-6. 
 
Figure 2-6: Benefits of IP 
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2.4.1 Medical Benefits 
The main driver of medical benefits is mainly controlling the glycaemic level (American 
Diabetes Association; ADA, 2015). Glycaemic level is a medical term that describes the 
general levels of blood sugar (glucose) in an individual who is suffering from diabetes 
illness briefly explained by (Güemes et al., 2016), 
The effective control of glycaemic levels has become a key aspect of diabetes treatment 
(Tarnow et al., 2008). The important of this value has also been recognised in the 
management of the ongoing effects caused by the loss of pancreatic insulin-production 
capacity in type 1 diabetics (Adams, 2008). Studies have suggested that insulin pumps 
may improve glycaemic control for children and young people (Silverstein et al., 2005; 
Pańkowska et al., 2009; Pickup and Sutton, 2008; Phillip et al., 2007; Hirose et al., 
2012a). Several studies have reported that IP therapy leads to improvements in glycaemic 
control in children with type 1 diabetes, with the controlled glycaemic level leading to 
improved cognition, behaviour and emotions (Grunberger et al., 2014). 
The following section will discuss the outcomes of the management of glycaemic control 
by IP therapy. 
 Improves HbA1c levels 
The main medical benefit offered by IP therapy is the improvement of glycated 
haemoglobin (HbA1c) levels (Hofer et al., 2010; Moser et al., 2015; Cummins et al., 
2010; Olsen et al., 2015; Shalitin et al., 2008; Kesavadev et al., 2010). HbA1c testing 
shows the amount of glucose that sticks to the red blood cells, which is proportional to 
the amount of glucose in the blood (ADA, 2015). ADA (2015) states that when the Hba1c 
level of a person is higher than 7%, they experience what is known as the dawn 
phenomenon [early-morning increase in blood glucose] and marked variability in glucose 
from day to day (Scheiner et al., 2009); hypoglycaemic episodes requiring assistance or 
a lack of awareness about hypoglycaemia (Reece and Williams, 2014; Bode et al., 2002a; 
Scheiner et al., 2009). Importantly, intensive IP therapy has been shown to lower HbA1c 
if managed correctly (Alsaleh et al., 2013; Pickup et al., 2002). 
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 Reduces risk of hypoglycaemia and lessens symptoms of hyperglycaemia 
Hypoglycaemia and hyperglycaemia are terms that describe the problematic and even 
dangerous situation in which glucose levels are either significantly below (hypo-) or 
above (hyper-) normal levels. “Low blood sugar is described as a glucose level of 
<3.8 mmol/L (<70 mg/dL), whereas high blood sugar refers to levels of >6.1 mmol/L 
(>100 mg/dL) (Diabetes Management, 2016)”. Patients who are hyperglycaemic (high 
glucose) can also become momentarily hypoglycaemic, under certain conditions, such as 
not eating frequently or after energetic exercise. However, correct use of IPs can improve 
glucose levels and prevent anticipated hypoglycaemia from exercise or fasting. This 
ability to set basal profiles is considered to be a main benefit of IP therapy (Schade and 
Valentine, 2002). 
However, it should be noted that utilising intensive approaches to normalising blood 
sugar levels can increased the risk of the most dangerous version of hypoglycaemia by as 
much as three times. In this form of glycaemia, patients are unable to manage the episode 
alone and generally require aid from other individuals (Hilliard et al., 2016). Clinical 
studies have suggested associations between IP therapy and the reduced risk of severe 
hypoglycaemia, as well as the requirement for associated medical care (Sulli and Shashaj, 
2003, McAdams and Rizvi, 2016b; Al Hayek et al., 2015; Bruttomesso et al., 2009). 
Overall, these studies indicate that diabetes can be manageable with balanced medication 
via IP therapy.  
 Manages the “dawn phenomenon”  
The dawn phenomenon refers to the occurrence of particular high levels of blood glucose 
in the early morning, which is attributed to the release of specific hormones during the 
night (Bouchonville et al., 2014). This can be partially addressed by IP therapy, which 
enables the user to set basal profiles, effectively enabling insulin dosage to be prepared 
in order to meet anticipated changes in need, such as occurs during the dawn phenomenon 
(Schade and Valentine, 2002). 
 Manages the insulin resistance of Type 2 diabetes 
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IP therapy is well established in the treatment of type 1 diabetes, but its application in the 
management of type 2 diabetes is still under debate. For this reason, the health authorities 
of many countries still do not reimburse the costs associated with IP use in the treatment 
of type 2 diabetes (Reznik and Cohen, 2013). The IP therapy has been recognised in cases 
of extreme insulin resistance and poor glycaemic control among some patients with type 
2 diabetes (Garvey et al., 1985). It was found that while these patients received 40% less 
insulin than they had previously required, they were able to reach a lower mean glucose 
level overall. This was accomplished through the delivery of insulin “transiently by 
intravenous insulin infusion” (Reznik, 2013, s219). Heinemann et al., (2015) suggest that 
intermittent use of IP may be especially beneficial for use with type 2 diabetic patients 
who do not respond well to oral measures. This is predicated upon the idea that insulin 
resistance will be lowered in response to better control of blood glucose levels (Reznik 
and Cohen, 2013) 
2.4.2 Non-Medical benefits 
Although medical benefits are always perceived and noted by physicians, the non-
medical benefits are often focused on the patients. However medical and non-medical 
benefits are somewhat connected. Because of the IP medical benefits as well as the 
technological capabilities (e.g. programmable and easy to use technology), the literature 
widely supports the position that IPs improve the Quality of life of patients (Reece and 
Williams, 2014; Bode et al., 2002a; Scheiner et al., 2009).  
Insulin pumps are able to closely mimic normal pancreatic physiology by means of a 
number of advanced features, such as bolus calculators, extended and dual wave bolusing, 
and temporary basal rates (Nicholls and Partridge, 2015; Plotnick et al., 2003). These 
functions can offer young people and their families a greater sense of control over 
diabetes, more independence, fewer physical complaints, and more flexibility with diet 
and schedules, enabling IPs to offer greater Quality of life improvements than injections 
(National Institute for clinical excellence technology appraisal guidance, 2008; Hoogma 
et al., 2006); Walsh & Roberts, 2006; Barnard et al., 2007; Barnard et al., 2016; 
Brottomesso et al., 2009; Hanas, 2010; Hirose et al., 2012; Chase, 2010). Some studies 
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have also reported specific QoL improvements for parents, especially in terms of reduced 
stress and fewer worries about hypoglycaemia, coupled with high levels of satisfaction 
when their child successfully adapts to IP therapy (Mednick et al., 2004, Müller‐
Godeffroy et al., 2009). 
 Procedures benefits 
IP therapy offers flexibility and the benefits of controlling the amount of insulin delivered 
to the patient body (Bolderman, 2002; Walsh and Roberts, 2006; Hanas, 2010; Chase, 
2010; Morrison and Weston, 2012). As the patient needs to manually start the process, 
they are able to improve their glycaemic control by taking the opportunity to pre-bolus, 
which refers to a bolus of insulin given before it is actually needed to cover the quantity 
of carbohydrates eaten. This can affect the quality of life by basically pressing a button 
on the pump to adjust the insulin doses to match the desired levels of food intake and 
physical activity at a particular time (Chase, 2010). In this way, by informing the pump 
of the required quantity of insulin to inject, IP users are able to replicate the release of 
insulin that occurs during normal function of the pancreas.  As mentioned earlier (section 
2.3.2), this normal pancreatic function is mimicked in two ways: the continuous, slow 
release of insulin (basal rate) between eating episodes; and a higher release of insulin 
taken to pre-empt food intake (bolus rate) (Steineck et al., 2015). 
 Dietary freedom and meal time flexibility  
IP users can have dietary freedom and meal time flexibility by eating when and what they 
want (Bolderman, 2002; Walsh and Roberts, 2006; Hanas and Adolfsson, 2006). This 
often means that they feel less guilty about sweet foods and skipping meals (Shulman et 
al., 2016), which may be because basal rates are determined by health care providers in 
collaboration with patients themselves, with the rate set at a level that meets the ongoing 
daily requirements of the patient (Cope et al., 2012).  Furthermore, as the majority of 
pumps on the market are able to store more than one pre-set basal profile, patients are 
able to create contingencies that enable them to react to disruptive events more effectively 
and with less risk of under- or overdosing (Scheiner et al., 2009). 
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  Flexibility and freedom/ Insulin availability and convenience 
As outlined above, IP therapy often improves QoL by reducing the impact of diabetes 
through greater flexibility and freedom to use the desired insulin medication (Walsh & 
Roberts, 2006; Chase, 2010). IP therapy also avoids the side effects of multiple daily 
injections, which can be uncomfortable and can cause insulin resistance in some areas of 
the body (Krzymien et al., 2016). In contrast, the IP requires a single needle stick every 
2-3 days, after which the device is attached to the body, meaning that the insulin will be 
with the patient all the time (Nishio and Chujo, 2015). In addition, IPs can be programmed 
to deliver insulin as desired for the individual patient, enabling them to choose when they 
sleep, exercise and eat, which makes activities like travel or work more straightforward 
(Hirose et al., 2012). IP therapy has also been credited for the improved socialisation of 
diabetic children, with parents, school staff and the children themselves recognising the 
improvements that the greater flexibility affords to their lifestyles and development 
(Shulman et al., 2016) 
Diabetic patients on a programme of multiple daily insulin doses may take as many as 
1,460 injections of insulin per year. In contrast, pump sets are only changed every 2 or 3 
days, creating less pain and increase lifestyle flexibility (Golden and Sapir, 2012). This 
helps patients to feel better, have more energy and feel more in control of their diabetes 
Bruttomesso et al., 2002). 
2.5 Drawbacks of IP 
The introduction of IP technologies into the daily routine care of a user imposes both 
psychological and ‘time-effort’ burdens that many patients and their families will find 
demanding (Acerini, 2016). IP therapy requires more work than multiple daily injections 
(Shulman et al., 2016; Alsaleh et al., 2012; Darby, 2006; Rankin et al., 2015; Sullivan-
Bolyai, 2004). Despite the evidence which is currently available of the potential benefits 
of using advanced technologies in diabetes management from the perspective of patients 
and physician, there are some limitations noted in the literature (Giani et al., 2015; Shah 
et al., 2016). Figure 2-7 outlines a synthesis of the literature on the drawbacks of insulin 
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pump therapy. Examples of these include: the higher cost compared with multiple daily 
injections; the increased risk for subcutaneous infections; the inconvenience of being 
attached to a device; and a theoretical higher risk for diabetic ketoacidosis (Moser et al., 
2015); Shetty & Wolpert, 2010; Saarinen, 2014). The drawbacks have been organised 
into the following categories: medical, management, quality of life, and psychological. 
These factors will be discussed in greater depth in the following sections. 
 
 
Figure 2-7: Drawback of Insulin Pump Therapy 
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As an inherently complicated health intervention, IP therapy necessitates proper training 
to be given to the user and/or the parent or caregiver. This training must provide adequate 
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case of pump failure, effective estimation of carbohydrate intake, the management of 
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pump efficacy (Shulman et al., 2016). In the case of younger patients, all individuals who 
interact with the child must be able to offer support across a range of settings, including 
the home and at school (Phillip et al., 2007, Borus and Laffel, 2010; Shalitin and Phillip, 
2008; Alsaleh et al., 2012, Darby, 2006).  
In order to enable users to participate in certain events, the flow of insulin may be 
intentionally interrupted. Alternatively, the interruption may be unintentional, such as in 
the case of depletion of the insulin reservoir or battery failure (Wolfsdorf et al., 2006). 
The IP currently on the market do not warn against dislodgment or certain other types of 
failure, such as leakage (Phillip et al., 2007), meaning that a certain amount of manual 
blood glucose monitoring is recommended. Should the levels be outside accepted 
parameters, or when the users are feeling unwell, other tests should also be performed, 
such as the checking or urine or serum ketones. In this way, it should be possible to 
respond quickly enough to avoid Diabetic Keto Acidosis (DKA) (Bolderman, 2002; 
Walsh and Roberts, 2006; Bruttomesso et al, 2009; Hanas, 2010). DKA is most common 
when users are insufficiently prepared to deal with hyperglycaemia, with emotional issues 
being the most common reason for the failure to administer insulin appropriately 
(Pańkowska et al., 2005). Therefore, patients should be comprehensively trained in all IP 
functions, so they are able to react calmly and effectively (Shalitin et al., 2010). This is a 
major reason why IP initiation in young children requires testing to ensure that adequate 
supervision is available for important tasks, like blood glucose monitoring (Weinzimer et 
al., 2004). 
Additional training and the reliance on a new device can place a heavy burden on families 
during the initial training and adjustment period (Malik and Taplin, 2014). Therefore, the 
following section will discuss a number of procedural factors that can affect the proper 
use of the IP: taking the correct bolus of insulin, changing the site on time, carbohydrate 
counting, and ensuring the correct infusion site location (Pickup et al., 2014). 
 Taking the correct bolus insulin 
The most common non-mechanical issue with regards to IP usage among younger users 
is forgetting to administer bolus insulin doses (Hanas & Adolfsson, 2010). This task is 
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comparatively simple, particularly since all correctly programmed pumps have the ability 
to determine the right bolus dose of insulin (Heinemann et al., 2005; Morrison & Weston, 
2013; David & Curtis, 2013), as long as the user enters their current blood glucose level 
and the number of grams of carbohydrate to be eaten. However, children may 
intentionally or unintentionally neglect to administer their dose (Liberatore et al., 2004), 
leading children to have unnecessary episodes of elevated blood glucose. For this reason, 
most current IPs are able to display the history of the bolus insulin delivery time. This 
can be complicated by the potentially large degree of variability in terms of the basal 
insulin and total daily requirement for young users, due to variations in physical exertion, 
sleep or hormones (Holterhus et al., 2007). Adolescence age are particularly have difficult 
time, includes suboptimal adherence to diabetes routines as a result of developmental 
behaviours, change in family dynamics, and with social pressures (Shulman et al., 2016). 
Children behaviour can affect the correct use of the IP, such as the patient choosing to 
avoid using the device at a social event (Comeaux and Jaser, 2010a).  In literature, it was 
already mentioned that the caregiver responsibility in the management of the IP and need 
to take proper actions, for example setting reminder alarms on the pump doing the correct 
boluses measuring the carbohydrate etc. (Comeaux & Jaser, 2010; Compas et al., 2012). 
As also mentioned by Shulman et al., 2016, “Pump therapy is thus a complex health 
intervention that requires the user or caregiver to be appropriately trained in the 
estimation of dietary intake, how insulin is delivered, pump failure, management of blood 
sugar levels, the effects of activity, and sick day management.” (Shulman et al., 2016 
p.65).  
 Changing site on time 
It is important for the IP to be changed and kept clean in order to ensure that the device 
is working properly. For this reason, the cannula, tubing and reservoir should be changed 
every 2-3 days (see section 2.3.1) and the cannula should be inserted into a different area 
of skin. Users may not make the required change to the sites, for reasons like forgetting, 
not wanting to reinsert a needle into their skin, or a desire to save unused insulin 
(Heinemann et al., 2015). However, if the length of time between changes of the infusion 
set gets too long, or if the skin is not adequately prepared for insertion, then this may 
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increase the chance of skin infection (Heinemann and Krinelke, 2012) or high blood 
glucose (Taylor et al., 2014; Roemer, 2012; Pickup et al., 2014). Reasons for this include 
(Roamer, 2015): 
- Degradation of the tubing and reservoir insulin due to high temperatures; 
- Saturation of the tissue at the cannula site is saturated, preventing further insulin 
absorption; 
- Insufficient pressure in the reservoir to deliver the remaining insulin; 
- Insufficient insulin in the reservoir. 
 Carbohydrate counting 
When patients are on IP therapy, they must still calculate and monitor the precise level of 
carbohydrates present in any of the foods that they consume. These values must then be 
used to deliver the correct doses of insulin to match the spikes in blood sugar. These 
values must also be tallied against variations in meal size, exercise, and other insulin 
doses (Kesavadev et al., 2010) in order to ensure the delivery of accurate quantities of 
bolus insulin. If required, the patient is also able to pause or suspend the delivery of 
insulin by the pump, for a variety of medical reasons (McAdans & Rizvi, 2016) as this is 
outside the scope of this research.        
 Correct infusion sites 
The greatest common mechanical issues that happens with pump use is an incorrect or 
bad infusion site (Bolderman, 2002). The infusion site is the location of the insulin 
insertion. Which is the thin Teflon or stainless steel cannula that delivers the insulin to 
the tissue under the skin. Most cannulas are inserted manually, while others are inserted 
with a ‘spring-loaded’ insertion device (Taylor et al., 2014; Roemer, 2012). The problems 
that occur in this regard tend to occur when the cannula becomes uneven or crumpled 
when inserted, other occasion when the tip of the cannula is pressed against muscle or 
other tissue that does not absorb insulin as its best.  Even when the precise cause of the 
problem is unclear, the fact that an issue exists will be signalled by a rise (sharp or steady) 
in blood glucose. Importantly, the ‘no delivery’ alarm built into all IPs will only trigger 
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when the tubing or cannula is blocked, which means that there is no discernible difference 
in terms of whether the insulin is being delivered correctly or being wasted (Roemer, 
2012). 
ii Medical concern  
Technologies for diabetes management, such as IP therapy, are designed to help patients 
to achieve the recommended levels of haemoglobin HbA1c, as well as to assist in the 
prevention of diabetes complications like the progression of micro- and macro vascular 
complications4 (Giani et al., 2015). However, it should be noted that IP may not be the 
right management option for all individuals with insulin-requiring diabetes and should 
therefore only be considered as “one of a range of options” (Morrison and Weston, 2013). 
Even when IP therapy is the most appropriate course of treatment, it is not necessarily 
without complications. Close monitoring should therefore be maintained to guard against 
outcomes that include infusion site issues, user error, pump failure, or blockages with any 
part of the infusion set (Heinemann et al., 2015; Suh et al., 2015). In this way, users can 
therefore be visible to major and potentially serious hazards: interruption of insulin 
infusion can result in hyperglycaemia and DKA, as well as delivery of excessive insulin 
which can cause severe hypoglycaemia. On the other hand, the available evidence on the 
safety and efficacy of IP remains limited (Heinemann et al., 2015).  
 Risk of Hypoglycaemia  
It is mentioned in the literature that inappropriate insulin administration, whether 
intentional or otherwise, can result in IP therapy causing hypoglycaemia (Shalitin and 
Phillip, 2008) Hanas & Adolfsson, 2006). Therefore, effective adjustment of the insulin 
dosage in the IP is essential, with viable strategies including the consumption of 
                                                 
4 “Diabetes is associated with both microvascular and macrovascular diseases affecting 
several organs, including muscle, skin, heart, brain, and kidneys”Cade, W. T. (2008) 
'Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy 
Setting', Physical Therapy, 88(11), pp. 1322-1335.. 
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carbohydrates immediately prior to exercise, consciously delivering a smaller bolus for 
the meal before exercise, or reducing the basal rate before exercise (Scheiner et al., 2009). 
 Infusion site reactions  
Users of the Insulin pump may experience allergic reactions to the skin and other skin 
irritation from the adhesive on the back of an infusion set. The precise type of reaction 
can differ according to the type of infusion set, the manufacturer, or the characteristics of 
the individual user (Bolderman, 2002; Walsh and Roberts, 2006; Bruttomesso et al, 2009; 
Hanas, 2010). Additionally, “skin irritation, lipohypertrophy, scarring and infusion site 
infections” (Shalitin and Phillip, 2008) have been recorded (Heinemann et al., 2015; 
Hammond et al., 2007 ). 
 Weight gain  
Previous studies have demonstrated that one of the unforeseen outcomes resulting from 
the higher level of flexibility afforded by IPs is the possibility of greater weight gain than 
experienced by patients using other therapies (Shalitin and Phillip, 2008, Plotnick et al., 
2003; Weintrob et al., 2003; Hanas and Adolfsson, 2006). This has been observed among 
users with a poor control over their diabetes (HbA1c 8%), who may experience weight 
gain after a few months of transitioning from multiple daily injections to IP therapy 
(Scheiner et al., 2009). Long-term pump use may cause side-effect of weight gain 
(Gender-Frederick et al., 2011; Weissberg-Benchell et al., 2003)  
 Risk of diabetic ketoacidosis (DKA) 
An important risk associated with IP therapy can be attributed to the “lack of a 
subcutaneous depot of intermediate- or long-acting insulin and the short half-life of serum 
insulin” (Shalitin and Phillip, 2008), which has the effect of increasing the susceptibility 
of patients to “ketonemia and DKA secondary to dislodgment or occlusion of the infusion 
set or pump failure”  (Shalitin and Phillip, 2008). This is important because of the serious 
repercussions of untreated DKA and the rapid onset time should a malfunction occur with 
the infusion set or insulin delivery. Unlike multiple daily injections, which creates a safety 
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net of long acting insulin, patients on IP therapy can experience ketoacidosis (DKA) 
within as little as 7-8 hrs (Bode et al., 2002b) (Cryer, 2012). 
iii Quality of life  
Numerous factors associated with insulin pump use may negatively impact QoL (Rankin 
et al., 2015). These factors include: the weight of obligations on the patient and their 
family (Phillip et al., 2007); more work for parents and other caregivers (Rankin et al., 
2015) (Lange et al., 2014); the need for comprehensive education (Lange et al., 2014); 
the fact that the device is not beneficial for long term use (Heinemann et al., 2015); the 
importance of proper management and procedures (Weinzimer et al., 2004, Shalitin et al., 
2010); school related issues (Hirose et al., 2012a) ; and the cost of the IP and its infusion 
sets (White et al., 2014; Cummins et al., 2010). 
 Weigh heavily on the patient and their family: 
The decision to participate in IP therapy can be significant for a patient and their family, 
with requirements for additional training and supervision placing a strain on the 
relationship between young patients and their parents or their caregivers at school (Phillip 
et al., 2007). For this reason, in order for the diabetes treatment to be successful, a heavy 
burden is placed on children to ensure self-management, meaning that younger users will 
generally require external assistance to ensure the effectiveness of their treatment (Hirose, 
2012). Overall, parental support is related with good glycaemic control in children 
(Hirose et al., 2012; Neylon et al., 2013; Hilliard et al., 2013; Hilliard et al., 2016) and 
this is subsequently linked with better life satisfaction in parents (Nylon et al., 2013; Hood 
et al., 2013). 
It have been said that there is more work for parents and/or the caregiver in taking on 
responsibilities for which they may not have been initially aware or prepared (Rankin et 
al., 2015). Alsaleh et al. (2012) argue that IP therapy actual entails more work than MDIs. 
This is sometimes exacerbated by difficulties that parents experience in involvement 
responsibility for their child's diabetes with others. For example, some parents reported 
difficulties getting schools to assist in pump management (Shulman et al., 2016, Low et 
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al., 2005); others perceived the complex pump management as a barrier to their ability to 
leave their child with outsiders (Duffey, 2015). 
This illustrates that pump initiation may be stressful for parents because of the demands 
of learning a new technology and because of frequent blood sugar testing. Further, 
unrealistic expectations regarding the potential benefits of the pump may be 
counterproductive and may in fact lead to disappointment. 
 Risks associated with prolonged usage:  
From a clinical perspective, the daily use of devices including automated parts in wide 
range of conditions poses considerable challenges to performance. This is important, as 
the consequence of this complexity and the intended duration of use means that “the 
precision of insulin infusion rates over the life span of a pump might be acceptable at the 
time of manufacture but may not be as precise following several years of real-world use” 
(Heinemann et al., 2015). Given that the pump will be worn for long periods and during 
everyday activities that can potentially damage it, such as sports, both the design of the 
device and strategies for its effective use need proper consideration (Potti and Haines, 
2009).  
However, this issue is complicated by the fact that some users may find that it 
uncomfortable or unwieldy to continually wear the pump and infusion set tubing, even 
when it has not been designed to be especially sturdy (Bächle et al., 2013, Bolderman, 
2002; Walsh & Roberts, 2006; Hanas, 2010). However, the pump must be worn while the 
user sleeps, works and plays, in order to ensure the delivery of a continuous flow of 
insulin (Millstein et al., 2015). 
 Cost of IP  
Generally speaking, in most countries, traditional insulin injections are the cheapest and 
most cost effective option for insulin treatment (Cummins et al., 2010). Pumps cost 
around £2500–3000 each, plus an additional annual fee for the various consumables 
required to operate the device, which can constitute a significant additional expense. 
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These consumables, including tubing, cannulas, batteries and reservoirs, typically cost 
£1,000–2,000 per year extra. It is also important to factor in the costs involved in the cost 
of providing education in the use of the device for caregivers as well as the patients 
themselves, including both the initial training and ongoing support, where required 
(White et al., 2014). 
As Insulin pump is more high-priced than MDI, few health care and insurance systems 
will only repay the supplementary costs when they judge the health of the patient show 
evidence of significant benefit (Heinemann et al., 2015). Despite all of these 
considerations and especially the significant financial investment involved, it is important 
to note that a percentage of those who ask for IP therapy fail to meaningfully improve 
their HbA1c (Schade and Valentine, 2006).  
iv Psychological stress 
Although clinical factors were mentioned. The social and psychological factors were 
obvious reasons for both the reluctance to try the pump therapy and the decision to 
discontinue therapy (Seereiner et al., 2010). The dependency on an external mechanical 
device can also have a number of physical or emotional side effects for some users, which 
may be exacerbated by the fact that the patient is connected more or less 24 hours per 
day. Unlike more traditional injection therapy, the presence of the IP device clearly 
indicates to others that the individual suffers from diabetes (Nicolucci et al., 2008), as 
well as continuously reminding the patient of the presence of the disease (Torrance et al., 
2003; Pickup et al., 2014; Cope et al., 2012; Forlenza et al., 2016). Hiding the device 
from others may even reinforce these negative emotions, potentially contributing to a 
growing sense of alienation, a poor self-image, and even cause lack of confidence or fear 
(Gonder-Frederick et al., 2010). 
Constant reminder 
One of the most important negative aspects to IP therapy is the presence of the device 
itself and the fact that this serves as a reminder of the disease being treated (Ramchandani 
and Heptulla, 2012). Although few patients discontinue insulin pump therapy because of 
the constant reminder (Hofer et al., 2010a, de Vries et al., 2011), it is important to note 
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that this weakness is not found in treatments like multiple injections, which allow patients 
to forget about diabetes after having the needle injection by the traditional insulin pen and 
afterword hides it in the bag (Raphael, 1999). 
Wearing a pump, despite it being about the size of a cell phone, can be difficult for some 
people, with a level of disruptiveness that has led some patients to state that its use is “like 
getting diabetes all over again” (Chase et al., 2007, p. 13). Adolescents report numerous 
practical challenges in wearing the pump unobtrusively (Alsaleh et al., 2012, Ritholz et 
al., 2007). This may explain the higher rates of pump discontinuation amongst adolescent 
patients (Hofer et al., 2010b), because teenagers are extremely image conscious (Alsaleh 
et al., 2012; Forlenza et al., 2016). This is particularly exacerbated among female patients, 
who are perceived to have greater risk of body image issues (De Wit & Snoek, cited in 
Mameli et al., 2014), which has been suggested as a risk factor for pump discontinuation 
(De Vries et al., 2011; Babar et al., 2009; Alsaleh et al., 2012, Ritholz et al., 2007) 
Bolderman et al., 2016; Hanas, 2010; Chase et al., 2007).  
2.6 Readiness to receive the IP  
The first stage in adopting the IP is the screening process, during which physicians 
recommend the patients to use the IP. This is because the particular characteristics of a 
patient are integral to the successful use of the device (McAdams and Rizvi, 2016b) , 
meaning that this decision those who may be noncompliant on insulin injection regimens 
or who do not meet certain requirements, as discussed below, are more likely to do badly 
on IP therapy and are generally therefore not selected (Grunberger et al., 2014; Pickup & 
Keen, 2002).  
The main challenge inherent in adopting any new technology as a medical solution is how 
much the patient and his family are ready to use it. The concept of technology readiness, 
meaning the “propensity to embrace… new technologies for accomplishing goals in home 
life and work” (Parasuraman, 2000), is typically used in conjunction with general use 
technologies in home and work. However, it can be a useful theoretical lens for 
understanding the adoption of new medical wearable devices, with a positive relationship 
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to optimism and innovativeness and a corresponding negative relationship to discomfort 
and insecurity. When this theory is applied to the adoption of the IP among young 
patients, the optimism and positivity towards innovativeness that is common among 
children does not necessarily guarantee success (Godoe and Johansen, 2012) . Indeed, 
children may look at this wearable device as a new version of traditional approaches using 
needles. This area has not been adequately explored in terms of the use of medical 
wearable devices. 
Another framework can be used for understanding the level of readiness among patients 
is the actors network theory, which shows that the interaction of beliefs, attitudes and 
behaviours of different actors shape the belief of the main actor (Pollack et al., 2013) (i.e. 
the patient in the current research) and therefore behaviour toward a certain object 
(Latour, 2005). Therefore, this study only investigates the patient and his surrounding 
circle (physicians and his family) actors, rather than focusing on the other two actors (the 
healthcare and dedicated follow up team) Figure 2-8.  
 
Figure 2-8: Scheiner et al., (2009) factors related to successful initiation of Insulin Pump therapy 
Therefore, this section will discuss the readiness towards adopting the IP to understand 
the different perspectives of the readiness’s of different actors, which is the patient 
readiness and family readiness, and readiness on the education readiness Figure 2-9. 
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Figure 2-9: Readiness elements 
2.6.1 Patient Readiness 
The assessment of the readiness of patients to receive IP therapy requires the 
consideration of several factors (Grunberger et al., 2014; Phillip et al., 2007; Liberman et 
al., 2014; ADA, 2004). Individuals are recommended for IP therapy based on their 
personal and psychological suitability, or in other words their physical and mental 
capacity to manage full adherence to IP protocols over a protracted period of time 
(Lawton et al., 2016). The literature describes several factors as being essential in 
achieving success in the use of IPs (see Figure 2-10), namely: background and knowledge 
of the patient; the psychological readiness of the patient; and their physical readiness to 
receive the IP.  
 
Figure 2-10: Factors of patient to be essential for achieving success in using the IP 
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i Background and knowledge readiness  
Grunberger et al. (2014) argue that successful implementation of IP is largely dependent 
on the skills, knowledge and resources to utilise this form of insulin therapy in a manner 
that is both effective and does not bring undue risk to participants. This means that the 
careful selection of both clinicians and patients is essential.  
IP therapy can normally be initiated when the diabetic patient is familiar with 
management of the device and associated tasks, such as carbohydrate counting 
(McAdams and Rizvi, 2016b).  With regards to the minimum age of patients, some argue 
that the IP should be limited to adults, with the cognitive and emotional development of 
children requiring patients to be at least 15 years old before commencing therapy (Cogen 
et al., 2002). However, Fuld et al. (2010) argue that patients of 15 and under should be 
considered, although the selection process should be conducted on an individual basis. 
The age at which the child will have the capacity to administer the functions of an IP 
independently is likely determined by numerous factors, but especially their maturity and 
physical aptitude (Klingensmith et al., 2001). As a consequence of this, there are no 
universal guidelines for the acceptable age to begin IP therapy (Cogen et al., 2002), 
although there is broad agreement that patient age and period of diabetes should not be 
main causes in determining when patients transition from injections to IP (Grunberer et 
al., 2014). It should be noted that the achievement of target HbA1c requiring greater 
efforts from the patient in the management of the IP (Olsen et al., 2015). 
In summary, patients who are 15 years old or younger can use IPs, taking into 
consideration various psychological and knowledge factors. The focus of this research is 
therefore to identify and analyse these psychological and knowledge factors with respect 
to the ages of patients.   
ii Psychological Readiness (motivation) 
According to scientific and professional literature, candidates for IP should satisfy the 
prerequisites of wanting to undergo IP therapy and being willing to perform the required 
procedures (Heinemann et al., 2015), like carbohydrate counting, frequent blood glucose 
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monitoring (typically 4-6 times per day) and participating in ongoing clinical support 
(Reece and Williams, 2014, Scheiner et al., 2009), as well as following manufacturer 
guidelines about how often IP components like the infusion set are changed.  
Willingness means the desire and motivation to do as well as the ability to perform. This 
means that the ideal candidate IP therapy is an individual who wants better glycaemic 
control, is well-informed about the various aspects of diabetes self-care, and who is 
motivated to take the steps to ensure their own health (Scheiner et al., 2009). Second, the 
motivations should be managed through the IP lifecycle.  This argument is supported by 
studies of emerging technologies which recommend the incorporation of standardised 
psychosocial measures in the evaluation of QOL and treatment satisfaction in addition to 
glycaemic control (Franklin, 2016). Research suggests that the greater flexibility afforded 
by IP therapy, and the corresponding benefits to independence and social life, makes this 
approach to insulin management particularly valued by young adolescents (Shulman et 
al., 2016). 
iii Physical readiness 
Success with IP therapy requires a thorough assessment of the physical and psychological 
readiness of a prospective candidate to meet the particular challenges involved in living 
with the device. Using the IP is not easy for a patient of any age or abilities, as it is a 
highly specialized gadget that requires developed self-management activities (Tobergate 
et al., 2013) which needs physical abilities for effective operation (Alvarado-Martel et 
al., 2015). In other words, the patient needs to press a button on the insulin pump and 
choose the appropriate dose. Injecting the appropriate insulin dose requires skill: “the 
intake of carbohydrates, the actual blood glucose level, physical activity, infection and 
stress are examples of variables that must be considered before the injection” (Sjöblad 
2008; Bangstad et al. 2009). 
Furthermore, the device requires programming and constant interaction from the wearer 
(Liberman et al., 2014). The consequence of this is that the long-term success of IP 
therapy is largely dependent on regular, accurate self-monitoring of blood glucose levels, 
supplemented by a readiness and ability to stay in contact with the professional team 
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associated with the device (Liberman et al., 2014). Bolderman (2013) adds that physical 
readiness to be a candidate (and/or parent(s) of a pump candidate) for IP therapy include 
a range of factors: the physical ability to view the pump screen and hear the alarms; 
sufficient dexterity to insert or charge the pump battery, and fill and replace the insulin 
cartridge/reservoir in the pump; the capability to insert an infusion set; a willingness to 
wear the pump; and the capacity to perform any other technical functions (Grunberger et 
al., 2014).
 
 
2.6.2 Family Readiness 
Because the scope of this research is to investigate the use of IP in adolescence (age<15), 
the role of family is discussed thoroughly because it has an immerse impact as illustrated 
in literature. Successful IP therapy in young children requires parents or caregivers to 
monitor, adjust and even ensure the delivery of insulin (Klingensmith et al., 2001,Cope 
et al., 2012), as well as to enter temporary basal rates (Forlenza et al., 2016), and to 
increase or decrease bolus doses for food consumed (Alsaleh et al., 2013). The children’s 
primary caregivers therefore need to be readily available to the children (Franklin, 2016). 
The consequence of this is that the possible effects on parents should be investigated, 
because parental involvement is inversely correlated with HbA1c in children treated with 
IP (Phillip et al., 2007).  
In effect, when the patient is a child of preschool or elementary school age, the actual 
user of the IP becomes the parent or caregiver. The result of this is that pump initiation is 
a more complicated process for young children (Klingensmith et al., 2001). The ADA 
emphasises that adult supervision remains important for older children and adolescents, 
and therefore full independence in the management of insulin should be attained 
gradually, with adult supervision being available until complete competence is assured 
(Silverstein, 2005). After careful analysis of literature, family readiness can be classified 
into psychological and knowledge readiness, which are discussed in greater detail below.  
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Figure 2-11: Factors of family to be essential for achieving success in using the IP for child 
i Family Psychological Readiness  
The ideal diabetic candidate for insulin pump therapy should have a motivated family 
who are committed in monitoring the blood glucose as a minimum four times per day and 
who have a working understanding of fundamental diabetes management, mainly 
carbohydrate counting, blood glucose measuring, and insulin sensitivity (Grunberger et 
al., 2014). The family or the caregiver should be motivated to encourage patients and to 
follow up with their children, as: 
“Encouraging parents to remain involved in monitoring the blood glucose and 
interpretation and reducing family conflict during adolescence may prevent 
deterioration of glycaemic control common in this age group” (Laffel et al., 2003) 
This is supported by other studies, which have found that parental involvement is 
associated with better glycaemic control in children (Neylon et al., 2013; Wu et al., 2014). 
This relationship between parents and their children is an important element in the success 
of IP therapy (Williams et al., 2004), with some suggesting that parents should assume 
over-arching responsibility for the management tasks related to their child’s diabetes 
(Silverstein et al., 2005). In this way, adolescents and older children could also be 
encouraged and empowered to use the pump appropriately with continued support from 
parents. 
Many parents of children with type 1 diabetes fear that hypoglycaemia may have 
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this reason, they are typically concerned with the complications of diabetes and therefore 
want to ensure continued control over their child’s glycaemic level (Hirose et al., 2012, 
Faulkner and Clark, 1998). It is common for parents to expect that achieving better 
glycaemic control through correct IP usage will result in fewer and less serious 
complications (Sullivan-Bolyai et al., 2004, Low et al., 2005). These fears and 
expectations may influence on parenting styles and the child’s corresponding physical 
and psychological health (Weinger et al., 2001; Anderson et al, 1991).  
ii Family knowledge readiness 
Before young children adopt the use of IP, an examination must be conducted into the 
readiness of caregivers to take responsibility for important tasks, like the monitoring of 
blood glucose levels (Phillip et al., 2007). Another important factor is parental knowledge 
of pump functions, which is strongly correlated with better outcomes. In contrast, parents 
who are less skilled with pumps are more likely to transfer responsibility for diabetes self-
management to their children, with measurably worse glycaemic outcomes (Mitchell et 
al., 2013). Indeed, diabetes technologies can inhibit parental involvement by exposing the 
‘digital gap’ that may exist between young people, who have grown up in the digital 
generation, and their parents, who often find technology less intuitive (Liberman et al., 
2014). 
Given the widespread agreement about the importance of the assessment of caregivers 
(Weinzimer et al., 2004), health care providers should therefore encourage pump 
competency among parents and a willingness to work with their child and healthcare 
professionals in order to ensure they can optimally support their children (Ritholz et al., 
2007; Hirose et al., 2012). Liberman et al. (2014) explain that when patients change to 
intense insulin regimens, such as the use of insulin pumps, this typically requires more 
education for parents or caregivers, such as in dealing with unexpected eating patterns, 
extreme glucose variability, and inconsistencies in insulin sensitivity. This means that 
parents must be willing to learn new but potentially challenging skills, such as the 
adjustment of doses, the insertion of infusion sets, or the operation of insulin pumps. The 
majority of parents become competent at these tasks within 1.5 to 9 months after therapy 
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begins (Sullivan-Bolyai et al., 2004). There may also be worries for parents, such as 
whether the children is receiving an incorrect dose of insulin, whether the button might 
be pressed accidentally to deliver insulin when it is not needed, or whether there may be 
problems with the technology, such as malfunctions (Hirose et al., 2012b). Although 
these worries are legitimate, effective preparation and education should help to ensure 
correct management of the IP. 
In summary, the role of family knowledge is immersing in the children proper IP use. 
This shall be reflected in assessing the family knowledge to have a confident supervision 
on their children in using the IP. 
2.6.3 Readiness improvement and education before using the IP 
The selection of candidates for pump therapy is necessary (Scheiner et al., 2009). The 
patient should be well educated on the management of the insulin pump, with the training 
having been based on a full assessment of the person’s attitudes, beliefs, learning style, 
ability and readiness to learn, existing knowledge, and goals (Lange et al., 2014). The 
patient education should also include the principles of basal-bolus insulin therapy and 
sick day management (Saboo & Talaviya, 2012; Reece and Williams, 2014). Perhaps the 
most important factors for patient success, and therefore the focus of the training, is the 
willingness and ability to conduct frequent blood glucose monitoring, coupled with 
realistic expectations of the benefits of IP therapy. Overall, this approach has been said 
to require, “an above- average level of diabetes management, more intensive patient 
education and training, and close follow-up” (Carrihill et al., 2013 cited in Amod et al., 
2013). Therefore, before transiting to the actual use of the insulin pump, education should 
be provided for insulin adjustment for exercise, prevention and treatment of hypo- and 
hyperglycaemia, carbohydrate counting, and important procedures like site preparation 
and infection obstacle (Saboo and Talaviya, 2012). 
Well-educated patients can affect the success of IP therapy (Grunberger et al., 2014), with 
sufficient knowledge of IP use to manage insulin helping to prevent complications, ensure 
better adherence to therapy and leading to better overall glycaemic control (Jasper, et al., 
2014). Thus, the family still require adequate education and support on IP use, especially 
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for young infants (Wilson, 2002, Brink et al., 2009, Doyle et al., 2004, Phillip et al., 
2007). The education for IP therapy is provided to the child with their parents and 
caregiver by a diabetic educator (Bolderman, 2013), and should be delivered in a 
structured, curriculum-based programme that prepares the individual to deal with the 
worst-case scenario (Bolderman, 2002 cited in Morrison & Weston, 2013). Each 
individualised education plan normally spreads learning over several weeks, with at least 
three 1-3 hour visits by the diabetic educator. The plan requires a thorough understanding 
of the knowledge that the patient has of diabetes, their personal learning style, and any 
knowledge defects they may have (Bolderman, 2014). These programmes seek to reduce 
the resistance or fear of the patient and their family with regards to the IP, thereby 
improving the ease and effectiveness of the adoption process.  
2.7 Chapter summery 
The IP as a wearable device that is programmed to maintain the steady level of insulin in 
the blood and is thus expected to improve patients’ medical condition as well as quality 
of life. In this chapter a theoretical background of the insulin pump (IP) was discussed 
with reference to the literature of different disciplines relevant to the research question – 
what are the reasons for the improper use of IP? In order to set this theoretical background, 
this chapter assumed that the main reason for the improper use is the perception of 
benefits, drawbacks and readiness to use the IP as shown in Table 2-1. Benefits found in 
literature were medical benefits and non-medical benefits (i.e. diabetic patient quality of 
life). The drawback of IP in both respects is well documented in the literature, covering 
several aspects, namely, medical, management, quality of life and psychological. Lastly, 
the readiness towards adopting the IP has been discussed and consolidated from the 
literature to understand the different perspectives of the readiness’s of different actors, 
which is the patient readiness and family readiness, and readiness on the education. 
Therefore, these elements were discussed in order to bring together multi-disciplinary 
literature sources on the medical, technological and psychological factors that influence 
the use of IP as a wearable device. 
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The main point of this chapter is Thus; it is not clear why do some patients misuse the IP. 
The IP benefits seem to be much higher than the drawbacks and also the readiness is not 
the only major determinant of the quality of use of the IP.  Therefore, the next chapter is 
to address different psychological, behavioural and social literature papers are consulted 
to develop a theoretical foundation for doing the understandings of this phenomenon 
Table 2-1: Summary of IP for children 
Benefit of 
IP 
Medical 
benefit 
Improves HbA1c level 
Reduces risk of hypoglycemia 
and lessens symptoms 
Manages the “dawn 
phenomenon” 
Manages the insulin resistance 
of type 2 diabetes 
Hofer et al., 2010; Moser et al., 2015; 
Cummins et al., 2010; Olsen et al., 
2015; Shalitin et al., 2008; Kesavadev 
et al., 2010 
Al Hayek et al., 2015; McAdams & 
Rizvi, 2016; Sulli & Shashaj, 2003 
Bouchonville, Jaghab, Duran-Valdez, 
Schrader, & Schade, 2014 
Heinemann et al., 2015;  Reznik & 
Cohen, 2013) 
Non-
medical 
benefit 
Procedure benefits 
Dietary freedom and meal time 
flexibility 
Flexibility, freedom of insulin 
availability and convenience 
Steineck et al., 2015;  Hanas, 2010; 
Chase, 2010; Morrison and Weston, 
2012  
Shulman et al., 2016; Cope, Samuels-
Reid, & Morrison, 2012) 
Krzymien et al., 2016; Nishio & Chujo, 
2015 
Drawback of IP 
Require Proper management Malik & Taplin, 2014; Borus & Laffel, 
2010; Shalitin et al., 2010 
Medical concern  David & Curtis, 2013; Pickup et al., 
2014; Suh et al., 2015 
Quality of life Rankin et al., 2015; White et al., 2014; 
Lange et al., 2014 
Readiness 
to receive 
the IP 
Patient 
Readiness 
Background and knowledge 
readiness 
Psychological Readiness 
Physical readiness 
Grunberger et al. 2014; Olsen et al., 
2015 
Heinemann et al., 2015; Reece and 
Williams, 2014, Scheiner et al., 2009 
Liberman et al., 2014; Bolderman et 
al., 2013 
Family 
Readiness 
Family psychological readiness 
Family knowledge readiness 
Wu et al., 2014; Grunberger et al., 
2014; (Hirose et al., 2012b) 
(Mitchell et al., 2013; Hirose et al., 
2012b; Mitchell et al., 2013 
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Readiness improvement and education 
Lange et al., 2014; Saboo & Talaviya, 
2012; Reece and Williams, 2014;  
 CHAPTER 3 Theories in Adoption of IP in Children 
3.1 Introduction 
The aims of this chapter are twofold. The first is to try to answer the research question 
(why some children use the IP improperly after its adoption) building on the research 
findings from literature. However, an investigation of the extant literature on the use of 
IP has not provided clear identification of the causes of misuse, therefore the main 
research question of this study remains unanswered. The second aim of this chapter is to 
develop theoretical foundations that can be used later in the following chapter for building 
the analytic framework that will provide the answers sought. 
According to the literature covered in the previous chapter, IP has several benefits for the 
patient and his/her family. Therefore, according to the Technology Acceptance Model 
and the Theory of Reasoned Action, perfect use of the IP can be expected because of the 
perceptions that these patients have of its benefits. Despite these benefits, there are some 
cases of patients who struggle and misuse the IP, or the IP is not seen to be improving 
their diabetes, as already discussed in chapter 2. Therefore, different psychological, 
behavioural and social literature papers are consulted here in order to develop a 
theoretical foundation for improving our understanding of this phenomenon. This 
chapter, as illustrated in Figure 3-1, will therefore first highlight and explain the theories 
in adapting the IP (TAM, TRA, TPB and HBM). Secondly, the behavioural models in 
accepting and rejecting medication by the patient the perception of benefits will be 
discussed. Thirdly, the sociological themes to develop the theoretical foundations for 
understanding how the child reasoning, attitude and perception are formulated. 
This will address the knowledge gap identified in the approaches to technology adoption 
and the actual practices of IP use in particular circumstances (in this study, the misuse of 
IP by children and adolescents where the role of caregiver is important). The key 
objective of this research is to consider how the person perceives and defines the 
technology and how their perceptions affect their attitude toward it and therefore the use 
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of it in everyday life. The adopted framework for understanding how perceptions are 
formulated is based on socio-materiality theory and is focused on the contradictions 
between different actors in the understanding of the technology.
  
Figure 3-1: Chapter 3 Structure  
3.2 Theories of Accepting New Medical Technologies 
Since medical wearable devices have certain unique challenges, a range of new 
frameworks have been developed to better understand these technologies. One of the most 
important of these, Ajzen and Fishbein’s theory of reasoned action (TRA) (Ajzen, 1991), 
which is of fundamental importance in the technology acceptance research discipline. 
This framework and has been customized in the IT context into the theory of planned 
behaviour (TPB) and the technology acceptance model (TAM). These are paralleled with 
and supported by several technology readiness models and innovation diffusion models. 
Finally, attempts have been made to develop a unified model that integrates all of these 
concepts into one cohesive whole, the best known of which is the Unified Theory of 
Adoption and Use of Technology (UTAUT) developed by Venkatesh et al. (2003). 
The TRA suggests that stronger intentions lead to increased effort to perform the 
behaviour, which also increases the likelihood for the behaviour to be performed (Ajzen 
and Fishbein, 1975). They suggest that two main factors, attitudes and subjective norms, 
determine the intention (ibid). Downs and Hausenblas (2005) added that “people’s 
intention, or motivation, is the main determinant of their behaviour” (p.4). Intention is 
influenced by people’s attitude (e.g., positive/negative evaluations developed from 
behavioural beliefs) and subjective norm (e.g., perceived social pressure to comply with 
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important others’ wishes formed from normative beliefs). The surrounding environment 
also plays an important role in determining behaviour. Badewi et al. (2013) explain that 
subjective norms (i.e. how others perceive what you do) and one's attitude (i.e. how one 
feels toward the technology) drive behaviour in particular ways. However, this argument 
can be criticized in the context of the insulin pump (IP), as the friends of a patient may 
not be using the IP, which makes the person stand out in the crowd, potentially making 
the user more noticeable or uncomfortable. This incidence of shyness in this context is 
more pronounced in developing countries than the advanced countries (Hofstede, 2010), 
therefore extra care should be taken to foster adoption in these environments.  
In the 1970, the Theory of Planned Behaviour (TPB) was proposed by Ajzen in an attempt 
improve the predictive power of the TRA, by taking into consideration perceived 
behavioural control (Ajzen, 1991). The TPB states that there are three kinds of categories 
of behaviour to consider (Ajzen et al., 2011): behavioural beliefs, which describe the 
understanding and evaluation of the most probably outcomes of particular actions; 
normative beliefs, which are concerned with the expectations of others and the 
corresponding motivation to modify behaviour to ensure compliance with these ideas; 
and control beliefs, which are concerned with the power of certain factors to either 
support or hinder the actualisation of certain behaviours. In a similar vein to the concepts 
in TRA outlined above, attitude in TPB refers to how one generally feels towards the 
object of the study (i.e. the IP in this research) (Fishbein and Ajzen, 1975). Perceived 
control can include both obligatory and voluntary usage (Fishbein and Ajzen, 1975; 
2010). Subjective norms, which are defined as norms of attitude and behaviour that are 
considered normal, typical or average, are used to describe whether or not others approve 
of a given behaviour (Armitage et al., 2001).  
The TRA has been further developed in many important directions, perhaps the most 
influential of which is the technology acceptance model (TAM) (Delone and McLean, 
2011). Davis's TAM (Davis, 1989) is one of the most commonly used theories within the 
field of technology adoption (Şener et al., 2015). In its original context, the TAM 
provided a way in which to understand the degree to which there was acceptance among 
consumers with regards to the technologies used in wearable devices (Holden and Karsh, 
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2009; Ayyagari et al., 2011). However, understanding how theorists developed and 
utilised the theory in different context may offer a better understanding of the adoption 
process of wearable devices in general and medical ones in particular. According to the 
TAM, there are a number of key considerations in determining the level of technology 
acceptance (Venkatesh and Davis, 2000). One of the most common and significant of 
these is the perceived usefulness of a device, which describes how significant a user feels 
that the technology will be in improving their job performance (Davis, 1989). Another 
important factor in technology acceptance is the perception of ease of use, which means 
the belief that a given device will be simple and stress free. There two determinants were 
added to the TAM to improve its predictive power (van Bon et al., 2010), in recognition 
of their role in influencing the attitude of users towards a given technology and their 
likelihood to use it (Davis, Bagozzi, and Warshaw, 1989).  
Venkatesh et al. (2003) formulated a new technology acceptance model which they called 
UTAUT, or the unified theory of acceptance and use of technology. Many predictive 
studies into the adoption of new technologies have subsequently utilised the UTAUT 
model (Morris, Davis and Davis, 2003), which is generally viewed as a more robust 
model than other similar frameworks, as it explains 70% of the variance in the usage 
intention. The UTAUT consists of (Venkatesh et al., 2003): expectancy of effort; social 
influence; performance expectancy, which is the combination of the perceived usefulness 
of a particular construct (Davis, 1989), the relative advantage that the technology offers 
(Moore and Benbasat, 1991), the degree to which it fits its intended usage or job 
(Thompson et al., 1991), the specific expectations that a user has about outcomes 
(Compeau and Higgins, 1995; Compeaust et al., 1999), and any motivation from external 
rewards (Davis et al., 1992); and finally, all other facilitating conditions (Venkatesh et 
al., 2003). Also, Chen and Shih (2014) have used the UTAUT model to evaluate model 
of acceptance of a product with wearable technology. These studies demonstrated that 
adoption will usually be low when technical difficulties occur or when patients already 
have good control.  
Indeed, the majority of UTAUT literature focus on voluntary and/or work contexts, rather 
than obligatory and individual use contexts. This suggests the importance of determining 
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whether this framework is fit to explain the adoption process. Furthermore, the 
surrounding context is widely recognised in the literature as the key reason for the use of 
IP, yet this theory fails to explain the impact of social influence on the use in the post 
adoption phase. This has led some academics, such as Alagöz et al. (2011), to argue that 
traditional acceptance models like the TAM and the UTAUT are not simply translatable 
and adoptable in the context of health-related technologies.  
3.2.1 Wearable Devices in Technology Acceptance Models (TAM) 
In research conducted in the field of wearable technology, the issue of perceived 
usefulness is of paramount important. In this context, it describes the ability of users to 
integrate the given technological device into their everyday life, which means that this 
factor is potentially one of the most significant in determining the adoption of a device. 
Şener et al. (2015) support this assertion, explaining that perceived usefulness has an 
indirect influence on purchase intention through its effect on attitude. With higher levels 
of perceived usefulness, consumers adopt a more positive attitude towards using and 
wearing the technology, effectively reinforcing the likelihood that they use it positively 
(Park and Chen, 2007). 
Hwang (2014) extended the TAM to examine the effects of consumer-oriented variables 
on the attitudes of consumers, looking at purchase intentions for solar-powered clothing. 
Similarly, Chae (2009) utilised the extended TAM to examine acceptance models of 
smart clothing and differences with regards to clothing acceptance through the 
classification of consumers depending on the level of technology innovation and fashion 
innovation. The variable of perceived usefulness has been argued to be the most 
influential in determining the attitude of users towards new technologies (Chae, 2009), 
with models like TPB and TAM having been used effectively in studies of wearable 
devices like smart bras or smart t-shirts (Turhan, 2013). Although these models can fit 
with these wearable technologies, there are certain challenges with regards to their use 
for medical wearable technologies that can affect the understanding of patient behaviour. 
For example, unlike something voluntary like sports wearable technologies, medical 
wearable technology is obligatory (Gonder-Frederick, 2011, Chiauzzi et al., 2015). 
Furthermore, these devices offer no clear tangible improve in lifestyle compared to other 
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wearable technologies (Gao et al., 2015). The consequence of this is that investigations 
into patient responses to wearable devices cannot be based on the same assumptions, 
meaning that it is necessary to go more in-depth into the literature conducted into medical 
wearable devices.  
3.2.2 Technology Acceptance Framework in Medical Wearable Devices 
Technology acceptance models are rarely used in the context of medical wearable 
devices, particularly in explaining the proper use of the IP. However, the TAM was used 
by van Bon (2010) to investigate the future acceptance of the artificial pancreas (AP) and 
its possible determinates. The AP will consist of a “subcutaneous glucose sensor, a 
continuous subcutaneous insulin pump, and a mathematical model that regulates the 
amount of insulin based on the glucose levels” (van Bon, 2010, p.597). The study found 
that the initiation to use the AP was highly dependent on trust, which was related to the 
quality of glucose control provided by the combined wearable technology. The definition 
of perceived usefulness in this context was the ability of the device to ensure improved 
glucose control and to thereby lower the impact that diabetes would typically exert over 
the daily lives of patients, leading to correspond improvements in overall quality of life 
(van Bon, Verbitskiy, von Basum, Hoekstra, and DeVries, 2011, Barnard et al., 2014). 
Previous healthcare literature supports this, demonstrating that “integration into existing 
health and psychosocial support infrastructure of the patient is a trigger for perceived 
usefulness” (Winkelman et al., 2005)   
Attempts to increase the predictive value of TAM have been based upon extending the 
variables of its perceived usefulness and ease of use (Bevier et al., 2014, van Bon et al., 
2011). In this context, the determinants of perceived usefulness are social influences, 
including peer pressure, conformity and persuasion, and cognitive instrumental 
processes, which refers to judgments and evaluation. Perceived ease of use was also 
improved with: perceptions of internal control (self-efficacy to perform a task), 
perceptions of external control (facilitating conditions such as specific training), intrinsic 
motivation (openness to process) and emotion (computer anxiety) (ibid). This framework 
enabled the identification of the major barriers to adoption, namely specific concerns 
regarding the number of obligatory components to be worn and issues of trust regarding 
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the degree to which the Artificial Pancreas would be technically accurate, especially in 
exercise situations (ibid). 
The TPB  emphasises the role of social support systems to bring about changes in 
behaviour or to help maintain existing behaviours (Shepard et al., 2012, Gonder-
Frederick, 2011). The study by Shorer et al. (2011) used the TPB to assess the role of 
parenting style in helping adolescents with type 1 diabetes to achieve metabolic control. 
“In a study of 100 adolescents and their parents, an authoritative nonhelpless parenting 
style was found to be associated with better adherence to treatment” (Shorer et al., 2011, 
p.1735). Omondi, et al. (2009) also applied the TPB model to understand physical activity 
behaviour among a group of type 2 diabetes patients in Kenya, enabling the prediction of 
diabetes management behaviour in much the same way as the other behaviour change 
models.  
This discussion has shown that technology acceptance models, including TPB and TRA, 
can be employed to successfully understand the adoption of IP. This is important because 
despite the existence of positive perceptions towards the IP, with subjective norms to use 
and to believe in the IP, some children are not using it appropriately. Nevertheless, the 
previous literature fails to explain, understand or to investigate this phenomenon. 
However, the next theory is the health belief model, which may explain parts of the 
problem.  
3.2.3 Health Belief Model 
Technology acceptance models have been adopted, refined and extended by researchers 
in the field of human computer interaction (HCI) in the area of medical devices. This new 
framework is known as the health belief model (HBM). The HBM was first described in 
the 1950s by a group of social psychologists who sought to understand why people 
rejected to take screening tests for the early discovery of asymptomatic diseases (Janz 
and Becker, 1984). Although the original function of this model was to anticipate the 
course of health behaviours performed by healthy people to reduce their chance of 
becoming ill (Becker, 1974; Becker and Maiman, 1975), later versions have also been 
successfully utilised in conjunction with those individuals suffering from chronic diseases 
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and conditions. The health care behaviour and decision making processes informed by 
this model stress the importance of the attitudes, beliefs and perceptions of those who are 
involved, namely the patients (Janz and Becker, 1984, Rosenstock et al., 1988). 
The most important patient constructs in this context include the seriousness of the 
particular health problem and the perceptions of each individual with regards to their 
personal susceptibility to harm. These factors in the HBM are supplemented by 
environmental conditions; individual coping styles; any obstacles to the attainment of 
goals that are perceived to exist (Rosenstock et al., 1988); as well as the perception that 
a patient has regarding their ability to successfully manage challenging situations, the 
benefit-to-cost ratio of the condition and its treatment, and the (Gao et al., 2015). In the 
context of diabetes, the likelihood of using diabetes technology can be influenced by 
condition-specific factors like negative emotional reactions to glucose readings, or the 
fear of hypoglycaemia and hyperglycaemia (Gonder-Frederick et al., 2011, Hood et al., 
2004, de Zoysa et al., 2014). 
Numerous studies support the relationship between the HBM and a wide range of diabetes 
self-care behaviours in adolescents, including insulin, diet, and exercise (Bond et al., 
1992, Cerkoney and Hart, 1980, Rosenstock et al., 1988). The HBM is a psychosocial 
model and as such “is limited to accounting for as much of the variance in individuals' 
health-related behaviour as can be explained by their attitudes and beliefs” (Janz and 
Becker, 1984).  With regards to health-related matters, Lewis (1994) argues that the 
value-expectancy approach can be explained as meaning: (a) the belief that illness can be 
prevented or improved by following certain types of behaviour; and (b) the wish to either 
recover from ill health or to avoid it altogether. The consequence of this is that a person 
becomes more likely to adopt certain health behaviours if they perceive themselves as 
being more vulnerable to a particular health risk, as well as the potential repercussions of 
the given illness (Barnard et al., 2015). The seriousness of the risk creates a proportional 
incentive for people to act. The HBM has therefore been widely used to investigate 
adherence behaviour with self-applied treatment (Conner and Norman, 1996); those 
based upon behaviour observations (Baum and Creer, 1986, Greca et al., 2003); and those 
that utilise physiological measurements, like blood glucose levels (Dolgin et al., 1986, La 
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Greca et al., 1990). However, self-reported health behaviour suffers from an 
unwillingness for patients to report non-adherence to the recommended form of 
treatment, which can result in the measures being deemed invalid or at least unreliable 
(Carpenter, 2010).  
In summary, the HBM fails to explain why some children are continuing to misuse the 
IP, regardless of the benefits that this technology offers, or the high level of trust and 
belief that exists in the IP. However, acceptance model theories, including the TAM, the 
TPB, and the HBM may be able to explain parts of the story. These frameworks all 
attempt to address the relationship between technology and the beneficiary, as if the 
patients are living in isolation, without communication, with the result that the situation 
and user behaviour may be misunderstood. For this reason, going deeper into the 
behavioural and psychological aspects antecedent to the proper use of the IP may enable 
the phenomenon of the misuse of devices in the post-adoption phase to be understood 
more thoroughly 
3.3 Behavioural models in accepting and rejecting enforced behaviour 
Doctors who are treating diabetic youngsters need to be aware that both diabetes and 
adolescence are challenging states for any individual, so having one process can make 
the other more complicated (Comeaux and Jaser, 2010b) (Davidson et al., 2008). 
Hamburg (1998) notes that adolescents meet different challenges, such as recurring 
themes of identity, achievement, autonomy, and intimacy. They also face numerous 
complex and important choices, such as those involving issues of self-worth, sexuality, 
attitudes to health, and decisions about their future (Hamburg, 1998). Given the need to 
be aware of the specific responsibilities associated with their disease, these challenges are 
likely to be exacerbated for young people who have chronic diseases like diabetes 
(Hamburg, 1998). For this reason, there are clear associations between the presence of 
chronic illnesses and increased absence from school, greater levels of pain and fatigue, 
and higher levels of parental involvement, all of which can complicate the normal 
processes of developing during adolescence (Seiffge-Krenke, 1998). 
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Psychosocial factors can influence both technology provision and clinical outcome, with 
technology also having a measurable impact on psychological outcomes, underlining the 
position that the “optimal use of the various diabetes self-management technologies is 
influenced by previous self-care behaviours, demographic and psychological factors” 
(Franklin, 2016). In one year, long event, more than half (56%) of the adverse events that 
patients reported in children could be attributed to pump malfunction, either transient or 
permanent (Wheeler et al., 2014). This may be exacerbated by the difficulty that many 
young patients report in keeping to their self-care regimen, with dietary adherence and 
correct blood glucose testing being particularly problematic (Wysocki and Wayne, 1992; 
Franklin, 2016; (Cogen et al., 2002). In essence, this shows that psychological factors 
play a crucial role in the proper use of the IP (Ratheau et al., 2011). In this context, 
psychological factors do not refer to the motivation to use as acceptance models, but 
rather they describe self-perception. Therefore, the following sections focus on the factors 
affecting adherence to medication and cognitive dissonance. This discussion of the 
factors begins with the question of why patients might resist or accept being forced to 
adopt certain medications, after which this chapter will proceed on to a discussion of how 
resistance can be reflected in the behaviour of patients.  
3.3.1 Patient adherence to medication / patient compliance  
Extensive research has demonstrated that a significant proportion of patients (as many as 
40% for the most complex regimens) fail to maintain good levels of adherence to the 
treatment recommendations for their condition (DiMatteo 2004c; Dunbar-Jacob et al. 
2000; Laederach-Hofmann; Bunzel 2000; Haddad et al. 2004; Haynes et al. 2004). For 
the most intrusive and complicated regimes that involve significant modification of 
lifestyle or habits, the level of non-adherence can reach 70% (Dishman 1982, 1994; 
Brownell and Cohen 1995; Katz et al. 1998; Chesney 2000; Li et al. 2000). In Saudi 
Arabia, a very significant majority (79%) of patients have been shown to be non-
compliant to their insulin regimen (Khan et al., 2012). 
Although the dictionary definition of compliance describes the behaviour of obeying the 
rules given by those in authority, the healthcare definition is when “patient’s behaviours 
(in terms of taking medication, following diets, or executing life style changes) coincide 
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with healthcare providers’ recommendations for health and medical advice” (Sackett 
1976, p.60). Although alternative terminology is occasionally used, the intended meaning 
describes the same meeting of patient behaviour with official healthcare advice (Jin et al., 
2008). For example, the term adherence is often used interchangeably with compliance. 
Adherence is defined as the ability and willingness to abide by a prescribed therapeutic 
regimen (Inkster 2006).  
The problem of non-adherence is not confined to the lack of effective treatment for a 
diagnosed condition. By failing to follow medication advice, such as regarding dosage 
quantity or frequency, patients may potentially eve n be harmed (Joshi and Milfred 1995; 
Salzman 1995; Bedell et al. 2000). For example, the mistaken belief that a patient has 
taken their prescribed medication may result in a doctor making changes to medication 
or dosage that can have adverse repercussions, leading to less than ideal health and 
harmful complications (Matin et al., 2005). Indeed,  the issue of medical non-compliance 
is a recognised and significant public health problem that places high pressure upon health 
care systems, both in terms of cost and the pressure on medical staff (Donovan, 1995). 
The factors most commonly associated with non-compliance in the context of diabetes 
patients are: the duration of diabetes, their knowledge about the disease, the frequency of 
their visits to the diabetic clinic, the patient’s family history of diabetes, a lack of support 
by their family, the occupation and educational of the patient’s parents, and whether they 
have a fear of hypoglycaemia (Riaz et al., 2014). More factors affecting the ability of a 
patient to adhere to medical devices are the characteristics of the child and family, the 
characteristics of the health care system in which they live, and the characteristics of the 
patient’s disease or regimen (La Greca et al., 2003). 
Because of the interconnectedness of many of these factors, it is difficult to deduce an 
accurate estimate of the levels of patient adherence. The particular reasons that a 
particular individual is able to adhere to a treatment regimen, or for being unable to do 
so, can be difficult to determine. Nevertheless, this evaluation plays an important role in 
choosing or designing effective therapeutic approaches to maximise adherence and 
thereby optimise the chance for successful treatment. When collaboration is effective and 
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appropriate, this can lead to greater levels of patient satisfaction, lowering their 
nonadherence and ultimately improving healthcare outcomes. For this reason, the next 
section provides a more in-depth discussion of these topics in an attempt to enable clearer 
understanding of the potential reasons for non-adherence of a patient with regards to an 
enforced medical device.  
3.3.2 Cognitive dissonance and Psychological Reactance behaviours 
Cognitive dissonance is a term used in “psychology and social psychology to designate 
feelings that are professed as disagreeable and which are prompted by cognitions 
(meaning perceptions, thoughts, opinion, attitudes, desires, or intentions) that are 
incompatible with his freedom”. (Jarcho et al., 2011). New restrictions are rejected 
because of active reactance to the limitation (Brehm, 1966), which happens in response 
to the feeling that an individual is being deprived of options to which they feel entitled. 
In its purest terms, people need freedom (Brehm, 1966), so they react to any restriction 
to their choices or actions, typically by resisting any behaviour they perceive to be 
inhibiting their freedom. Brehm (1989) describes the term ‘psychological reactance’ as 
this strong response to attempt to reduce the freedom of a person in response to either 
direct orders or being denied permission to undertake a particular activity. Typically, 
when denied an option, people will often want it more (ibid). Having said this, the patient 
can follow under the psychological reactance toward using the insulin pump, coming to 
manage it correctly. 
As stated by Pickup et al., (2014) patient of insulin pump should be adequately 
psychologically stable. There has also been a growing interest in the range of 
psychological problems associated with insulin pumps (Aberle et al., 2009), indicating 
that it would be more ”appropriate to use specific, validated psychological instruments 
pertaining to, among other factors, coping, self- efficacy, depressive symptoms, quality 
of life, and treatment satisfaction for surveying these issues in pump patients“ (Pickup et 
al., 2014, p.148).  
To sum up, cognitive dissonance theory is arguably one of the main theoretical angles 
from which to better understand the behaviour of patients towards compliance with 
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certain wearable technologies. This may be more important in the context of working 
with children, due to their inability to understand the rationale for using medical devices. 
This inability to comprehend their physical need to use the IP could be a main cause of 
their cognitive dissonance. The capacity to understand the need for use may in fact be a 
developmental process based on the age of a patient, their interactions with others, and 
the way that surrounding environment knowledge feeds into their minds. Therefore, the 
next section examines the ways in which understanding of the IP is formulated. This may 
comprise another building block to greater adoption, supplementing the understanding 
offering by TRA, TAM and HBM. In other words, learning how patients perceive and 
believe in the IP, may provide better and more functional understanding of their 
consequent behaviour.  
3.4 Social Theoretical Foundations 
The aim of this section is to develop the theoretical foundations for understanding the 
formulation of child logics. Logic means the values, definitions, perceptions and 
discourse that direct behaviour (Thornton, 2015).  Once a certain logic is created in the 
mind of a child, this will inform his behaviour, so understand this development can 
provide useful insights into their interactions with the IP. Because some children are too 
young to create their own logic, they are extremely vulnerable to adopting logics of their 
parents and the surrounding environment. Indeed, it is intuitive that if the parents and 
doctors have aligned logics, the child may follow this logic, leading to successful use of 
the IP. However, it is somewhat unclear what occurs when the logics of parents 
contradicts the logics of medical personal. It is also unclear how the way in which a child 
interacts with the IP can create their own logic, or how different logics can interact to 
create a new logic, which is called the Socratic approach to building knowledge and ideas 
(Bereiter and Scardamalia, 2014). Therefore, the next two sections seek to build a 
theoretical foundation to enable these knowledge gaps to be bridged.  
3.4.1 Contradictions 
Contradictions is a concept used in literature to show a conflict between two perspectives, 
discourses, logics, ideas, or mentalities (Ford and Ford, 1994, Scott, 2013, Leonardi, 2013 
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; Van Parijs et al., 1982). Contradiction is defined as “contradiction refers to these various 
ruptures and inconsistencies both among and within the established social arrangements.” 
(Seo and Creed, 2002) Another definition by Greenwood et al, (2011) “Contradictions 
and complementarities between logics potentially provide divergent bases of valuation 
and critique, categorization of the real, and alternative modalities of action”.  In terms of 
logics, contradiction has been recognised as being important in the medical sector and 
has been studied in this context. For example, Kristiansen et al. (2015) demonstrated how 
different assumptions by different roles in the hospital create contradicting logics, with a 
new a way of management being created.  
Logics can be an effective way of explaining how people behave (Kim and Park, 2011), 
as they influence people’s practice and “shape their assumptions and values, influencing 
how they perceive, pay attention to, evaluate, and respond to environmental 
stimuli”(Ocasio, 1997; Pache and Santos, 2010). However, although studies have not 
examined how contradictions in the logics of patients and doctors with regards to medical 
wearable devices, research has endeavoured to shed light on the conflicts between 
medical staff and admin staff, as well as between different medical institutions. Indeed, 
the perspective of institutional logic offers a meta-theoretical framework that enables the 
effective analysis of the interrelationships that can exist between individuals, institutions, 
and organisations (Thornton et al., 2012). This is important within the context of 
healthcare organisations, where the existence of competing and contradicting logics has 
been shown to be commonplace. Through understanding the way in which institutional 
logics and healthcare practice are connected, it is necessary to properly study the way in 
which individuals relate to one another socially (Thornton et al., 2012). In other words, 
medical personal is controlling their behaviours and practices, which may or may not fit 
with the discourse and logics of their patients.  
Logics and the contradictions between logics create a unique form of sensemaking to 
different actors (Kristiansen et al., 2015). The term ‘sensemaking’ refers to a social 
process and describes the way in which people process information or events that defy 
their normal expectations, perhaps because they are new or ambiguous (Maitlis and 
Christianson, 2014) Sensemaking is the key mechanism in social interaction that 
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positions the identities and practices of actors within the broader cultural edifice 
(Thornton et al., 2012, Thornton, 2015); (Weber and Glynn, 2006). For this reason, 
sensemaking is an instrumental part of social interaction and enables logics to be linked 
to the complex interrelated practices that can exist across different groups of actors in 
many contexts, such as healthcare (Thornton et al., 2012). In other words, doctors can 
make decisions based on sensemaking that mainly are derived from their professional 
world view, rather than from patient psychological needs perspectives. The patient is also 
assumed to take actions and form behaviours to the IP based on their view towards their 
own interactions with the IP and what shall be (i.e. subjective norms). The main thing 
here is that the communicative and sensemaking process between different parties should 
be aligned and consistent, otherwise it can be expected to result in the creation of a new 
form of unintended behaviour. Here, the aim of this research is to find out why some 
diabetic children are misusing the IP even when the benefits are clear to their doctors. 
This misuse may occur due to the differences in understandings, which create competing 
logics.  
3.4.2 Sociomateriality  
The proposed theory to understand the evolution of differences in logics is the 
sociomateriality theory. In the context of this research, the IP is a technical solution from 
the medical personal perspective, whereas for the patients it is a long life tool integrated 
in a human body (i.e. their own) (Krzymien et al., 2016). Different perceptions regarding 
the same technology can create different understandings and different definitions. Here, 
the aim of sociomateriality is therefore to explain the way in which different relationships 
with technology and people can lead to the creation of such a wide range of different 
views, opinions and logics (Hultin and Mähring, 2014). Sociomateriality is a theory 
originally built upon the intersection of technology, work and organization (Mueller et 
al., 2016) in an attempt to understand “the constitutive entanglement of the social and the 
material in everyday organizational life which creates a certain way to define technology” 
(Orlikowski, 2010, p.1437). Sociomateriality makes a philosophical statement about the 
relationship between the social and the material that begins, quite overtly, with the name 
‘sociomaterial’, a deliberate fusion of the words ‘social’ and ‘material’ in which “the 
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social and the material are considered to be inextricably related — there is no social that 
is not also material, and no material that is not also social” (Orlikowski, 2007, p.1437).   
Sociomaterial perspectives have been adopted by researchers who are most interested in 
the intersections that can exist between digital self-tracking devices and human actors 
(Pantzar and Ruckenstein, 2015).  
One promising area of research is that of ‘sociomateriality’, which seeks to challenge the 
deeply rooted belief that it is necessary to investigate work, organisational structures, and 
technology as separate areas of research, rather than an intimately interconnected whole 
(Orlikowski et al., 2008). This approach holds that technical and social matters are 
inherently connected, so the traditional views of technology should be challenged and 
reframed, to allow the many new, complex and vibrant sociomaterial configurations 
inherent to modern organisational practices to be studied more effectively (ibid). This 
approach creates a unique way of understanding technology, life, and how we understand 
our positions in the life (Orlikowski and Scott, 2008). It should be noted that most 
sociomaterial research is currently being developed in information systems in 
organisations (Fuenfschilling and Truffer, 2014). Therefore, this research constitutes a 
novel approach to understanding patient perceptions and views with regards to a certain 
wearable medical technology, in this case IP.  
3.5 Knowledge Gap Analysis  
i A new holistic approach for understanding children reasons for improper use of IP 
Technology acceptance models like TPB, TRA and UTAUT are useful to understand the 
process by which new technologies are adopted in business, the behaviours of employees 
towards technology, and the attitude and behaviour of patients towards technology 
(Mathieson, 1991; Ajzen and Fishbein 1980). However, the ability of this theory to 
understand wearable technologies has been questioned. Relatively few studies have been 
conducted to understand this theory in the context of wearable technologies. The general 
evidence shows that if the patient perceives there to be benefits to a given piece of 
wearable technology, s/he will adopt it appropriately. However, the subjective norms of 
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TRA, which are used to measure the frequency and means of technology adoption, hold 
that few people are diabetic and need to use the IP. Therefore, this research aims to 
develop a novel holistic approach for better enabling a comprehensive understanding of 
the adoption process of the IP, taking into consideration the users in isolation, without 
peers. 
Existing theories do provide the use of perceptions of ease of use and usefulness as a 
driver for the utilisation of technology. However, as these theories are used to understand 
behaviour of children in the pre-adoption phase (Davis et al., 1989), it is insufficient to 
rely on only these perceptions in examining the proper use, after integrating the IP into a 
patient’s body (Ajzen, 1985; Godin et al., 1996). The literature review failed to show 
compelling research into the factors affecting the proper use of devices in post-adoption 
behaviour in the IP context. Thus, this research seeks to address this gap, by providing 
better understanding of the factors affecting post-adoption behaviour.  
Because a patient uses the IP alone in his environment, often feeling obligated to use it, 
he/she may be more inclined to react against the IP. Particularly given the assumption 
that many children may not able to comprehend the rationale for using the IP. As 
comprehension comes from the understanding that the child derives from the surrounding 
environment, an inconsistent message from the parents or physician may affect the 
perceptions and logics of a diabetic child with regards to the use of the IP. This can lead 
to improper or discontinued use of the IP. This analytic approach has not been used before 
to understand the problem of why some children are not using the IP properly, even 
though they presumably know about its benefits. 
ii The role of family in the improper use of the IP 
The family or the caregiver affects the degree to which children use the insulin pump 
properly (Mitchell et al., 2013; Liberman et al., 2014). The main determinants of how a 
family can facilitate or hinder a child’s proper use of the IP is their readiness to the IP 
(Maahs, 2010). The readiness of a family can be understood in terms of their 
psychological and knowledge readiness. Regarding the psychological readiness, parents 
should be motivated for their child to use the IP in order to improve their diabetes (Laffel, 
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2003, Grunberger et al., 2014). The knowledge factor of parents on how to use the insulin 
pump is critical in the case of children below 18 years (Liberman et al., 2014; Mitchell et 
al., 2013). The primary role of family knowledge and motivation is to instil proper IP use 
in their diabetic children, which is reflected in assessing the family knowledge to ensure 
confident supervision in the use of the device.  
The motivations of parents toward engagement and involvement with helping their 
children is not necessarily fixed through the time, often having been shown to decrease 
after their child receives a pump (Mitchell et al., 2013). Having a depressed parent will 
double the risk for children, and in cases where both parents are depressed, children are 
four times more likely to have mood disorder than youngsters with healthy parents 
(Talakoub, 2012). This can often be reflected in the level of HbA1c, which can indicate 
improper use of the IP. In this way, decreased levels of family involvement with their 
children in using the IP is highly correlated with the level of HbA1c (Liberman et al, 
2014; Franklin, 2016). More national studies are needed to assess control of diabetes 
among diabetic patients in Saudi Arabia (Aljabri et al., 2013), especially because the 
psychological factors pertaining to families have not investigated in many eastern 
cultures, such as Saudi Arabia, which possesses different cultural values and principles 
in the relationship between parents and family (Georgas, 2003); (Almutairi, 2015). This 
focus on the family role in an Arabic country is another knowledge gap that shall be 
spotlighted in the current study, with regards to the improper use of the insulin pump. 
iii  Parents, Diabetic child and Doctors’ perceptions, views and definitions towards 
the IP 
In both Arabic and western culture, illness is often a matter of a shame (Hofstede, 2010). 
Patients in Saudi Arabia are psychologically disadvantaged by the way in which society 
looks at them (Almutairi and McCarthy, 2012). It is therefore expected for children using 
the IP to experience some of this stigma. However, relatively literature has been 
undertaken to investigate how society, including family, perceive diabetic children who 
use the IP. In the context of the current study, the more important point is how the child 
perceives the society looking at him and the effect that this prejudice might have on 
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behaviour. There is no any evidence in literature to show or explain how the diabetic child 
perceives himself, according to other perceptions, using the IP in the public.  
Parents are often the key factors affecting the way in which diabetic children perceive 
themselves. However, it is not clear from literature how these parents perceive their 
children and the consequences of these perceptions. Moreover although the IP has been 
shown to be inherently appealing to patients and families (Shulman et al., 2016), it is less 
clear whether doctors and the use of complex technical language affects the diabetic child 
or their family (Elzubier, 2002). It also remains unclear whether the conflict in logics 
between the medical perspective of doctors rather than the lifestyle perspective of the 
diabetic child could affect the use of the IP. These knowledge gaps have not been 
answered in the literature on the use of medical wearable technologies and especially in 
the context of obligatory use among diabetic children.  
3.6 Chapter Summary 
Few literature sources have sought to understand why some diabetic children are misusing 
the IP, despite the benefits having been recognized in literature and in medical practice. 
Therefore, throughout this chapter, different theories have been critically evaluated to 
understand why classic theories (e.g. TRA. Health Belief Model and TAM) that seek to 
understand technology usage may not function well in this context, as summarised in 
Table 3-1 . Based on these understandings a new theoretical angle has been introduced. 
This new theoretical angle is based on sociological, psychological and behavioural 
research in an attempt to unify their findings.   
The proposed theoretical perspective to understand the phenomenon is mainly focused on 
how a diabetic patient perceives the technology, how he/she perceives himself/herself 
living with the technology, and how other people perceive him/her as the user of the 
technology. All of these perceptions are developed from studying the interactions of 
patients with doctors and caregivers. If the diabetic child receives an inconsistent message 
from his parents and physicians, this may affect his perceptions and motivation to use the 
IP. All of that (i.e. patient understanding of the reasons for using IP and his/her 
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interactions with parents and doctors) can lead to the improper use of the IP. Thus, the 
new analytic approach will be developed in the next chapter to consider patient behaviour, 
not only in pre-adoption, but also in post-adoption phases. 
Table 3-1: Summary of theories 
Theories of 
accepting new 
medical devices 
Known Unknown 
Theory of 
reasoned action 
(TRA) 
Stronger intentions lead to increase 
effort to perform the behaviour, which 
will increase the likelihood for the 
behaviour to performed. (Ajzen and 
Fishbein, 1975) 
Theories are used to understand 
behaviour of children in the pre-
adoption phase (Davis et al., 1989), 
Intention is influenced by people’s 
attitude, which is the main 
determinant of their behaviour 
(Downs and Hausenbles, 2005) 
Provide way in which to understand 
the degree to which there was 
acceptance among consumers with 
regards to the technologies used in 
wearable technologies (Holden and 
Karsh, 2009; Ayyagari et al, 2011). 
The impact of social 
influence on the use in the 
post adoption phase. 
factors affecting the proper 
use of devices in post-
adoption Behaviour in the 
IP context 
How the intention to use is 
affected with an obligatory 
technology. 
 
Technology 
acceptance 
model (TAM), 
Theory of 
planned 
behaviour   
(TPB) 
Unified Theory 
of Adoption and 
Use of 
Technology 
(UTAUT) 
The use of perceptions of ease of use 
and usefulness as a driver for the 
utilization of technology 
Technology acceptance models like 
TPB, and UTAUT are useful to 
understand the process by which new 
technologies are adopted in business, 
the behaviours of employees towards 
technology, and the attitude and 
behaviour of patients towards 
technology (Mathieson, 1991; Ajzen 
and Fishbein 1980). 
Few studies have been 
conducted in an attempt to 
understand this theory in 
the context of wearable 
technologies 
 
No any evidence in 
literature to show or 
explain how the diabetic 
child perceives himself, 
according to other 
perceptions, using the IP in 
the public. 
Health belief 
model (HBM) 
The belief that illness can be 
prevented or improved by following 
certain types of behaviour; and (b) the 
HBM fails to explain why 
some children are 
continuing to misuse the 
IP, regardless of the 
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wish to either recover from ill health 
or to avoid it altogether 
benefits that this 
technology offers. 
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CHAPTER 4 Research Methodology 
4.1 Introduction 
This research seeks to investigate the adoption of Insulin Pump (IP) in Saudi Arabia, with 
focus on the barriers to successful adoption. IP adoption in this context requires a broader 
context, including all the factors that may be involved – not only the patient and the 
medical personnel, but also the patient's family, friends, social pressures, etc. Therefore, 
it requires an inter-disciplinary analytical framework that, in this study, captures the 
distinct perspectives of change agents (medical personnel) from Saudi Arabia, diabetic 
patients and their care-givers from Saudi Arabia (but can be in future extended to capture 
other significant factors in other cultures, countries, or age groups).  
Thus, for the purposes of this study, the main aim is to understand why diabetic children 
are misusing the IP. The objectives are focused on understanding the different discourses 
among different actors, looking at how the contradictions affect the use of the IP and may 
lead to its misuse. The problem is not only in the interaction between patient and the 
wearable device from the technical perspectives (Patel et al., 2012; Regittnig et al., 2013), 
but also from the attitudinal and psychological perspectives (de Vries et al., 2010; Binek 
et al., 2016) of the diverse agents involved (medical personnel, patients, caregivers).  
This chapter will discuss the research strategy and research quality. The research method 
is detailed and structured on two main phases Figure 4-1. The first phase is to understand 
the reality from the doctors' perspective through interviews. The second phased is for 
understanding the patient and his/her family perspective through case study research. The 
research quality will include the reliability, validity, credibility, reflexivity and 
transferability.  
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Figure 4-1: Chapter 4 Structure 
4.2 Research Strategy  
The main motivation for the selection of a qualitative approach for this research is its 
suitability for the study of people in their natural settings and its ability to enable a deeper 
understanding of phenomena in terms of the meanings people bring to them (Atkinson 
and Hammersley, 1994). The methodological focus of this approach is on the narrative 
analysis, reports, personal experiences, and observations, in an attempt to provide new 
insights to often familiar situations (Cohen et al., 2013). As per the maxims of qualitative 
research, the truth is based upon the idea that individuals develop within social settings 
(Creswell, 2013). Qualitative research is therefore more substantial to the researcher than 
others because of the likelihood of different outcomes (Guba and Lincoln, 1981; Creswell 
1998). The qualitative approach relies upon analysis of the content, the discourse, and the 
context of each story, focusing on insights and understandings. In the current research, 
the aims of the discovery stage were to discover what the informants say and do, in order 
to capture their viewpoints, perspectives and attitudes from their personal perspectives, 
then to use this data to address the research questions.  
The research strategy for this research has two main components: interviews conducted 
with medical personnel in Saudi Arabia, who are the change agents; and case studies 
conducted with Saudi patients and their families. Both studies were carried out in Saudi 
Arabia. The first discovery stage is to understand the change agent (doctor and educator) 
practices adopted. The goal of comprehending the reality from the perspective of the 
Research Strategy
Phase 1: nterview 
Research
• Structured Interviews
•Unstructured Interviews
Phase 2: Case Study 
Research
• Structured Interviews
•Unstructured Intervies
Research Quality
Research Reliability
Reflixbility
Credibility
Validity
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Chapter 4  Research Methodology 
 
 
 -82- 
change agents (medical personnel). The use of interview research (13 unstructured and 
22 structured interviews) is intended to provide understanding of their views, definitions 
and discourse in terms of the IP (detailed description is provided in section 4.2.1). The 
second phase is to capture the perspective of the patients and their parents regarding their 
views, definitions and discourse on the IP using case study research. 
 
Figure 4-2: Research Strategy 
4.2.1 Phase 1: Interview Research  
In order to establish the broad context in which new technology is being adopted into the 
daily lives of patients in in particular communities, as well as to provide some insights 
into how these are controlled by the doctors and educators, I used a set of establishing 
questions with the doctors and the diabetic educators. These questions are: when does the 
doctor recommend the IP, when does doctor choose not to recommend the IP, and when 
does the doctor withdraw the IP. These were intended to provide information on the three 
key strategies used by doctors and educators in managing the adoption of new technology 
and its integration into the daily life of the patient.  
The significance of in-depth interviews in this context is that they help to elicit the 
perspectives, definition and narratives of each interviewee, enabling effective 
documentation of the pre-defined issues. These interviews also enable both the 
interviewer and the participant to include or elaborate upon any ambiguity that may 
Interview Research
Understanding the change agent' 
perspective
Understanding the change agent (doctors' 
and educators practices)
13 unstructured interviews and 22 
structured interviews
Case Study Research
Understanding the patient and his/her 
family perspective
Understanding psychological factors (i.e. 
motivations and emotions) for the  
improper use by 2 children (2 case studies)
Interviews with patient, his family, 
Chapter 4  Research Methodology 
 
 
 -83- 
emerge during the interview. Nevertheless, it ought to be borne as the main priority that 
once answers are repeated and no extra knowledge gained in an unstructured interview, 
the participants can be guided by a more structured interview structure to provide more 
responses, thus ensuring more reliable results and findings. The interviews should then 
be ended once the picture obtained is sufficiently clear (i.e. saturation level is reached) 
(Glasser and Strauss, 1991; Charmaz, 2012). This section will explain the rationale for 
performing the unstructured interview and the structured interview. 
i Unstructured interview  
The unstructured interview is an examination process that enables an exploration of issues 
and collection of rich data on the contexts being researched, as it permits the participants 
to recount their stories in detail (Denzin and Lincoln, 2000, Tod, 2006). This approach is 
most commonly employed when there is minimal to zero learning or data on the research 
question (Legard et al., 2003). The researcher typically listens to the interviewees and 
assists them, by addressing the discussion to topics that they consider to be significant 
and essential. These interviews are usually recorded, as well as being annotated by field 
notes. I believe that this type of interview offers the potential for valuable insights into 
the underlying reasons for the improper use of the IP by children. This understanding can 
be facilitated by the arrangement of a schedule in which there is a discussion with the 
interviewer that is more likely to make interviewees more explicit about more issues. 
These interviews also have a tendency to empower the social qualities, attitudes and 
standards of participants, enabling them to be more effectively investigated by an 
interviewer (Mason, 2002; Tod, 2006). Although unstructured, as a rule, the interviewer 
uses pre-structure interview questions and probes during in-depth interviews to start the 
conversation, as well as to explain or to elicit additional data from participants. 
Qualitative research, which stresses the in-depth investigation of a small number of 
communities, often utilises snowball sampling (Biernacki and Waldorf, 1981) rather than 
random sampling. That was also the approach adopted in the current study, with the 
doctors referring me to other quality doctors and educators who might be willing to take 
part in my research. The number of respondents was based on theoretical sampling 
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(Charmaz, 2012), which mainly focuses on the saturation level of the findings and results. 
As the emphasis in the current study is on quality rather than quantity (qualitative rather 
than quantative date), interviews were held face-to-face and, with the addition of 
following up sessions, took an average of 1 to 2 hours per participant. Appointments were 
made in person, at the reception of each clinic, with some interviewees being met face to 
face beforehand, to deliver the consent form and arrange the appointment for a time and 
location most suitable for them. 
The interviews were held in the doctors' clinics, after I had made an appointment and 
described the reason for the interview. A consent form was presented (Appendix A) and 
explicit consent obtained from each participant to be interviewed. During each 
unstructured interview, it was important for the participants to feel unstrained, with plenty 
of time available for them to discuss how they understood and described their experience. 
As a consequence, the interviews took about an hour to an hour and forty-five minutes, 
using questions that were designed to identify patterns and common themes in the 
accounts given by each participant.  
ii Structured Interview 
Before finishing the analysis of the unstructured interviews, another wave of structured 
interviews was launched to extend and validate the findings, using a structured interview 
approach following a well determined interview guide. The interview guide was 
developed based on the findings of the unstructured interviews. The structured interview 
guide was administered over the phone, because most the medical personnel were too 
busy to schedule a face-to-face interview. Phone interviews also made it easier for the 
researcher and to organise and schedule the data collection. As with the previous data 
collection stage, the sample size was defined by saturation level. In other words, once the 
results were perceived to be repetitious, it was determined that there was no need to 
increase the sample size and the recruiting process was halted. A total of 22 respondents 
was deemed sufficient, as the latest 8 respondents did not add anything in terms of 
understanding the behaviours, motivations and attitudes of patients, with regards to either 
the IP or its improper usage.  
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4.2.2 Phase 2: Case Study Research 
The second phase was the case study with the beneficiary (i.e. the patient and their 
family). These case studies comprised “an empirical inquiry that investigates a 
contemporary phenomenon within its real life context” (Yin, 2003, p.13). However, it 
should also be noted that this research took the stance that a “…case study is defined by 
interest in individual cases, not by the methods of inquiry used” (Stake, 2003, p.134). The 
purpose of the second phase of this research was to obtain a different perspective than 
that of the change agent perspective (i.e. doctors and educators). Instead, the case studies 
sought to examine the problem from the perspective of the patient and their families, 
rather than the doctor. (Gummesson, 1991) stresses that while case studies vary in 
character according to the phenomenon studied, there are two types of particular interest: 
the type that attempts to derive general conclusions from a limited number of cases; and 
the type that strives to reach specific conclusions regarding a single case, because the 
specific ‘case history’ is of particular interest. This research took the latter approach, 
which was deemed to have the characteristics required to ensure the provision of different 
perspectives in the development of the framework.  
Criteria were used to select sites for the study (patients and family using the insulin 
pump), which included consideration of manageability, diversity in family conditions, 
ages and gender, and the willingness of respondents to speak freely with the interviewer. 
In addition, informal networks were used to identify the most appropriate cases, because 
of the unavailability of the patients’ information in the public domain (e.g. websites or 
public directories) and the limitation that medical personnel are not allowed to declare 
names of the patients. For this reason, I approached my informal networks to find children 
with diabetes who were struggling or frustrated with the IP. I found four viable children 
and selected two of these to participate. These two selected children are different gender 
(one male and one female) and different age groups (8 years and 15 years). The aim is 
not to contrast the participants, but to find evidence for supporting and extending results 
of the interview research with respect to different ages and genders.  
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i Interviews 
Each case involves an interviews with different actors, which were held face-to-face, at 
the house of the participating families. Meeting the patient and his/her family in their own 
house makes the interview more natural, helping them to talk more freely and for the 
patient and their behaviour to be observed. This also enabled the researcher to observe 
how the diabetic children viewed and interacted with the IP and how the family interacted 
with him/her regarding the IP. This opportunity to observe the patient and his family 
behaviour is more useful and valuable than only conducting interviews. 
ii Observation  
Observations comprise the informal observation and recording of materials, situation, 
occasions, narratives and practices as they happen in an individual’s environment. This 
is an adaptable data collection process that does not restrict what the spectator ought to 
watch and note, instead holding that everything is potentially valid and useful for the 
purposes of recording and checking (Holloway and Todres, 2007, Parahoo, 2006). 
Nevertheless, an unstructured observation can become more particular in terms of when 
and where observations are conducted, the most important parts of the setting or 
behaviour to monitor, and how to effectively document observation. The objective of an 
unstructured observation includes the collection of subtle elements, practices and 
associations in all of the specific settings that as could be expected under the particular 
study circumstances. Then, without filtering it through any interpretive process, to depict 
the important conduct and attitude with regards to the IP that can properly explain the 
motivations to misuse the technology. Unstructured observation effectively serves the 
function of enabling in-depth comprehension around an undefined subject (Bowling, 
2014, 2002). This method therefore appears to be highly appropriate to the objectives of 
this research, the overarching aim of which is to search for knowledge, to investigate and 
increase understanding about the misuse of the insulin pump among children.  
Hence, it is believed that looking into the subject, not confining the view by adopting an 
unequivocal theory or agendas, and maintaining flexibility in the observation of the 
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contexts associated with the research question may be facilitated by viewing the setting 
normally as it happens.  
4.2.3 Ethical Considerations 
Because the study involved human participants it was necessary to consider ethics and 
gain ethical approval from the researcher’s university. Ethical approval was granted. 
Towards this informed consent was conducted whereby participants were informed about 
the purpose of the study and their consent was gained. The participants were also 
informed about their right to withdraw from the study at any time. 
 
4.3 Research Quality  
Research quality describes the process of ensuring that the output of this research is 
trustworthy and captures reality, in addition to providing the data required to address the 
research question. There are different research quality criteria. This section outlines the 
five research quality aspects used in this study, the first four of which pertain to 
trustworthiness and the final aspect being concerned with the applicability of this research 
in different places (i.e. ‘generalisability’). Given that data are collected from people and 
understood by people, and in recognition of the fact that human nature is inherently 
subjective in understanding and presenting ideas, the four aspects are reliability, validity, 
credibility and reflexivity. Reliability describes the degree to which participants can be 
relied upon to be truthful in telling facts and giving their perspective (Rossman and Rallis, 
2003). This is important, because participants may give false information misrepresent 
what believe in because they may feel threatened, under observation, or shy about 
expressing their ideas frankly (Kirk and Miller, 1986). Because of this, I adopted different 
measures, as discussed later, to ensure the integrity of the interview and the ability of 
participants to speak freely. 
The second issue, validity, concerns whether I understand what the participant wants to 
say correctly (Arksey and Knight, 1999, King and Horrocks, 2010). Therefore, during the 
interviews, I occasionally paraphrased the answers given by respondents to check that my 
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comprehended meaning matched the content that they had intended to convey. In 
addition, with the medical personal.  I sent the interviewees e-mails to summarise the 
main points we had addressed in their interviews. While with the parents I phoned them. 
Credibility is the third issue and refers to the degree to which the written records of 
findings are correct and trustworthy, with no mistakes having been made in reporting 
observations or scripts (Lincoln and Guba, 1985). Therefore, all interviews were recorded 
(except where specifically forbidden by participants), transcribed and translated to ensure 
the integrity of reporting my findings. 
The final consideration is reflexivity, which can be explained as the trustworthiness in 
deriving my framework and that the rationale for my interpretations of the data are the 
best fit for the intended purpose. Thus, using literature, I evaluated different potential 
understandings of the salient facts, and derived from these the most meaningful 
interpretations of the improper behaviour of children in dealing with the IP.  
 
Research 
Quality 
Definition Measure used 
Reliability Participants are telling the truth 
and their discourse is constant 
over time. 
Asking the same question in different 
ways at different times.  
Allowing doctors who refused to be 
recorded the chance to talk without 
recording. 
Showing a consent form to confirm that all 
data gathered are confidential and will not 
be shared with anyone. 
Trying to help them be relaxed  
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Validity Ensure that the understanding 
of the researcher matches that 
of participants. 
Paraphrasing the answers and ensuring 
similar results. 
Emails were sent to give confirmation of 
the interviews. 
Credibility  Ensuring that everything 
written is correct, truthful and 
trustworthy. 
Consistency of the report with few 
contradictions between findings by using 
a recorder and recording interviews, then 
checking transcripts.  
Reflexivity Ensuring that the researcher’s 
understanding is correct and her 
interpretations are the most 
suitable in the context. 
Evaluating different possible 
understandings of the facts using literature 
review and different rationales.  
 
4.3.1 Reliability 
In the context of academic research, ‘reliability’ is traditionally understood as being a 
measurement of the consistency, stability and reputability of the responses of study 
participants, considering if the same questions were asked at different times (Stenbacka, 
2001). Reliability is problematic and even practically impossible because human 
behaviour is not static, is highly contextual and changes continuously depending on the 
influence of numerous factors. This dynamic nature of human behaviours can make it 
more difficult to achieve consistency in qualitative studies (Cohenetal, 2007).  
However, in qualitative research, reliability can be seen as being highly influenced by 
whether the participants are telling the truth and saying what they want to say. In other 
words, it was essential that my participants would not face any pressures to tell me false 
information, especially what they thought I wanted to hear, and that they would have the 
freedom to talk. I attempted to remove bias from the discourse of interviewees, as well as 
to ensure that participants felt unthreatened and comfortable that they would not be 
misrepresented, or under psychological disadvantage due to his illness. I also rephrased 
questions in different ways at different times, to facilitate understanding and improve the 
chance for good data to be gathered. Participants were assured that the data gathered 
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would be confidential and used only for research purposes. As permission was required 
for the interview recorded, some medical personnel refused to allow this during their 
interviews. 
I followed recommendations from Arksey and Knight (1999) regarding the importance 
of building rapport in my interviews. Participants were given the scope to express their 
personal perspective of things, inviting their trust and openness. In the first child case 
study, I used different measurements reassure the boy, encouraging him to talk freely 
without shyness, manipulation of his opinions, or making him feel that he needed to 
present a different image. In addition, I invited the family with the young diabetic child 
to visit a family entertainment restaurant with my own family, to allow the participating 
family to relax, to build rapport, and to better observe the child and his mother in a public 
place. I tried to be open with the child and talk about different subjects in open 
conversation, like studying in UK and my long-term aims. I also brought a gift for the 
other child and his family to help them to relax and not worry about our conversation. 
Therefore, despite the boy in the first study being very young and shy about his IP, I was 
able to obtain useful information about his true feelings.  
4.3.2 Validity  
In the current research, ‘validity’ is deemed to measure the degree of matching that exists 
between what a researcher understands from the participant and what the participant 
intends to convey (Patton, 2001, Seale, 1999). This definition is not necessarily similar 
in other research, especially that which is quantitative positivistic in nature (King and 
Horrocks, 2010). Therefore, to ensure the researcher understanding matches the 
participant understanding. In an attempt to ensure that the participants conveyed their 
intended meanings, the researcher paraphrased their answers and sometimes repeated key 
comments back to them. In addition, I summarised the dialogue of the doctors and asked 
them to check that I had understand them correctly.  
4.3.3 Credibility  
In qualitative research, credibility is regarded as the degree to which the research data are 
conceivable and reliable (Lincoln and Guba, 1994). Credibility describes the research 
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findings matching reality and is therefore somewhat similar to internal validity. It is 
dependent on a researcher to evaluate the degree of validity in their own study, given their 
personal comprehension of the research topic. The majority of positivists recommend that 
no separate reality exists to be found, arguing instead that all individuals develop their 
own picture and perceptions (Smith and Ragan, 2005). This means that, from an 
interpretive point of view, comprehension is co-constructed and that there is therefore no 
objective truth or reality to which the outcomes of a research study can be referred. 
To ensure the credibility of this research, I did my best in capturing and archiving all 
interviews correctly. I followed two techniques in an attempt to avoid incompleteness of 
the data gathered, by recording the interview when accepted by the informant and 
extensive note-taking in all of the interviews (Robson, 2002). In this way, as well as 
creating good records for later analysis, I tried to address the validity of the collected data 
through avoidance of potential distortion or misrepresentation from remembered 
comments (Cohen et al, 2007). Therefore, credibility was ensured by carefully checking 
the correctness of what was written, matching the truth and maintaining trustworthiness. 
This was checked by measuring the consistency of the report with the few contradictions 
between findings 
4.3.4 Reflexivity 
Reflexivity is usually a component of qualitative research, as it is a particularly viable 
strategy to enable qualitative researchers to approve their practices (Cutcliffe and 
McKenna, 2002, Pillow, 2003, Kingdon, 2005). This useful evaluative process involves 
the interviewer consistently monitoring and assessing how their behaviours, beliefs and 
attitudes influence the setting of the research, especially the fieldwork engagement and 
data analysis (Gerrish and Lacey, 2006). In the specific context of case study approach 
and interviews, there are various issues related to, which ought to be considered. 
One of these problems is objectivity, given that reflexivity is so dependent on the 
individual experience of the interviewer issue. (Savage, 2006). They contend that the 
outcomes created from utilising this technique are not legitimate, as a result of the chances 
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that could occur due to the ‘reactivity and subjectivity’ of the specialist (Spenziale and 
Carpenter, 2003). 
Alternately, it can be argued that the cooperation that exists between interviewees and an 
interviewer is a potentially useful tool for the effective construction of “interview 
questions and comprehending the answers during the data collection” (Berkwits and 
Aronowitz, 1995, p. 410). Lietz et al. (2006) underscore the significance of reducing the 
effects of the interviewer within an interpretive research by suggesting that the researcher 
organises the attitudes, emotions and encounters of the interviewers and gives them 
precedence over that of their own. 
Regardless, reflexivity is generally perceived to be rooted in the position a researcher 
takes in the research in terms of their understanding and selection of cases. Ultimately, 
the most important outcome to stress is the importance of striving to attain objectivity in 
selecting cases and interpreting the facts (e.g. transcripts and interviews).  
 
 
Figure 4-3: Reflexivity elements 
Intreprtation
Culture
Selectivity
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i Reflexivity of my Cultural: Position of the researcher  
My position in the case studies also afforded me permission to enter the home of 
participants and be honoured to speak to the members of the family as a guest, in contrast 
to many others (such as researchers who are male or foreign), who would have been 
denied access or placed under different, more onerous restrictions. This advantage has 
been acknowledged in the literature, as in “the investigation of national associations in 
Arab society, these paradigms are the outcomes of the constrained access of the male 
interviewer to collect useful evidence. I trust that under these conditions, just female 
scientists can easily access the information required” (Soraya, 1994). 
As a component of culture, I may have overlooked some points of interest that I may have 
learned to underestimate but which an outsider may have taken consideration. I also 
actively confronted the expectation of interviewees that I would intrinsically comprehend 
their experience or the importance of their words without clarification. For instance, on a 
few occasions, they asked me, "you realise what I signify" or "you know", anticipating 
that I should reply "yes" without further elucidation. In such circumstances, I requested 
them to clarify, by saying: "what do you mean by that", " or by offering a clarification 
that would show that I concurred or could not help contradicting their message. 
I would also contend that originating from the same culture, and in addition being of a 
similar gender of the mother, is likewise critical where a shared comprehension of general 
social standards and conventions affords valuable knowledge of guidelines, limits, and 
desires. However, I understood that I ought to be clear about these negative perspectives 
and issues which I have made an effort not to put my research data for fear of bias. 
Therefore, I attempted to separate myself as an insider with the end goal of analysis and 
in concentrating on the investigation. I purposefully endeavoured to position myself as 
an outsider in discussions, especially those about a participant's way of life, society, or 
social standards, which I achieved by alluding to these perspectives as "their" way of life, 
"their" social rules or "their" nation. By utilising "they", "them", and "their" rather than 
"we", "us" or "our", I sought to demonstrate that I recognised my position as being distinct 
from that the interviewees and abstained from giving the impression of complete 
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comprehension regarding their way of life and experience with society. I supplemented 
my management of this issue by offering explanations to those interviewees who 
continued to expect my comprehension.  
ii Reflexivity in analysis and interpretations 
A researcher’s awareness of their own experiences, bias, attitudes and beliefs creates the 
risk of influencing their data interpretation (Reid et al, 2005). As noted above, this is 
referred to as reflexivity and it is important to acknowledge these influences within this 
study. I am not a diabetic and I do not have any member of my family who uses a medical 
device. The function of the case study with the children was observe how the patient and 
their family view of the IP. However, considerations of reflexivity allow a researcher to 
write about their beliefs, biases, orientation, and past experiences that can affect their 
interpretation of the data, and approach to the study (Creswell, 2013). Reflexivity is also 
considered in developing cohesive interpretations of different facts. Therefore, for 
virtually every interpretation I performed, I used comparative and contrasting theories in 
order to understand the facts, then noted the reason for my selection of a specific 
interpretation.  
iii Selectivity and bias  
In the case of the case study component of this research, the selection was based on a 
rationale that a family perceives that doctors believe that their child is failing to use the 
IP correctly. For this reason, an 8 year-old male child was chosen for the first case study, 
with his selection being based on references from his relatives. To be precise, his family 
is the neighbour of one of my relatives. Permission was sought from the parent and after 
consent was obtained from his mother, I interviewed and observed the diabetic child, his 
mother, sister, and their servant. He comes from a relatively large family: he has a sister 
‘Mariam’, aged 15, and two brothers, who are aged 6 and 4. The child’s mother is a 46 
year old high school teacher in a public school. His father is a pilot who travel extensively. 
Finally, they have a servant in the house who joined the family one year ago. The child 
suffers from Type 1 diabetes, which was first diagnosed when he was 6 years old. He has 
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been on insulin injections since that time, until he turned 7 years old. The child was 
interviewed indirectly and observed. A series of semi-structured questions were directed 
to him. He is a sociable person so he can talk very well and explain, although he did not 
want to show or discuss his pump initially. However, once I had explained to him that my 
son wears a hearing aid because he has problem listening, the boy became willing to show 
me the pump.  
In the second case study, a 15 year-old female was selected. Explicit consent was obtained 
from the adolescent and her family to conduct an interview and observation of the girl. 
The selection of this participant was because her failure to correctly use the IP had 
resulted in her being admitted to hospital. It was therefore deemed interesting and 
valuable to investigate the kind of perception that could lead to profoundly improper use 
of the IP. The female girl was seen in a small gathering, during which I introduced myself 
to her. I was then invited to their house for a dinner. The adolescent was interviewed 
indirectly and observed. A series of semi-structured questions were directed to her, with 
a smaller number of supplementary questions being asked of her mother. The girl was 
initially diagnosed with diabetes when she was 8 years old, however she has only been 
on the insulin pump for 18 months. She comes from a well-known family in Jeddah, 
whose family bought her the insulin pump to improve her diabetes, and because she 
always forgets to take her insulin injections when she visits friends, which happens 
regularly. The parents therefore felt that the IP was a better choice, enabling their child 
more freedom and a better life style once it was connected to her body.  
The adolescent is a very sociable girl who likes to be involved in events and social 
activities. She spends a lot of time visiting or hosting social events, with most of her time 
outside school being spent at events, at homes, or in restaurants. Her image is important 
to her and she likes fashion, so is reluctant to show her insulin pump to other people, even 
to her friends. She feels shy about telling her friends that she is diabetic. 
4.3.5 Transferability  
The data are transferable or generalizable if they fit into new settings outside the specific 
research environment. Transferability is undifferentiated from outside legitimacy, that is, 
Chapter 4  Research Methodology 
 
 
 -96- 
the degree to which discoveries can be summed up. Generalisability alludes to the extent 
to which one can expand the record of a specific circumstance or populace to different 
people, periods or setting than those specifically studied (Maxwell, 2002). Transferability 
presents a risk to substantial inductions in the common understanding of information and 
is a particularly important issue in qualitative research due to the inherent subjectivity 
that arises from the role of the interviewer as an important instrument. A qualitative 
researcher can improve transferability by enumerating the examination techniques, 
settings, and generalisations associated with the study (Thomas, 2010). Seale (1999) 
asserts that transferability is accomplished by offering a rich depiction of the settings to 
furnish participants with adequate data to ensure that they have the capacity to judge 
findings and then to apply them in different settings with which they are familiar (p. 45).  
4.4 Chapter Summary 
This chapter had discussed the research approach and methods adopted and reflected in 
the way which data about the problem situation should be gathered Figure 4-4. 
This research is an interpretive qualitative research. Its strategy is based on two phases: 
the first is understanding the perspective of medical personnel (change agents), through 
interview research and the second is understanding the patient in his context with his/her 
interactions with others in a case study. Finally, research issues such as the credibility, 
objectivity and reflexivity of the research method were discussed with reference to both 
the studies reported in the literature and the study carried out in this project. 
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Figure 4-4: Chapter Summary 
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CHAPTER 5 Technology Adoption framework for IP (TAF 
IP for children) 
5.1 Introduction 
This chapter aims to develop the technology adoption framework (TAF) for IP for 
children. The chapter is divided in to two stages Figure 5-1. The first stage is developing 
the analytic framework to understand the causes of IP misuse based on the perceptions 
and interactions of the three kinds of agent. This framework consists of several levels of 
analysis and presents novel analytical constructs. The second part of this chapter is 
describing how the approach undertaken and applied in the problem situation practice, 
which consists of the research model, change agent perspective, beneficiary perspectives, 
and lastly the interpretations.  The chapter will conclude with the summary. 
 
Figure 5-1: Chapter 5 Structure 
5.2 Developing the Analytic Framework  
The analytic framework consists of three main elements shown in Figure 5-2. The 
research perspective is to detail the philosophical stances underpinning the framework. 
Next is the level of analysis, which comprises facts data collection, classification and 
segmentation; interpretation of classified data and of the relationships between those 
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involved; and the explanation of the causes, reasons, motivations, attitudes underlying 
the informants observed behaviour. The final level is that of the analytic constructs, which 
are the actors and technology.  
 
Figure 5-2: Analytic Framework Elements 
5.2.1 Research Perspective 
This section will discuss the understanding of the analytic framework in terms of the way 
in which the knowledge is gained and defined (Galliers, 1991). After comprehensive 
analysis and critique of the current literature, no framework or theory has been identified 
that is able to comprehensively address the complexity underlying these research 
questions. The analytic framework is therefore predicated upon the assumption that no 
single clear conceptual framework can be deduced from literature. The research gap is 
that no current research has investigated the reasons for the improper use of the IP by 
children in Saudi Arabia from the sociomateriality perspective. This research adopts an 
interpretivist epistemology that is primarily based on the interaction of the researcher with 
the lived experience, based on the beliefs of those involved. This epistemology has been 
selected in an attempt to better obtain a new and in-depth perspective on the patients' and 
their families' drivers to misuse the IP.  
Research 
Perspective
Level of 
Analysis
Analytic 
Constructs
Chapter 5  Technology Adoption framework for IP (TAF IP for children) 
 
 
 -100- 
5.2.2 Level of Analysis 
The main aim of this research is to gain a better understanding of why some patients are 
misusing the IP. The analytic framework will combine three approaches. The first, used 
to understand the differences in discourses, dialectics and contradictions between 
different actors, is the contradiction approach (Seo and Creed, 2002; Van Parijs et al., 
1982). The second is sociomateriality (Leonardi, 2013), an analytic approach that can be 
used to understand how interactions between the individuals, technology and society are 
able to shape views, understanding and behaviour. Different actors often have different 
perceptions, which can result in the creation of a new perception with regards to the focal 
agent (users’ perception) (Van Parijs et al., 1982). For this reason, the third is the theory 
of reasoned action (TRA), because new perceptions towards technology are generally 
assumed to affect the attitude and the way the technology is utilised, as illustrated by 
frameworks like TAM, TRA, HBM (Ajzen, 1994; Mathieson, 1991, Montano and 
Kasprzyk, 2015, Gao et al., 2015). In simpler terms, the interactions, and presumably 
contradictions, between different actors having different discourses to understand and to 
define a particular technology mean that the focal user can generally be assumed to have 
a new consolidated view towards that technology. This will typically be reflected in 
his/her attitude and behaviour towards the technology.   
The analytic framework will be based on three levels of investigation. The first level is 
based on the facts, narratives and discourse of the diverse agents involved in this context, 
in an attempt to properly comprehend the perspective of each agent. This level utilises 
three main categories to make sense the facts: the discourse perceptions (including 
opinions and subjective norms) towards the IP; discourse is “defined as the symbols, 
idioms, metaphors and adjourns” (Johnson-Laird 1983, p.377); and the perceptions as 
mental models of each, looking at how each party perceives the other and the object (i.e. 
technology) (Johnson-Laird, 1983). 
The second level seeks to understand why parties say and do particular actions (i.e. the 
interpretation of classified data and of the relationships between those involved). This 
level seeks to go more in-depth by associating different perceptions together to construct 
appropriate mental models in order to uncover how the various interactions and 
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contradictions shape the perceptions (Van Parijs et al., 1982). This is important, since 
different kind of contradictions creates different kinds of behaviours (ibid)(Leonardi, 
2009). Here the analytic framework serves to provide and derive an understanding of the 
facts, taking into consideration the various theories that can be partially or wholly utilised 
to explain those facts. As a consequence of this, the proposed analytic framework restricts 
the understanding into a limited number of main interpretations: understanding how 
different discourses and perceptions shape the perception of beneficiaries, using both 
contradictions and socio-materiality theory; and understanding how the produced 
perception creates a pattern of behaviour, using TRA (i.e. the belief that subjective norms 
affect attitude, which in turn affects behaviour).  
The third level is what I propose based on my understanding of the data and my 
interpretation of those findings in the research context (i.e. an explanation of the causes, 
reasons, motivations, attitudes underlying the informants observed behaviour). This level 
is provided in the discussion as future research.  
These three levels of knowledge were formulated as a pyramid, illustrated below in 
Figure 5-3, to highlight findings from the preliminary evaluation that have been 
synthesised, combined in this research. Then, through the use of the different 
interpretations I developed my explanation. To validate my explanation and ensure that 
it is based on strong evidence, the explanations are contrasted and supported with 
literature in order to evaluate their external validity (i.e. applicability and generalizability 
What I explained
What I interpreted
What I observed and was told
Figure 5-3: Level of knowledge 
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of these propositions in different contexts). Finally, I propose an analytic framework that 
can be utilised by other researchers operating in different contexts to support them in 
facilitating their acquisition of interesting results and findings based on the three level of 
analysis described above. 
 
 
5.2.3 The Analytic Constructs 
The concept of the adoption process was originally borrowed from the organisational 
transformational process (Venkatesh et al., 2012, Thong et al., 2006,  Lee et al., 2015). 
The transformation of organisations is usually undertaken by external persons, otherwise 
known as change agents, to the people who will be changed and who shall therefore 
benefit from the change, because of which they are called beneficiaries. This process is 
typically championed, managed and followed up by the sponsors in order to ensure the 
quality of the change. This is also true in the medical context, when a doctor and educator 
introduces the IP to a diabetic child and their family. Here, the main beneficiary is the 
diabetic child, who can be expected to be the one who is most affected and whose lifestyle 
is directly changed. The supervision, controlling and following up is carried out by the 
sponsor, who in this case is the parents.  
The main reason for the adoption of this framework in this research is that it offers an 
understanding of the practices, discourse and perception of each actor. As with the 
literature on transformational changes (Badewi et al, 2013), every stakeholder may have 
a different, specific agenda of benefits from the change. For this reason, each stakeholder 
is likely to be acting and defining the change based on their personal perception of the 
benefits and problems associated with the change. This recognition of individual agendas 
may be a reason why this framework has been shown to have significant success in 
information technology adoption (Karahanna et al., 1998). It is for this reason that the 
idea of different actors is used to investigate the different perceptions and motivations 
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(i.e. perceptions of benefits and dis-benefits) that arise from the change in the lives of 
diabetic children due to the existence of the IP. 
To understand the facts, I interviewed the main actors: namely, the change agents (doctors 
and medical personnel) and the beneficiaries (diabetic children, who are the users of the 
IP, and their care givers). Working from ‘what I was told’, I identified the discourse 
utilised by each participant, the main ideas that each individual has focused on and the 
ways in which they define and approach the technology differently. In this way, I 
‘interpreted’ the main clashes in their understandings and identify how these are reflected 
in their behaviour (i.e. to discern why they do what they do). From that, I drew my 
conclusions and endeavoured to form a cohesive explanation.  
  Analytical Constructs 
 Technology Actor 
 
 
Facts 
The definition of the IP for different actors. (How they view the IP, 
benefits and drawbacks? In addition, attempt to capture the 
discourse used to express their views.) 
Interpretations/
Understanding 
Understanding the misunderstandings and contradictions that exist 
between actors in understanding technology functions 
Explanations/ 
propose 
How the interactions and contradictions are to shape the attitude, 
motivation and behaviours of the diabetic child towards the IP?  
Figure 5-4: The analytical framework 
5.3 Summary of the (TAF IP for children) 
The framework is built on two main theoretical ideas. First, the contradictions in 
understanding a single object can lead to a new understanding and definition of this 
object. This is because the definition of the object, such as an IP, can lead to a particular 
attitude towards it, which in turn results in particular behaviour and patterns of use.  
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Second, theoretical foundation is provided by the sociomateriality approach, which 
considers how technology affects us and how we affect the technology. In other words, 
different ways of perceiving the technology can lead to different uses of the technology, 
which leads to different outcomes. These outcomes and this way of using the technology 
affects our life and our perception towards life. By combining both theoretical 
foundations which are the contradictions and sociomateriality, the assumption is that the 
different actors (doctor, caregivers, patients, their family members) have different 
perspectives, definitions, attitudes and motivations that determine their views on why IP 
should be used). Special attention will be given to the contradictions among them in 
understanding and motivations towards the IP. The interactions between these 
contradictions may lead to a unique perspective of the child towards the IP and therefore 
unusual behaviour (i.e. misusing) towards the IP. Based on these assumptions, the 
research question, aim and objectives were addressed. 
The analytic framework was developed through explicating the research issues that arose 
when technical and psychological perspectives were brought together in a unified 
framework. These issues influenced the choice of levels of analysis, analytic 
constructs and finally the application of this analytic framework to a real-life problem 
situation that led to the scientific explanation 
5.4 Approach of the analytical framework  
This section describes how the approach undertaken in this research was applied in the 
problem situation in practice. The focus here is to better understand the relationship 
between the change agent (doctors and educators) and the beneficiary (the diabetic child 
who benefits from the IP and his/her family), as well as the ways in which this relationship 
may affect the perspective, attitude and behaviour of the beneficiaries toward the IP. The 
implementation of the analytical framework and research methodology has two discovery 
stages that target the change agents and beneficiaries. Because the focus is on the 
perceptions of change agents and beneficiaries of the technology, the research method is 
empirical – the discovery stage is based on unstructured and semi-structured interviews 
in phase one and case studies in phase two. 
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The first discovery stage is to understand the perspective of change agents toward the IP. 
In this case, the change agent is the person(s) who introduces and follows up the IP device 
with the patient. As described in the previous chapter, a change agent is expected to have 
effects on the perception, attitude and behaviour of the diabetic child and his family 
towards the IP. Therefore, their practices and the reasons behind these practices are 
crucial in encouraging the patient child to avoid improper use of the IP. The discovery of 
these was conducted by means of unstructured and semi-structured interviews. 
Furthermore, how change agents act in the relation to other actors (e.g. family and friends) 
is also considered, in order to investigate what makes it possible for them to change 
patients’ perspectives. The aim of the second discovery stage, carried out by means of 
case studies, is understanding the differences between beneficiaries (i.e. the diabetic child 
and his/her family) and change agents, with particular emphasis on studying how the 
interactions between them develop and influence the beneficiary perspective, attitude and 
behaviour toward the IP.  
In this chapter the application of the analytic framework, developed in section 5.2, is 
centred on the change agent perspective in the first part of the chapter (section 5.6). The 
second discovery stage takes two case studies centred on the perspective of the patient 
and the family towards the IP, the interaction with change agents, and how all of them 
perceive technology (section 5.7). 
5.5 Research Model 
Previous research into the understanding and improvement of technology usage 
behaviour has developed four main theories. First, technology acceptance models (TAM), 
which claim that the main drivers of behaviour are motivations to use and that these are 
informed by the perception ease of use and usefulness (Şener et al., 2015). Second, 
theories that seek to explain the relationship between change agents and beneficiaries, as 
well as the ways in which the characteristics of change agents can affect the perceptions, 
attitudes and behaviours of beneficiaries (Venkatesh et al., 2012, Thong et al., 2006). 
Third, the contradiction perspective, which shows how discrepancies and conflicts in the 
discourse can result in unintended consequences (Schultze and Stabell, 2004). Fourth, the 
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sociomateriality approach, which holds that perception towards a given technology is 
built by the interactions between that technology and its users. 
Drawing from each of these theoretical frameworks, the three main elements of the 
research are: 
 How the change agents (i.e. doctors and educators) perceive the IP and persuade 
the patient to adopt its use, which influences their interaction with the 
beneficiaries; 
 How the caregivers (i.e. parents) perceive relationship between their diabetic child 
and the IP; 
 How the diabetic child perceives the IP and himself with the IP, and the influence 
of their belief in the ways that others see them, looking at the way that these 
perceptions impact upon behaviour. 
In order to understand these relationships, two research stages have been designed. The 
first stage is based on the interviews with the doctors and educators (Change Agent). The 
interviewees were asked to discuss how they perceive and define the IP, their motivations 
to prescribe it, convincing tools and mechanisms, how they manage poor IP behaviours 
with patients, and the most likely reasons for this improper use from their perspective. 
The aim of this phase is to better understand how change agents perceive the IP, which 
can in turn influence the perspective of their patients towards the IP.  
The second stage is based on two case studies with two diabetic children (Beneficiaries 
Diabetic child) and their families (Beneficiaries). This area of study aimed to understand 
the relationships between the patients and the IP, as well as how this understanding is 
formulated through the use of narrative analysis (patient stories with the IP, with parental 
opinions of the IP, and both good and bad stories with the doctors). As shown in the 
Figure 5-5, this procedure seeks to provide an understanding of the misunderstandings or 
contradictions between all actors, which can build unintended perceptions towards the 
technology that formulates unintended attitudes and therefore behaviours towards the IP.  
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Figure 5-5: Model to understand diabetic child behaviour 
A wide range of research strategies and approaches are available for this investigation. A 
good example of these possible options is ethnography, which is a potentially helpful way 
to understand the beneficiary’s perspective. Ethnography would require me to follow and 
observe the patient and his family from pre-transition to post-transition, however it is not 
necessarily the case that the patient would be engaged in improper behaviour with the IP. 
Indeed, by default it is assumed that most of users are properly using it due to its obvious 
benefits. There is also the risk that the presence of the researcher would influence 
beneficiary behaviour, adversely affecting understanding of potential problems. This is 
especially problematic given that the aim is to highlight the situation of beneficiaries who 
are engaged with improper behaviours and who struggle with the IP.  
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Therefore, the adopted approach in this research is the inversed method. In other words, 
I searched for families who are struggling with the IP due to non-medical reasons. 
Through the use of my informal networks, I was able to find two families who have 
diabetic children that use the IP and who are struggling with its use, leading them to feel 
at least partially dissatisfied with it. I approached these families and started narrative 
research to capture their discourse. In other words, the interviews and observations are 
led by the stories about and from the patient, his/her family, his/her doctors, and his/her 
educators. Questions were developed from the analytic framework in the previous 
chapter. To avoid any subjectivity in the interviewees, I met doctors and educators alone 
and then met the diabetic child with his/her family alone. 
Because the study is focused on children who cannot express themselves entirely, 
meaning that the observation of their interactions with their parent and other family 
members is especially important. Both case studies were carried out in Saudi Arabia, in 
two different locations, which means that it took a few weeks to look for suitable, willing 
participants. 
5.6 Change Agent Perspective  
This section aims to define and to thereby better understand the roles and powers of the 
change agents, which allow them to affect the perceptions of patients. An attempt was 
also made to learn how they act in the context of those roles and how this makes it possible 
for them to change patients’ perspectives. Therefore, the first point is to understand why 
change agents are prescribing the IP. The answer to this question should help in 
understanding how the IP is defined and justified by the change agent. The second point 
is the power used by change agent to push patients to adopt the IP. The aim of this 
question is primarily to understand how the relationship is established between 
beneficiary and change agent, as well as to clarify the communication sent to the 
beneficiaries to motivate them to use the IP. Finally, the study sought to identify the 
discourse used by the change agent in describing the reasons for improper use in order to 
facilitate understanding regarding the perception and definition of the problems facing 
the IP.  
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5.6.1 Change Agent Motivations to prescribe the IP 
There are different motivations for prescribing the IP to diabetic patients. In order to learn 
some of these from practising medical personnel, I asked each change agent why they 
prescribe the IP. 
The first motivation is the real need for the patient to use the IP, from either a medical or 
social perspective. These can be seen in the following: 
“I prescribe the IP because it has several benefits to patients… All diabetic 
patients want to have a like normal life, without worrying about diabetes. This is 
why I prescribe the IP – to make the patient’s life better.” DP.B  
"Some patients are facing issues with needles and do not want to have many 
injections. So the IP is better alternative to the needles injections, they will have 
it attached for 3 days and must be replace after 3 day with a new infusion set." 
DP.As 
Thus, the insulin pump is prescribed by doctors to control diabetes and to achieve the 
target HbA1c level.  Indeed, over 60% of the change agents that interviewed are strongly 
arguing for the IP for those in type 1 diabetes, whereas none of them are strongly 
recommending it for type 2 diabetes. This may be an indicator that it is not possible to 
verify that the first cause of the decision among many doctors is monetary motivation, 
however the motivation for doctors to advise the use of the IP for the sake of patient 
health and wellbeing can be verified. Doctors were found to only advise IP for type 2 
diabetes in special cases. 
 "If the patient is insured, it is better, because the treatment is expensive. I simply 
need to write a good report to the insurance company recommending that he 
needs the IP. The same is true with the diabetic organizations  that we have … 
they will only reduce the price of the device...”DP.Al 
There also seems to be a common belief that prescribing the IP can make medical 
personnel more famous in children diabetic clinics. 
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"I was told that the more the doctor prescribes insulin pumps, the more popular 
he will get.” E.MP 
For this reason, prescribing an IP can be seen as a mechanism to attract more patients, 
because Saudi Arabia has few doctors in this sector and who are therefore capable of 
prescribing it. One of the supporting evidence for this assertion is the following quote:  
“I have patients who come from different cities to me treat their diabetes with the 
IP” DP.Ab 
Theme Sub-theme 
Non-patient motivations Profit. Be famous. Attract patients 
Patient related motivations Improving quality of life  
Patient medical reasons 
 
5.6.2 Using change agent power to avoid improper use of the IP  
There are numerous different motivations for change agents to prescribe the IP, so they 
use a range of mechanisms and powers to convince patients and their families to use it. 
In this respect, a number of questions were asked to participants, including: “How do you 
motivate and encourage your patients to use the IP?”, which is addressing non-medical 
superiority authority motivational techniques; and “What if the patient and their families 
are not interested in the IP, but you see necessity?”, which is investigating medical 
superiority authority motivational techniques. 
One mechanism cited by interviewees is by influencing the perceptions of the patients 
and their families.  
“The patient wants to have a better lifestyle and to avoid injecting lots of insulin 
to the body. If we address these points to them, I believe that they will use the IP 
in the right way.” DP.M  
The first technique, which adopts the medical superiority power, is to show potential 
beneficiaries the future state their life will be in should the illness, arguing that the IP has 
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the potentially to prevent this. The second strategy is to show them their current state of 
health, explain how it is miserable and to persuade them that their situation would 
improve through use of the IP. This can be seen in the following comment:  
Some of my patients are experiencing troubles with the having a better control of 
diabetes because of the life style they have, they are always out with friends and 
don’t take the normal insulin pens, so I am telling them that the IP will be better 
for them so they can have the insulin at any time without it, they can suffer a lot” 
D.H 
Both techniques come from the knowledge power of the change agents, which enables 
them to affect the beneficiary’s perceptions and attitudes toward their current and future 
health situation. Change agents use their medical knowledge power to convince the 
patients that they should use the IP by showing that it is necessary to their health. Doctors 
believe that before the transition patients are more likely to listen carefully and believe 
everything: 
“Most of my patients were my clients. Once I referred them to use the IP, they 
trusted me and they did that.”  
Manipulating realities Theme  Sub Theme 
Using medical superiority 
power 
Showing that their future 
health will suffer if IP is 
not used 
Focus on medical reasons. 
Focus on deteriorations in 
patients' health without the 
IP. 
Using knowledge power Showing that the current 
state is miserable and that 
IP will improve quality of 
life 
Focusing on social and 
psychological benefits of 
the IP. 
5.6.3 Reasons for improper use from change agent perspective 
Understanding patients’ demotivation factors from the perspective of the change agent 
could be challenging. However, the aim here is not to claim these factors are final results. 
Instead, differences and similarities could match the gap between the assertions of change 
agents and the human and social beneficiary actors. From the perspective of change 
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agents, the post-transition phase motivation of patients starts to decrease. After the first 
four interviews, the reasons for this became clear and were integrated into the interviews 
that followed. Indeed, although they are known to the change agents, they have found 
only two clear strategies to deal with these issues: threatening the patient and their family 
about health risks; and telling the patient and their family to switch back to needle 
injections. Analysis of the interviews suggests that these strategies are only effective in 
the short term and that once patients fall in the motivational trap of not being interested 
in using the IP, these strategies become ineffective. Indeed, according to the change 
agents, literally all cases fall in the motivational trap and are therefore not able to use the 
IP in a proper way. According to the analysis of those interviewees who use enforcing 
motivations, their patients either quit, move to using a different change agent, or use the 
IP with enduring and continuous problems and disputes.  
Nevertheless, it is interesting to learn how the change agents’ perceptions of the impacts 
of the IP on the lives of beneficiaries are true from the perspective of those patients. This 
issue is dealt with in greater depth in the next section.  
Because of the adverse relationship between the change agent and beneficiaries, 90% of 
the doctors perceive the main reasons for the misuse of the IP to be attributable to patient 
carelessness. 
“The most important thing determining the proper use of the insulin pump is the 
carelessness of the adolescent diabetic patients.” DP.An 
“Once, I had a patient who admitted that he does not want to take responsibility, 
even though he was motivated. He always forgot to count carbohydrates or to 
measure his blood glucose.” DP.A  
“Some patients do not care about the consequences of not following the proper 
monitoring and counting carbohydrates. They come to the clinic with a high 
HbA1c level, because they have not entered the carbohydrate that they ate.” DPN 
Their perspective may or may not be correct. However, according to the health belief 
model (HBM), if the patient believes and sees the value of the medical device, he can be 
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expected to be significantly more likely to use it. The issue here is the inability of the 
change agents to properly understand the psychological motivation and de-motivation for 
using the IP. This can be understood in reference to a critical factor like ‘feeling being 
enforced’, where only few of doctors agree that this may be an important factor. This 
position is also contrary to theory. For example, the psychological reactance theory states 
that once a person loses his freedom due to any decision or technology, s/he will reject 
it.5 This may partially explain the misuse of the IP, however very few of the doctors 
interviewed  believe that the main reason for misusing the IP is the ‘feeling being 
enforced’ and those that believe this only use psychological indicators to assess IP 
performance in a very small number of cases. Only one of the change agents recognised 
that psychological reactance toward obligation to use the IP is a strong factor in its misuse, 
noting that this reaction becomes more common if the patient begins using the IP after 
childhood.  
“Adolescent age is the most difficult age to treat diabetes. A 4 year old patient is 
easier than a 12 year old. The older the age, the higher the perception of seizing 
freedom due to the IP.” DP.B. 
This psychological reactance is clearly illustrated in this anecdote:  
“This adolescent has something called disobedience. He might not want to do 
something because he does not feel like doing it, even though he knows the proper 
way, but he does not want to do it… He said to me ‘I didn’t feel like entering the 
carbohydrate and measuring my BG. I feel that I am being restricted by a certain 
boring daily routine’.” DP.An 
Another factor for misuse from the change agent perspective is too much confidence in 
the technology. The literature states that the greater the trust a person has in technology, 
the more they will use it. However, change agents in this research, too much confidence 
can lead some patients to believe that the IP is infallible. The result of this is that they do 
                                                 
5 This is a realistic interpretation, but it may be revised in light of additional data. Different kinds of patient 
will then be able to modify or refine that interpretation. 
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not follow procedures carefully, believing that no ill effects can occur, and therefore 
experience problems from the IP usage.  
“Some patients, especially adolescents, think if they get the pump they are 
controlling their diabetes without the proper bolus correction, healthy diet and 
exercise. I believe here is the problem and the mother of all devils.” DP.B 
“I have a few patients who do not come for the follow up diabetes routine check-
up, maybe because they think the pump is working fine and it is safe enough, thus 
they do not need to come back to follow up.” DP.B 
“Where is the parent? she have to look at her child, and remember why at the 
first she had it for her child. This is a much known case. They are irresponsible”. 
Dada 
Change agents cite other problems, like social issues (being shy about using the device in 
public) and human factors (the IP routine adversely affecting lifestyle). Nevertheless, 
although many change agents claimed that the behaviour of beneficiaries potentially 
hinders the proper use of the IP, they do not have any clear strategy to deal with these 
issues. Design issues were cited as one problem, as the IP is big enough to be visible 
under clothing, which is particular problematic for girls who wear light clothes in social 
gatherings. This was noted by E.RS:  
“I have a few girls who eat and do not enter the carbohydrate and measure her 
blood glucose if she was with her friends, she does not want to show that she is 
wearing a medical device. So she eats without pumping, this affects her BG a lot, 
and I had gave her several warnings.” E.RS 
Another change agent also said, 
“Children who play a lot and do not record their blood glucose before and after 
the meal can have a problem, and that why we try to tell the parents to tell the 
school to monitor the child’s activity. That’s why it’s important to have a family 
who understands.” E.M 
Chapter 5  Technology Adoption framework for IP (TAF IP for children) 
 
 
 -115- 
“The most problems we face is that parents don’t measure the blood glucose of 
the child to be entered, they are not accurate enough…. It is very important that 
they do that, because the insulin pump is programed to eject the insulin desired” 
EP.AS 
“They had seen it before I prescribe it, and know that it will be connected to them 
and must take the responsibility, especially the parent, they are the responsible 
for their children, they would know how their child will use it.... if they can’t use 
it in the correct way, then it’s not for them, simple” DP.An 
“Measure issue is the carbohydrate count. . . I am not sure how much I want to 
emphasize about that. Patents and patient don’t count the carbohydrate, even 
though they had attended the education on diet, and they know how to do it,, I 
have several times asked the patient, and the mother, they know how, but are too 
lazy to think harder and take it seriously” EP.E 
However, this does not absolve change agents of their inability to handle patients who are 
sensitive to this unintended consequence of the ‘poor’ design of the IP. However, 
sensitivity to these issues can be proposed as being a likely reason for some degree of 
improper use of the IP.  
For this reason, claiming that carelessness is the main reason for the improper use of the 
IP strongly suggests that miscommunication exists between the two actors and is 
therefore one of the factors in the misuse of the IP. 
Having discussed the perspectives of change agents, the next section will now examine 
those of diabetic patients. 
5.7 Beneficiary Perspective: Diabetic Child and family  
The three main actors are change agents (i.e. doctors and educators) and beneficiaries (i.e. 
patient and caregivers). In the diagram below (Figure 5-6), the orange character depicts 
the main user beneficiary, i.e. diabetic child; the blue character on the left denotes other 
actors (change agents); and the character on the right represents the beneficiary as a 
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caregiver. Each actor has their own views, perceptions and language used with the regards 
to the IP. The relationships and interactions between these different actors combines to 
formulate the patients’ specific perceptions towards the IP. 
  
Figure 5-6: Contradiction Framework 
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5.7.1 Change agent perceptions 
i Discourse used in defining the IP 
Doctors always explains the IP using medical language and metaphors. As illustrated in 
Figure 5-6, change agents simply view the IP as a medical tool that enables the regulation 
of the sugar level in blood, where improper use adversely affects the patient health. 
“The IP will control the diabetes of the diabetic patient by having it programmed 
with basal and bolus… but the patient needs to record BG and enter the carb of 
all food consumption.” DP.A. 
Other studies have shown that doctors focus more on the medical aspects of the IP than 
the social aspects (Lawton et al., 2015). In other words, the discourse of change agents is 
largely characterised by the use of technical and hard language. The following quotation 
is an example of density of technical medical words in defining the medical device.  
“We want to achieve the HbA1c level of the patient reaching normal levels. If it 
is used correctly, this is the main point: to control the diabetes and achieve the 
target HbA1c level… the Basal is programed to produce insulin during the day 
and the bolus when the child eats… so he needs to enter the BG and the 
carbohydrate count to produce the correct amount of insulin…” DP. E. 
“The patient will need to understand the basal and bolus and when to use it, 
because the purpose is to prevent hypoglycaemia, hyperglycaemia and DKA from 
happening.” DP.A 
This is supported by institutional logic literature, which shows that medical staff almost 
always prefer hard, deterministic and technical language (Witman et al., 2011). 
ii Discourse used in understanding patient behaviour  
To understand the interactions between change agent and beneficiaries, the change agent 
were asked questions that sought to uncover their perceptions of the technology, how they 
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deal with it, and their beliefs in the value of the technology for their beneficiaries. The 
summary of the findings of these questions are illustrated in Table 5-1. It is evident from 
the analysis that change agents favour technical and medical language, with the view of 
the IP almost solely as a technical device rather than one that is connected to a human 
body forever.   
Question Answer Evidence Reflections 
How they define 
the IP, and when 
do they 
recommend it? 
It is a technical 
device to 
improve patient 
health 
“She is not counting the 
carbohydrate properly. 
She is also not monitoring 
her blood glucose.” 
F.Ch-Agent 
 
“The routine check-up on 
the HbA1c is an important 
appointment for diabetic 
patients.” M.Ch-Agent 
Technical and 
medical language  
How they deal 
with it? 
Convincing the 
patients to use it 
for their health 
“I told her several times, 
if she is not using the IP 
as it should be, we will 
need to switch.” F.Ch-
Agent 
 
“The problem with 
Mustafa is his family does 
not care about how to use 
the IP. This is not good for 
their son’s health issue.” 
M.Ch-Agent 
How they 
believe in it for 
their 
beneficiary? 
It is necessary to 
help them 
overcome their 
medical issues 
“IP is critical for Nora, as 
she may fall into DKA 
without it.” F.Ch-Agent 
Reactive strategy in 
handling improper 
use. A1 c level poor 
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Table 5-1: The interaction between change agents and beneficiaries 
 
It should also be noted that change agents tend to use a reactive strategy in following up 
the patient use. They focus on the measurement of HbA1c level to determine the quality 
of IP use, despite the fact that HbA1c is a lagging indicator not a leading one, meaning 
that it is primarily useful in detecting abnormality after extensive misuse of the IP. 
However, if the change agent understands the attitude, motivations and demotivation for 
beneficiaries to use the IP, these can be a leading indicator for improper use.  
5.7.2 Caregivers’ perceptions, feelings, attitudes and behaviour  
i Discourse used in defining the IP  
Parents do not perceive this technology (IP) as a source of pain and control imposed on 
their children. Instead, they view it as safe and easy enough even to delegate the 
 after misusing the 
IP. 
 
Continuously 
blaming the family 
and the patients, 
putting the 
responsibility for 
correct use on 
them. 
How the patient 
uses the IP and 
the proper use of 
the IP? 
Careless and 
disengaged  
 
“She is not coming to the 
3 month check-up. I had 
to call her several times to 
come. She has become so 
careless about showing 
up for appointments.” 
F.Ch-Agent 
 
“Mustafa’s family do not 
care enough about the use 
of the IP. They do not 
have sufficient time to 
manage their son’s IP 
properly.” M.Ch-Agent 
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supervision of the device to others who may not be sufficiently qualified to perform the 
tasks.  
“The insulin will be attached to my child, and it will be much safer for him to eat, 
as well as at night time…. the insulin will be ejected to him according to the 
settings. And if he needs more, it will be extending a bolus.” M.Mtr 
As the other mother said, 
“I feel more confident about my daughter wearing the IP. It is going to be 
with her all the time and control her diabetes” F.Mthr 
In both case studies, parental confidence has led to delegation of following up whereas 
different in who will take the power. For young children (M.Pai), the power is instead 
given to uneducated servants and siblings, whereas in the case of older children (F.Pai) 
the power is given to the patient him/her self. In the female case, the mother had sufficient 
confidence to delegate the full power to the 15-year-old diabetic child, who is arguably 
too immature to fully undertake this responsibility.  
Perception 
towards 
Technology 
Evidence Reflections 
Safe to use “The IP is really safe to use. I never ever 
thought it can harm my son.” M.Mthr 
 
“Do not worry, the IP is really safe enough 
for my daughter. She knows how to use that 
very well.” F.Mthr  
Delegation of 
usage to other 
members of 
the family 
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Easy enough to 
be used by other 
members 
“My daughter is old enough to take 
responsibility. She is 15, so she can take care 
and monitor her diabetic young brother.” 
M.Mthr 
“I told Maria (servant) whenever she puts the 
food on Mustafa’s plate, she should know the 
carb count and enter it into his IP, or tell him 
to enter it. Sometimes Maria does not obey my 
orders and does not know what he has eaten.” 
M.Mthr 
ii Discourse used with the child  
The role of the caregiver is crucial because children are connected psychologically with 
their parents as well as because mother’s are closer to their children; because mother’s 
typically look after health roles in Arab culture (Al-Ayed, 2010). Thus, by understanding 
how parents perceives the technology, as well as how they think their child and friends 
perceive the technology, the reasons for any positive or negative attitude towards it can 
be better understood. Therefore, the parents were asked a number of questions on the 
topic: 
 “Are you happy with IP used by your son/daughter?” 
 “How do you feel your son/daughter feelings towards the IP?” 
 “Do you think your son is happy with it?” 
 “Do you think the doctor is happy with the way your son using the IP?” 
 “How does he/she use the IP in public (e.g. friends, relatives) perceive the IP?” 
 “How does he/she react when manage their IP, or when you manage the IP?”  
The potential misuse of the IP should not necessarily be attributed to the diabetic child. 
The perceptions of their parents toward dis benefits, which are then perceived by child, 
have been reflected in the post transition phase. The parent’s perceptions may also vary 
towards different age groups. In addition, the potential use or misuse of the IP could be 
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affected by the child’s emotions, which influences the behaviour and attitude of parents 
towards the technology.  
 
a. Perception towards the child  
The older the child is, the lower the feeling of pity and the greater likelihood of delegation 
and forwarding of responsibility to them. However, in situations when the child is not 
sufficiently mature to take the responsibility, the reaction might be disobedience or 
psychologically reacting against this technology. The mother insisted that her child knows 
how to use the pump and manage her diabetes very well, but the adolescent takes sole 
responsibility, noting that:  
"I do not know how to count her carbs and measure her blood glucose better. She 
knows more than her mother." F.Mthr 
Answer Evidence Reflection 
Old enough  “She is old enough to do it. We have 
spent enough time with the educator to 
teach her and she knows what is good for 
her health.” F.Mthr  
The problem occurs because 
of the misunderstanding 
between mother and the 
child. The mother believes 
that the daughter is old 
enough to carry out all of the 
responsibilities. However, 
the daughter is careless 
about accomplishing the 
tasks. This leads the mother 
to see her daughter as 
disobedient. In response, the 
mother becomes 
disinterested and disengaged 
in following up. 
Reliable 
enough 
“Nora knows more than me, so I feel 
confident that she knows how to use the 
insulin pump and when to eject and when 
to correct the bolos.” F.Mthr 
Careless “She knows what is good for herself. She 
keep copying her friends and showing off 
with her friends. What can I do for her? 
I can’t help much” F.Mthr 
 
“I told her father about her actions… 
maybe he can do something” F.Mthr 
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Disobedience  “I told her to buy dresses that can open 
from the front, so that she can eject 
insulin when she goes to the party, but 
A.P does not listen to me.” F.Mthr 
“Nora tells me that it’s her choice and 
she can wear what she wants.” F.Mthr 
“She wants us to realise that we are the 
issues for her diabetes.” F.Mthr  
 
b. Feelings and behaviours towards the diabetic child using the IP 
The younger the child the more the emotions and behaviour of the parents are affected by 
the feelings of the child (Morris et al., 2007). For the first case study with the young 
diabetic child, the mother reported being affected by her son feeling odd, in pain, or being 
controlled. This resulted in her showing extra sensitivity and pity towards him, which 
affected her emotions and may have led to misuse the IP as accepted. This results in the 
mother not cooperating in proper use of the device. In fact (M.Mthr) is intentionally (from 
interviews) and unintentionally (I saw from observations) reacting negatively against the 
proper use of the IP by giving her son more freedom, less pain, less control, and more 
sweets. As an example of this, during observed case study I intentionally was talking 
about something outside the scope so that I can observe how the mother is treating her 
child (in both meetings and interviews), I saw her son incredible amount of sweet. It was 
also interesting that she did not offer his siblings the same quantity of sweets or told him 
to stop or even. This is an indication of the psychological reactance behaviour (Lauren, 
2012), which states that the more one feels restricted in the use or consumption of a certain 
product, the greater the motivation to consume it. In this case, the same behaviour was 
noticed for the son (M.Pai). During the observation, I looked at her son while he was 
eating lots of chocolates and his mother told me: 
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“It’s ok, I will record the carb count. I do not want Mustafa to feel different or 
restricted because he has diabetes… and that is the feature of the IP, that it gives 
flexibility in eating.” M.Mthr.  
In addition to this, the mother knows that her son is eating chocolates extensively in 
school, which is contrary to the correct management of diabetes and use of the IP. 
However, she does not want to ask him about his consumption levels, as she wishes to 
prevent him from feeling guilty about the quantity of sweet that he consumes.  
“I am not sure what he eats in school. I will try to ask later what food they serve, 
but I have not yet, because B does not tell me what he has eaten.” M.Mthr 
The sweet diet is even reflected in the body weight of the child. His doctor perceives that 
the mother is careless and may withdraw the IP because of that view: 
“Mustafa is getting overweight. If his mother does not improve his diet, we need 
him to go back to the insulin injections. This is the problem of the mother’s 
responsibility towards her child.” M. Ch. Agent 
Furthermore, regarding her son’s feelings of pain, I noted that she admitted to sometimes 
forgetting to replace the IP. This kind of behaviour was used as an example of 
carelessness by change agent.  
“Ahh sadly, sometimes I forget to change the IP every 3 days. I know it should be 
changed regularly, but I forget!” M.Mthr 
Table 5-2: to the mother of the young boy: How do you feel your son/daughter feelings 
towards the IP? 
Answer Evidence 
Feeling odd “Wallah! My dear I want him to feel like his brother and sister, 
that he is not sick.” M.Mthr 
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“I do not want him to feel that he has restrictions. It’s enough 
that he is already diabetic, and a medical device is connected to 
him.” M.Mthr 
Feeling of pain “He always panics when I change his syringe because it hurts 
him a little bit. That’s why I try to change it for him every 4 days 
and when I do, I try to make sure it is clean around it… but if 
Mustafa is getting itchy, I change it right away.” M.Mthr 
Being banned 
from sweets 
“I do not want Mustafa to feel that he is a special person who 
cannot eat what he wants, and be left out, or feel different from 
the others.” M.Mthr 
Feeling of pity “Poor boy, alhamdulillah, he is in a good health but I still feel 
sorry for him.” M.Mthr 
5.7.3 Patient self-perception 
Observations and questions have been used in this research to understand how the 
interactions between different actors can shape meaning and opinion of technology. 
Observations were used to understand the interactions between the patient and their 
family regarding the IP, as well as the relationship between the patient and the IP. In order 
to obtain an insight into the way that patients perceive themselves in the context of the 
IP, as well as their perception of the IP and their understanding of the perceptions have 
of them, the following questions were asked: 
 “Are you happy that you are using the insulin pump now?” 
 “Do you use it when you go with your friends or in public?” 
 “Is it ok if they see that you are wearing the IP?” 
 “Have your friends commented about you if you are wearing an IP?” 
 “What is your thoughts about wearing the IP in public?” 
The aim of these questions was not only to understand the attitude of the patients toward 
the technology but also to understand how they view the perceptions of others towards 
him/her and the specific technology. This is informed by the belief that these views shape 
the understanding, perception and attitude of diabetic youngsters toward the IP.  
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i Discourse used in defining the IP 
Children, because they are young, have a more limited understandings of the world than 
adults. They talk about the IP as a device to replace needles, or for the older child, a way 
for her to administer insulin and improve her lifestyle. Investigating the discourse of the 
two diabetic children shows that patient feelings towards technology are strongly 
influenced by their belief about how others perceive them and how they perceive the 
technology. The resultant perceptions are affecting the motivation of patients, leading 
them to avoid using the IP in certain environments and contexts. This improper use of the 
IP eventually weakens HbA1c levels, as noticed by change agents.  
The main three observations in both cases are the perception of feeling odd or standing 
out in society, feeling restricted by the technology, and feeling pain. These emotional 
responses result in psychological reactance, leading to the avoidance of IP use and for the 
younger child to attempt to make his device more attractive, by playing with it. These 
situations both lead to misuse of the IP and consequently less control of the patient 
diabetes.  
Feelings Behaviour 
Feeling odd Playing with the IP to show friends he is unique. 
Avoid using it in public and when she meets her friends.  
Feeling restricted Avoid using the IP in public. 
Feeling pain Replacing and changing the IP every 5 days instead of every 3 
days. 
Lifestyle  IP is a tool to improve the lifestyle with diabetics. 
 
a. Lifestyle motivation  
 
Lifestyle can be extremely important for different age groups. Additionally, the lifestyle 
of an adolescent (F. Pai) high school, is likely to be very different than that of a school 
aged child (M. Pai). The adolescent mentioned that she wants to improve her lifestyle 
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despite having diabetes her entire life, claiming that being a diabetic is frustrating because 
she has to monitor the food she eats and to keep injecting insulin. She explained that, 
“When I go out in public shops or restaurant, I cannot eject insulin because some 
places don’t have restrooms, or if they do, they are dirty. The insulin pump is 
much better because I have the insulin with me all the time, I don’t need to store 
it in a cool place and it is programmed to give me insulin.” F. Pai 
She had also identified that she does not want to remember to take insulin pens with her, 
because of the difficulty involved in storing them.  
In the case of the younger child, his attitude when he was explaining about the needles of 
the insulin was one of disappointment that the other children in the house do not have to 
take needles. He said that he understands the reason for this, but still hates it.  
“Ok, I know why I take the needles, but why is it me, and my other brothers do 
not feel the pain of the needles that I feel.” M.Pai 
Therefore, the child stated a preference for the IP, because insulin injections are painful, 
restrict his food intake and make him feel uncomfortable if he needs to inject while with 
his friends. 
 
b. The feeling of being odd in society 
 
This section is based on the answers of the question “How others perceive you because 
of the IP?” The difference between the two cases are mainly due to their particular age 
and gender factors. In particular, the girl wants to be attractive, while the boy wants to be 
strong, leading them to behave differently from one another. Three behaviours were 
attributed to the feeling of being odd: hiding the IP in their clothes whenever they can; 
taking it, or not delaying the entry or input of data into the device to meet with her friends 
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in social gatherings, as well as wearing light clothes (female); and attempting to impress 
friends to avoid being seen as weak or ill when noticed with the IP (male). 
Feeling Behaviour  When 
Feeling 
being odd 
Hiding the IP in 
clothes 
When they are out in public or with friends. Do not 
want to be perceived as different. 
Taking it off / 
delaying use 
Female delays the entry of data into the device to 
avoid using it with friends and in social gatherings. 
Sometimes she even unplugs the device, depending on 
her clothes. 
Playing with it The male, when friends notice the IP, he impresses 
them by playing with its buttons.  
 
 Avoid Using the IP in the Public 
The data show that the adolescent patient (F.Pai) stops using the IP in public places 
because of a perception that others view  her negatively, thinking that she deserves pity 
or should be ashamed because she is ill. This perception was expressed by both the child 
and her mother. This view can encourage a diabetic child to avoid the use of the IP in 
public unless wearing dresses that hide the IP. However, in female gatherings where she 
can wear light clothes, she takes it off or unplug it from her body. So it does not show 
there is a device connected to her. 
Due to a belief that others look at her negatively because of her diabetes, the adolescent 
beneficiary is trying to hide any manifestation of the illness, most visibly represented by 
the IP. During the observation and interviews, I told her that I really wanted to see how 
she used it, so she used it in front of me and became engaged because I told her that I was 
conducting research. 
 
Chapter 5  Technology Adoption framework for IP (TAF IP for children) 
 
 
 
 
 
 
 
 
 
-130- 
Perception Quotation Reflection 
on 
behaviour 
Quotation 
Using IP is 
shameful "People feel pity 
towards the IP. They 
feel sorry!" F.Pai 
 
Avoid 
using the IP 
in public/ 
when going 
out 
“I cannot use the 
pump in public and 
take it out from my 
dress, I just cannot, 
it’s embarrassing and 
I will wait until I go 
home and do it.” 
F.Pai 
“I do not like to use it in 
front of my friends and 
enter the carbohydrate of 
the food I eat… I usually 
mean to do it later, but 
sometimes I forget… It is 
very difficult for me to do 
it in front of my friends.” 
F.Pai 
Being 
diabetic in 
Saudi culture 
is shameful  
“If people know you 
are a diabetic they will 
look at you as though 
you are defective, and I 
do not want that” 
F.Pai 
"You know how the 
cultural is, they think 
it’s shameful to be 
diabetic. Especially if 
they see a device 
connected” [whispers] 
“It’s hard to get 
married if people think 
you are diabetic.” 
F.Mthr 
 
 Playing with the IP 
Similar feelings were noted with the younger child (M.Pai), although this manifested in 
different behaviour. Both the young male child and his mother feel that society looks at 
him negatively. When his friends know about the IP, he tries to persuade them about its 
uniqueness in an attempt to avoid being labelled as weak or ill. When I asked to see the 
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IP, the boy initially refused to show it to me. However, after convincing him that I was 
interested, he showed me the device and started playing with buttons in an attempt to 
impress me, perhaps as a reflective behaviour.  
Perception Quotation Reflection on 
behaviours 
Quotation 
Using IP is a 
shame 
"My friends look at me 
as if I am different or 
ill. But I am not!" 
M.Pai  
Attracting or 
impressing 
others because 
he has 
something 
unique 
“If they see my IP I show 
them the buttons and how it 
works. I want to impress 
them with it.” M.Pai 
"He often plays with the 
IP in the school and puts 
several false entries. It 
won’t harm him, but it 
will make noises and the 
teacher calls me." 
M.Mthr 
Perception of 
being Odd  
"Mustafa feels like he 
is not normal like them 
because he is 
connected to a medical 
device." M.Pai 
ii The feeling of being restricted / lifestyle/ showing off  
This section is based on answering the question, "How do you perceive yourself with IP?" 
Once a diabetic child feels that they have had their freedom inhibited, with their behaviour 
being restricted and observed, they may psychologically react against this restriction. 
Lifestyle restrictions include food consumption, fashion, and daily activities. Freedom 
here not only refers to movement, foods and clothes, but also the freedom from being 
observed. When the child is young, the mother will ask all of the family to constantly 
watch their behaviour, which can lead young patients to resent the IP. However, the first 
perception of restriction is in terms of food consumption, as values need to be counted 
and the BG tested. 
There are two main perceptions noted by the diabetic children here are the perception of 
being observed and the perception of being restricted. A feeling of constantly being under 
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observation can lead a child to lie and to eat when they are away from their supervisor, 
such as at school. One of the mothers (M.Mthr) stated that her son eats chocolate when is 
away from her, which she allows out of a feeling of mercy. In this case, the patient loves 
sweet foods, so is very involved and aware of how the IP shapes his relationship with 
what he loves (chocolate). This makes him very aware of being restricted because of the 
device, with the outcome being that eating too much chocolate becomes a psychological 
reactance to the perception of restriction. The result here is aligned with psychological 
reactance theory, which notes that people will attempt to retrieve freedom (such as by 
eating) when they are restricted from access to what they like (e.g. food) (Lauren et al., 
2012).  
For the older child, clothes and fashion are more important. Although she can use the IP 
underneath her clothes, she explains that she wears an ‘abaya’, a form of traditional gown 
that makes it difficult for her to take the device out and enter data, such as the correct carb 
count or the bolos. Her attitude is to avoid discussion of that problem and the attendant 
risk of high blood glucose, so rather than learn about her insulin value she prefers not to 
take the IP with her. Her mother noted that the child does not show rejection and loves to 
wear light clothes in female only meetings, so sometimes does not wear the device, which 
conflicts with the need to wear the IP at all time, except for shower or maximum 1 hr off. 
It seems that she may be intentionally picking these clothes as reflection that she is normal 
and is retrieving her the freedom that she feels has been seized by wearing clothes that 
nearly shows the IP to be attached to the body.  
 Feeling Quotation Behaviour  Quotation When 
Feeling 
being 
observed 
“I do not love the IP 
because it bothers me 
when Maria and my 
brother ask me what I 
eat. I can eat whenever I 
want and anything… I 
Doesn’t say 
how much he 
eats 
chocolates 
 
"Sadly, I 
know he eats 
lots of 
chocolates in 
When he 
knows that 
he is not 
supposed to 
eat and not 
saying the 
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get so angry when my 
sister asks me, I do not 
like that...” M.Pai 
Active 
resistance 
and 
complaining  
school. But he 
does not say."  
 
amount he 
ate for it to 
be recorded. 
Feeling 
being 
restricted 
"The doctor told me that 
I have to watch what I 
eat, and not too much 
sweets, or hamburger 
and pizza! I have to do 
tests and put the carbs in 
the device. But he 
warned me a lot because 
it makes me fat." M.Pai 
 
Eating un 
proper diet 
“I prefer to wear 
light clothes in 
the female 
gathering… Yes, 
it does not fit 
with the IP. It’s 
my decision, I 
can handle it” 
F.Pai 
When he 
gets the 
chance to 
see sweets. 
Wearing 
light clothes 
In female 
only 
meetings. 
 
5.8 Interpretations: Contradictions 
Different discourses to the same thing is a sign of different understandings and different 
views towards the same objects (Wandel, 2001, White, 1992). This is also reflected in the 
implications and consequences of multiple realities as they are perceived by different 
actors (Parker, 2011). Contradictions (mismatch, non-alignment, discord) have been 
observed between the beneficiary discourse and change agent discourse. Therefore, 
because the caregiver and the diabetic children perceive and define the IP differently, this 
can result in the emergence of miscommunications and misunderstandings.  
This is similar to the findings of the study by Herman (2006), who claims that 
beneficiaries almost always utilise social and soft emotional language rather than 
technical and medical language to explain the IP. This kind of discrepancy in discourse 
between different actors can result in conflicts in understanding and opinions about 
certain technology (Scott, 2012). Therefore, by consolidating different discourses in this 
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section, three main contradictions can be seen between the actors. These will be discussed 
below. 
5.8.1 First contradiction: between change agent and the diabetic child 
The first clear contradiction in viewing and understanding the IP is between the change 
agents and the main beneficiary of the device. Different discourses between actors can 
lead to weak communications and weak informal ties between them (Foucault, 1980). 
This is the case in this relationship, with doctors perceiving the IP as a medical device 
and diabetic children seeing it as a device that will make their lifestyles better, with the 
result that the communication and understanding between the two actors are weak. 
Diabetic children have a discourse full of soft language, using feelings, emotions and 
reflections on life, which is in stark contrast with change agent discourse, which is hard, 
medical and technical. As mentioned by (Appelboom et al., 2014) ”Although healthcare 
is always trying to increase patient’s autonomy and create a harmonious relationship 
between physicians and patients, endowed with this technology some patients could 
erroneously disregard the role of the physician”(p.6). 
Firstly, as the IP is connected to the human body it can be expected to have psychological 
and social implications, as explained below. However, the change agents ignored these 
aspects in the interviews and instead continually blamed the final behaviour, which they 
labelled as careless, on the irresponsibility of the beneficiaries, instead of focusing on 
other factors that affect the use of the IP. In other words, the doctors’ messages and 
authority constantly stress the idea of the important it is to use the IP for medical reasons. 
However, diabetic children often seem unable to comprehend the consequences of 
misusing the IP, leading their doctors to stop talking to the children and place blame on 
their caregivers. One doctor said, 
“I do not blame the child; he is too young to understand and care. I always talk 
to the parents.” DP.E 
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“It’s not the children who are mis managing the Insulin pump, it’s the parent who 
lack the responsibility” E.M 
Differences in the level of perception influence the required need for constraint between 
different actors. Constraint can incite psychological reactance behaviour if the enforced 
person feels no necessity for the limitation (Lauren, 2014), as happened in the cases in 
this research. The doctors believe the IP to be a critical tool for improving the health of 
patients, whereas the patients perceive it more as a tool to improve their lifestyle. This 
pushed the children to react against the IP. As the older diabetic child said. 
“I do not know why the doctor is always threatening me to use the IP! It seems 
silly, I hate this way of doing things. Ok I understand what he wants, but it’s my 
device in the end.” F.Pai  
Therefore, the patient reacts against the perception of having unnecessarily lost their 
freedom by undertaking actions to restore that freedom by intentionally not using the IP 
in public. 
 Change Agent(CA) Diabetic Child Consequences 
CA is looking at IP as a 
technical device  
Defines IP as a 
machine for 
improving lifestyle 
Communication and 
understanding between them are 
weak.  
CA is enforcing and 
blaming for not using the 
IP properly 
Feels restricted and 
that he seems odd 
Psychological reactance: acting 
against the IP and internationally 
avoid its use or misusing it. 
5.8.2 Second contradiction: between caregiver and change agent 
The second contradiction is between the change agent, who views the IP as a medical tool 
that is dangerous if mismanaged, and the caregivers, who believe that the IP is safe for 
Chapter 5  Technology Adoption framework for IP (TAF IP for children) 
 
 
 
 
 
 
 
 
 
-136- 
their children. The role played by the IP in controlling glucose level means that doctors 
(change agents) stress the importance of educating caregivers about certain procedures in 
order to ensure that the IP is utilised properly.  
 “IP is important for patient health, but only if used in the right way. Otherwise, 
it will be harmful and I have to withdraw it. Actually, I see this case with lots of 
patients. They are not using it properly and I need to threaten the parents as well 
as the child… but it’s the parents who are the ones to blame! ”. DP.B  
However, the caregiver has a very different perception and discourse towards the IP, 
viewing it as a safe tool that improves the lifestyle of their diabetic children. In other 
words, they do not perceive the device as being harmful, even if when misused or when 
the doctor’s rules are not followed closely. In terms of sociomateriality theory, they look 
at the tool as a techno-psychological element in their life, which is an object that affects 
users psychologically and sociably (Leonardi, 2013). This can be seen in the restrictions 
that the IP puts on lifestyle, even though the main intention to adopt it to bring about a 
better way of living. The IP affects the ability of their children to eat sweet foods like 
other children, to let their daughters wear light clothes easily, allowing them to simply 
count nutritional values each time they eat food. These factors encourage the caregiver to 
adopt more lenient rules on the use of the IP, which is perceived as careless by doctors. 
“It is the family! They should take more care of their children. And this is the 
main problems we are having… they do not take enough responsibility in 
measuring their children’s blood glucose and doing the correct carb ratios. It 
seems a careless issue more than anything else” D.M 
This pushes doctors to use stronger language and threaten the withdrawal of the IP in 
response to perceived misuse.  
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 “The IP is a serious tool that must be used carefully, otherwise negative results 
can happen… they have to take responsibility for its management.” DP.As 
 
Change Agent 
Perspective 
Caregivers 
perspective 
Reflection 
Medical Tool Perception of making 
their children feel odd 
Doctors are blaming the 
caregivers for being careless or 
irresponsible. 
Focuses on medical use 
without focusing on 
psychological reasons 
Feeling sorry and 
mercy towards their 
children 
Caregivers are not strict in 
applying the IP rules. 
Safe to use 
 
5.8.3 Third contradiction: the relationship between patient and caregiver  
Because caregivers are most influential on the life view of their children (Morris et al., 
2008), some of the discourses are not contradictory, but instead seem to be supportive. 
The supporting discourses pertain to the perceptions of being odd and restricted, whereas 
the contradicting discourses are those concerned with being safe and delegate against 
being a diabetic lifestyle tool. 
i Supporting discourses: perceptions of being odd and restricted  
The first discourse common between the patient and their caregiver are the perceptions 
of feeling odd or restricted. As the caregivers are looking sympathetically at their children 
with the IP, this can be translated in leniency, leading to intentional reduction of 
supervision and less enforcement of correct or regular IP use. Previous studies have 
shown that some parents of children with chronic medical conditions may feel 
overwhelmed and incompetent in dealing with the demands of the illness, leading them 
to withdraw from their child (Power and Franck, 2008; (Bevans and Sternberg, 2012). 
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Thus, when the child does not like the procedure of changing the IP syringe every three 
days, even crying or panicking at the idea, parents may feel sorry for them and delay 
maintenance of the IP, as seen in this account: 
“Well, because he takes a shower every day, the infusion is being cleaned. And 
when the reservoir still has insulin I sometime delay it to the fourth or fifth day, 
but not always.” M.Mthr  
Another example of this relaxation of IP rules is the failure of parents to watch the weight 
of their children (Gender-Frederick et al., 2011; Scheiner et al., 2009). However, the IP 
can affect the weight of a child if it is used improperly. This was observed by some of the 
change agents: 
“IP can affect the weight of the child, because he has flexibility in eating but needs 
to enter the carb of that food and his BG so the pump will produce the desired 
insulin. But if he is eating a lot, then it can affect that.” DP.E 
The psychological reactance of children towards the IP due to the restrictions on their 
lifestyle results in their parents feeling sorry for them and giving them greater freedom in 
their use of the IP. This can manifest in different ways, with the young boy eating lots of 
chocolate without intervention from his mother, while the girl takes the IP off in public 
or when wearing light clothes, with her mother’s consent to do so. Both final behaviours 
are contrary to the correct use of the IP.  
 
Caregiver 
Discourse 
Patient 
Discourse  
Reflections Evidence 
Feeling odd Being odd Using too much 
sweets and he knows 
his mother will not 
blame him.  
In the interview, his 
mother stated that he 
was eating too much 
chocolate and that she 
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feeling of pain 
and sorry towards 
their children 
Being 
Restricted 
was feeling sorry for 
him. 
Taking off the IP 
when she goes out. 
Her mother accepts 
this behaviour 
without advising her 
otherwise. 
“My mom knows I am 
wearing these clothes, 
but she does not 
mind.” F.Pai 
“I am sorry for her. 
She is still young and 
she wants to enjoy her 
life. I cannot stop her 
from doing that.” 
F.Mthr 
 
ii Contradicting Discourses: Perception of Being Safe versus Perception of being a 
lifestyle tool  
 
There are two different discourses between the caregiver and the child. The caregivers 
believe that the IP is safe and simple enough to be used without supervision, while the 
children believe that it is a tool that helps to improve their quality of life. The two 
discourses are not directly contradicting; however they are different and can lead to 
unintended consequences.  
Because of the perception of the caregiver that IP is easy enough to be managed by 
anybody, the mother of the boy child delegated his sister (aged 10 years) and her servants 
(Servant), who is largely illiterate, to take responsibility for managing the IP on his behalf. 
During a conversation, she also added while laughing, 
“…they fight a little, but hopefully they should get along” M.Mthr 
Because of the immaturity of the child and the perspective that the tool is not critical or 
complex, despite being an important part of diabetes management, this constitutes misuse 
of the IP. In addition, the mother delegates management of the IP to her servants: 
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“Sometimes the servant and Mustafa’s sister count the carbs and of course 
measure his BG” M.Mthr.  
Neither the servants nor the sister of the diabetic child received any orientation or training 
in the effective use of the IP by the diabetic educator. It is therefore anticipated that this 
delegation of authority can lead to unpleasant experience by the patient, especially when 
the siblings are young enough to bicker and argue:  
  “My sister does not know anything.” M. Pai.  
This dissent and disagreement can cause the resistance of the child to the IP or the tasks 
involved in its correct usage. The sister affirmed this, by adding: 
“My brother does not listen to me and be calm. He always panics and gives 
me a hard time, but I have to listen to my mother and do it for him. Mustafa is 
a stubborn boy.” M.Sis 
Therefore, because the mother perceives the technology to be extremely simple and safe, 
she elects to delegate responsibility to another of her children, in turn increased resistance 
in her diabetic child with regards to the use of the IP. This kind of behaviour is seek by 
the change agents as a good example of carelessness. However, the problem is arguably 
more to do with the erroneous perception that the device is safe and uncomplicated.  
Likewise, the mother (F.Mthr) delegated the responsibility of managing the IP to her 
diabetic daughter, who is currently only 15 years old, stating that: 
“Nora is old enough to take her own responsibility.” F.Mthr 
This has led to many problems between the child and her caregiver, directly affecting the 
correct usage of the IP. I saw continuous tension between the mother (F.Mthr) and the 
adolescent (F.Pai) during their daily life, with the mother continually blaming her 
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daughter for improper usage and management of the IP, but not interceding to ensure its 
correct application.  
This may be because caregivers see the tool as being safe and straightforward, they do 
not believe that there is a need for excessive restrictions or regulations on its use. This in 
turn leads to tendency of carelessness in using the IP without much care from the patient 
perspective.  
Other Actors Perception Diabetic Child 
perception 
Reflection on attitudes and 
behaviour 
Caregivers believe the IP is 
safe and children are old 
enough to use it a lone 
IP is a lifestyle 
tool to improve 
the quality of 
life. 
Caregivers delegate the authority of 
managing the IP to the child, servant 
or sister. 
Caregivers believe it is 
very safe and anybody can 
manage it to the children 
Disputes between the child and other 
family members or servants. Also, the 
feeling of being observed by all 
family members, which pushes him to 
hate and avoid using the IP. 
 
5.9 Summary 
This chapter applied the analytical framework for understanding the reasons for the 
improper use of the IP, although the literature showed different benefits in this regard. 
The analytic framework provided a new understanding of this phenomenon, by 
illustrating that the different views of the IP between different actors lead to different 
expectations. Because of the mismatch of expectations, their behaviour differs from what 
is expected. In other words, the explanation is found in the contradictions between the 
expectations of the three types of agent involved – change agents, patients and caregivers. 
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Starting with a number of different initial assumptions about the purpose of IP – to control 
sugar levels (medics), to improve the patients’ quality of life (parents), to make patients 
feel equal with their peers (patients) – the contradictions persist and may even increase. 
Because of these misunderstandings, the diabetic patient has a confused view towards 
himself/herself with the IP, with a corresponding resistance towards the device. This 
resistance is reflected in the improper use of the IP, such as failure to enter data (e.g. on 
the correct carbohydrate) regularly, failure to measure the blood glucose before and after 
food consumption, and failure to change the infusion sets every 3 days  
This analytic framework helped in understanding the phenomenon from a new 
perspective. However, there are a few drawbacks and some weaknesses in the application 
of the framework. Therefore, the next chapter seeks to evaluate the analytic framework 
and the results found through the use of this framework.  
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CHAPTER 6 Discussion 
6.1 Introduction 
Wearable devices are an emerging research area in the field of assistive technologies, as 
discussed in Chapter 2. An innovative aspect of the current research is the view of Insulin 
Pump (IP) as a type of wearable device that is more closely connected with the user than 
many of the more common technologies, such as goggles, e-rings, or smart clothes.  This 
makes the IP more intrusive and therefore its adoption presents greater challenges than is 
the usually the case with other wearable devices. 
This chapter seeks to provide an explanation of the discovery results and the answer to 
the research question: what are the barriers to successful adoption of IP? In simple terms, 
the explanation seems to be found in the contradictions that exist between the differing 
expectations of the three types of agent involved in this context, namely the change 
agents, patients and caregivers, as discussed in chapter 5. This starts with variations in 
the initial assumptions of parties regarding the purpose of IP, namely to control sugar 
levels (medics), to improve the quality of life of patients (parents), and to help young 
users to feel comfortable and equal with their peers (patients). These contradictions persist 
through the pre-adoption to post-adoption phases.  
The adoption of new products remains an important issue for both researchers and 
practitioners (Huh and Kim, 2008). Extensive research has been conducted in terms of 
technology adoption in the context of wearable devices, however most these studies have 
focused on the utilisation of the technology acceptance model (TAM) and its various 
extensions (Nasir and Yurder, 2015; Gao et al., 2015). For instance, the TAM was used 
to investigate consumers’ intention to use smartwatches, one of the most popular types of 
wearable device (Chuah et al., 2016). It examined the adoption challenges mostly 
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associated with wearable devices or related technology issues. The focus was to 
investigate the relationships between the objective characteristics of wearable devices, 
user perceptions and attitudes, and the behaviours that exist towards the use and adoption 
of wearable devices. Although useful, this approach typically neglects the role of 
individual, family and social characteristics, all of which are critical in successful new 
product adoption. Little is known about the reasons why some people are more likely to 
adopt wearable devices, or about the effect that individual, family and social 
characteristics have on the use and adoption of wearable technology 
6.2 Literature Review and Knowledge Gap 
Initially, this research focused on attempting to understand why some patients are 
misusing the IP in the post-adoption phase, despite its obvious benefits. Based on a 
comprehensive review of literature, several different theories were found to explain this 
phenomenon. As an example of this, the theory of reasoned action (TRA) holds that the 
behaviour and, more specifically, the intention to use a given technology is subject to the 
attitude of the individual towards the object (the IP). Meanwhile, the health belief model 
(HBM) demonstrates that the more the trust in the technology and the greater the belief 
that it can contribute to the improvement of personal health status, the higher the 
intention to use. Although these theories explain certain factors, there are still cases in 
which patients continue to misuse the technology despite believing that it has the ability 
to improve their health. Therefore, a novel analytic framework is proposed to understand 
this phenomenon. This framework examines the misuse of the IP through the 
contradictions between different actors. In other words, if different actors have different 
views about the same thing, this can negatively affect the way that a diabetic child feels 
about and uses the IP.  
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6.3 The Research Analytic Approach: Evaluating the analytic 
approach 
6.3.1 Summary of Analytic Framework 
The first main contribution of this research is the framework developed to understand the 
misuse of the IP by diabetic children.  A range of different theories have been offered to 
explain the general misuse of wearable technology (Gao et al., 2015 ,Rauschnabel et al., 
2016, O'Kane, 2014), as well as medical wearable technologies (Li et al., 2016, Chan et 
al., 2012) and even more specifically, the use of medical wearable technologies by 
children (de Vries et al., 2010; Binek et al,, 2016). In this capacity, the dominant theories 
are the TRA and the technology acceptance models (TAM) (Gao et al., 2015), which 
focus on the perceptions of benefits from the device, irrespective of whether they are 
intended for medical or sport applications (Lunney et al., 2016). In the medical context, 
this approach is referred to as the HBM (Rimer and Glanz, 2011;  Montano and Kasprzyk, 
2015). The case of Saudi Arabia remains highly unusual in this discipline (c.f. Rendell et 
al., 2013; Hayek et al., 2014), with Saudi people generally having a higher level of belief 
in the ability of IP to improve the quality of life than many other countries (Carter, 2014). 
According to these theories, it should therefore be expected that the use of the IP is better 
in the Saudi context. Meanwhile, there is some evidence that the IP is not well used and 
therefore does not have the anticipated successful output. The problem may therefore be 
that these theories fail to explain the phenomenon or, alternatively, there may be certain 
factors affecting the way that these patients perceive the IP. It is known that once the 
attitudes and belief in technology is positive, the motivation to use it improves, which is 
then generally reflected in the quality of usage (Ajzen et al., 1986; Montano et al., 2015; 
Şener et al., 2015; Nasir and Yurder, 2015). However, it is not yet known how these 
attitudes and perceptions are developed. This research contributes to the field by 
identifying a number of mechanisms that create different views toward the technology. 
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In order to answer this research question through a focus on contradictions, the analytic 
framework has been based on the differentiation between facts, interpretations and 
explanations. In other words, contradictions cannot be understood directly from facts, 
until those facts are consolidated into one context that can then be examined from 
different perspectives, which enables the contradictions to be seen. There are also 
different constructs that should be magnified to understand the contradictions. The first 
analytical construct is that the main actors in this research are the diabetic child, the 
medical personnel (doctors and educators) and the parents. The second analytical 
construct is the interaction of these actors with the technology.  
The human logics towards technology are a key determinant of behaviour with devices 
and innovations (Hultin and Mähring, 2014). Logics are created through interactions, 
understandings and perceptions, and can control the human behaviour without a clear 
rationale or intention (Wandel, 2001; Foucault, 1988). Based on the theory of 
sociomateriality, which refers to the ‘inherent inseparability’ of social and material 
aspects of organizational work (Orlikowski and Scott, 2008), these logics are created by 
interactions with the technology and with people within the technology context (Hultin 
and Mähring, 2014). The main rationale in this aspect of the investigation is concerned 
with the way that individuals perceive themselves with the technology. In other words, 
the person (in this case, the diabetic child) can see his relationship with the technology 
by perceiving how others perceive him. These others include his friends, medical 
personnel, and most importantly, his parents, who typically exert a powerful influence 
over the health of their child (Miller and DiMatteo, 2013). Indeed, how others define and 
perceive the IP is assumed, and has been found, to affect the understanding that children 
have of the IP. What is interesting here in this research is that the contradictions between 
agents seem to create a resistance mentality towards the IP.  In order to better understand 
this relationship, it is advised that the sociomateriality theory be utilised, due to its focus 
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on understanding relationships in recognition that the role of different actors with the 
technology shapes perceptions, attitudes and behaviours toward it (Leonardi 2013). 
6.3.2 Analytic Framework Evaluation 
i A holistic analytic framework 
This research is the first to introduce an analytic approach to understand why diabetic 
children are misusing the IP in Saudi Arabia. The analytic approach is different in certain 
important aspects from other traditional approaches, such as HBMs (Gonder-Frederick et 
al., 2011) and TAMs (Gao et al., 2015). Firstly, this analytic approach is comprehensive 
and holistic, not being restricted to the perspective of the patient, instead incorporating 
those of related medical personnel and caregivers. The literature also recognises that the 
attitudes of caregivers towards the IP can affect their children (Forsner et al., 2014, 
Alsaleh et al., 2014), much like the behaviour of a patient towards the IP is also affected 
their own attitudes (Chen et al, 2012; Perry et al., 2017). Beliefs about the IP prior to 
adoption, which have been shown to affect the condition of the illness (Hirose et al., 2012, 
Grunberger et al., 2014; Horise et al., 2012), are also important in conceptual models of 
the possible relationship among factors that influence the adoption of diabetes 
technology. These results are all drawn from a mono-perspective analytic framework. In 
contrast, the analytic framework devises in the current research incorporates the three 
perspectives of the three actors under the same analytical umbrella.  
ii Epistemological Stance 
This research is novel in combining three levels of understanding for reality into a single 
epistemological stance in an attempt to derive a conclusive understanding of how the 
perspectives of different actors towards the IP and their dialectics are building the mental 
model in the minds of children with regards to technology. In this research, the 
construction of these mental models (Jones et al., 2014) is understood through the 
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perceptions and attitudes towards objects through dialogue of different actors, which is 
not new (Delgado-Galván et al., 2014). This approach was also used in teaching children 
new things and concepts, using what is called the Socratic approach (Helterbran and 
Strahler, 2013). The current research employed this approach in the investigation of 
medical wearable devices, in an attempt to understand how different actors with different 
discourses create a new mind-set that leads to unintended behaviour. This approach was 
provided helpful insights about the factors and metaphors controlling the mind and 
behaviour of diabetic children.  
Research credibility is about ensuring the correctness and accuracy of the findings 
(Lincoln and Guba, 1985). Traditionally, credibility can be improved through the use of 
thematic analysis (Forsner et al, 2014), which is primarily focused on the repetition or 
recurrence of themes (Braun et al, 2013). This research contributes to this discussion by 
showing a new angle for the analysis and understanding of participants. It should also be 
noted that this research differentiated between facts, my interpretations and explanations. 
In other words, it is not necessarily essential to see recurrence of the codes among 
multiple responses to ensure the credibility of the results. Instead, the objective is to take 
the perspective of every actor as factual, when they talk about themselves and as opinions 
when they talk about others. In essence, therefore, all feelings, emotions and personal 
experiences are perceived as being factual from the individual perspective of each 
interviewee. However, when all of these facts come from different actors, the 
consolidated view can enable patterns and contradictions to be seen in those personal 
facts. This contradiction that exist in terms of understanding reality creates a unique 
perception of reality. This idea is not completely new, however, with many studies having 
used philosophies to differentiate between facts and interpretations (Ahlen et al., 2006; 
Sandelowski, 2000; Tellis, 1997).  
The use of socio-materiality in understanding the patient logics  
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In this study, the sociomateriality approach is used to examine the interactions between 
people and technology, as well as how the interactions between them affect perceptions 
about life and towards people (Orlikowski, 2010). A sociomaterial perspective builds 
upon research in sociology, the philosophy of technology, science and technology studies, 
and quantum physics (Barad, 2007, Leonardi, 2013); This useful theory has been widely 
used as an aspect in analytic approaches. Indeed, the idea of a sociomaterial model has 
also been developed “as an analytical framework that can assist in research and design of 
learning technology by providing a pertinent lens to examine emergent socially and 
materially intertwined learning practices” (Johri, 2011, p. 208). What is really new in the 
current context is the combination of sociomateriality with different levels of analysis. 
This approach clearly illustrates that technology enforces a certain life pattern on the user. 
The perspective of users towards technology begins to be shaped by their interactions 
with it, as well as with other people and the external environment. Although this approach 
not been used before in terms of the IP for adolescents, but it offers a useful tool to better 
understand the reality creation process in the minds of many different actors. 
Indeed, the contradictions between the diverse perceptions of reality regarding the 
different factors at play in this study context can result in conflicting messages being 
presented to the minds of diabetic children. This is reflected by the various perceptions 
and understanding of the technology. The importance of studying the contradictions 
between different actors has been recognised in other studies, having been aligned with 
actor network theory (Prout, 1996) or used in assistive technologies research. In the latter 
discipline, studying contradictions showed that when disabled people perceive the 
community has certain perspectives and attitudes towards them that contradicts with their 
own views, they abandon using them (Shinohara and Wobbrock, 2011, Pape et al., 2002). 
However, the current research is the first to recognise the importance of understanding 
the way that these contradictions between actors on the perception, attitude and behaviour 
toward medical wearable devices inform its usage by children patients.  
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In summary, it can be claimed that these results would be difficult to achieve without 
combining multiple different analytic approaches in this way. Other important findings 
of the analytic framework are presented in section 6.5. It is believed that these also could 
not have been realised without the adoption of this unique analytic framework. 
6.4 Areas of improvement in using the analytic framework to other 
domain 
6.4.1 Sampling technique 
It is clearly shown that this analytic framework is based on case studies approach. 
However, the analytic approach does not clarify the basis for the selection of cases. Nor 
does this framework guide researchers with regards to sample size or the recruitment of 
sample participants. It is assumed that the researcher can identify the most relevant cases 
and participant population to address the research aims, which suggests that snowball 
sampling is likely to be the most relevant approach.  
6.4.2 Evolving the level of contradictions among different actors through time  
The current analytic framework does not note anything about the evolution of 
contradictions among different actors. However, my findings suggest that it would be 
beneficial to consider time as being a critical factor in understanding the contradictions. 
In addition, it should be noted that prior to the adoption of the IP, both the beneficiaries 
and change agent seem to share the same understanding of the logic. The reason for this 
may be that the IP is almost always introduced to the beneficiaries by the change agent. 
As found in interviews, in pre-transition, both doctors and educators strive to 
communicate the positive aspects of the IP to the patient, in terms of lifestyle, safety and 
mobility, with much less focus on the technical sides of its use. This is particular 
important because patients do not usually have any background knowledge of the IP, the 
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change agent is the only player in creating and manipulating the reality in minds of 
diabetic patients and their family. However, after some time of the IP being used by the 
diabetic child, especially after the wearer has been exposed to the external environment, 
including friends and family, deviations may arise in understanding and defining the IP. 
These changes may lead to the conflict. The current framework does not address this 
point; however, it suggests that the time factor may be an important consideration.  
With consideration of the time factor, it becomes apparent that the motivation can be 
viewed as an evolving process that is affected by the level of conflict. There is no clear 
evidence from the findings to support this observation, as it was not planned for in the 
analytic framework, and therefore the absence of the time factor from the current 
framework therefore potentially constitutes a legitimate criticism of its design.  
 
6.4.3 Generalisability of the analytical framework  
The generalisability or applicability of the analytic framework is accepted with certain 
conditions. This analytic framework has been evaluated in the context of Saudi Arabia, 
Pre-transition Transition Post-transition
Motivation  Motivation Motivation
Perception Ease of 
use 
Perception of 
Usefulness 
Perception Ease of 
use 
Perception of 
Usefulness 
Perception of 
Usefulness
Perceptions of 
disbenefits
Self Perception because of the 
IP 
Relationships with the Parents 
Relationships with the 
Doctors 
Doctors 
Intervention
Doctors 
Intervention
Time
Doctors 
Intervention
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which is profoundly different from many other contexts, such as the UK or Japan. 
However, the analytic framework may be useful if it is able to address the differences in 
defining the IP/wearable medical device among different actors, irrespective of their 
culture. This may be significant, given the substantial role that culture can play in the 
level of psychological reactance of some diabetic children towards the adoption and use 
of the IP. Therefore, application of this research in different cultures may be viable and 
valuable, taking into consideration these cultural implications on the findings. Regardless 
of the culture, however, the contradiction analytic framework could be extremely useful 
for contexts in which contradictions prosper. Therefore, the following assumptions would 
decrease the importance of using this analytic framework.  
Assumption1: if the parent of the diabetic child has a medical background (is a doctor or 
other medical personnel), they may adopt the same discourse and understanding as the 
change agent. This can decrease contradictions enough to be useful for analysis.  
Assumption 2: if the wearable medical device is too small to be noticed by others, this 
might decrease its impact on patient self-perception. This may, in turn, decrease the 
contradictions.  
Assumption 3: if the baby is too young to understand and to define the influence of the 
IP on how he looks like with it ‘because accepts the use of the IP unconditionally and 
incorporates it into his everyday life automatically’.  This has precedence in literature, 
which has shown that the success of the IP success is generally more prevalent in infants 
than in older children (Phillip et al., 2007). It can therefore be presumed that resistance is 
often a function of the contradictions in defining the IP.  
Assumption 4: if the change agents use psychological measures to ensure the mutual 
understandings between different actors, thereby lowering the number and severity of 
contradictions, which in turn decreases the need to utilise this analytic framework.  
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6.5 The Research Framework  
The second contribution of this research is the application of the analytic framework to 
answer the research question of this thesis. The three actors are all interacting with the 
technology from different perspectives: the change agent looks at the IP as a medical 
device that improves the condition (Scheiner et al., 2009, Lawton, 2015, Blackman et al., 
2014); the parents primarily look at it as something that may improve the quality of life 
of their children (Grunberger et al., 2014) and their diabetic children are more likely to 
look at it as something that is being forced on them. However, it should be borne in mind 
that the perception of children in this matter is often unclear and complex. This is an 
important consideration because it is this perception that is most likely to shape the 
attitude of a child towards these devices, in turn affecting their consequent behaviour (i.e. 
proper/improper use)  towards the technology (Venkatesh, 2000). In this research, the 
perception of patients towards technology has been found to be determined by how the 
main stakeholders define the technology and the way in which they perceive the patient 
with the IP. In other words, as discussed later, when a mother is lenient towards her patient 
because of the IP, the child is likely to act and behave accordingly.  
The third contribution is not only related to the way that the attitude and behaviour of the 
patient are affected by how others view the technology and view the patient using that 
technology; it has been shown that contradictions between different actors also serve to 
create different patterns of understanding and definitions towards the technology. It is 
already known that patient selection affects the success of IP therapy (Grunberger et al., 
2014). However, it is less clear how certain factors can impact on the perceptions that the 
caregiver and the patient have of the IP. The following section will discuss the perspective 
of the three actors (change agent, caregiver and patient) toward the IP.  
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6.5.1 Change agent perspectives towards the IP  
i Change Agent discourse towards the IP 
This research captured the discourse, views, and perception of participants with regards 
to the IP. This has enabled an investigation of the change agent logic towards the IP. 
Previous studies have already noted that the logic of doctors is strictly determined by a 
deterministic view towards the world (Sidorkiewicz et al., 2016). In other words, medical 
personnel use assertive discourse in the management of hospitals (Witman et al 2011), 
followed by orders and care for the patient health (ibid; Ha and Longnecker, 2010). This 
research has contributed to the literature by showing that doctors are using the same 
discourse, not only in the management of hospitals, but in the direction and guidance of 
their patients, which here refers to diabetic children and their caregivers. The second 
change agent discourse is to transfer the main responsibility for the proper use of the IP 
to the parents alone, as found in other research (Taylor et al., 2013, Hilliard et al., 2014). 
This illustrates that the discourse has potentially serious implications, as medical personal 
stop thinking about improving their understanding of why a problem might exist in IP 
usage.  
ii Change Agent Tools in Managing the IP performance 
Lawton et al. (2015) state that doctors in the USA recommend “individuals for insulin 
pump based on their assessments of personal and psychological suitability, or in another 
word physical or mental capacity to manage an insulin pump”. Doctors in other countries, 
like the UK, Canada and the USA, have been found to use psychological indicators to 
ensure that diabetic children are using the IP (Grunberger et al., 2016, Lawton et al. 2015, 
Liberman et al., 2014). This research, contributes to this knowledge, by demonstrating 
that many Saudi doctors are adopting the same practices prior to the adoption of the IP 
by their patients.  
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A number of studies have expressed the position that these indicators are a continuous 
process (Lassmann-Vague et al., 2010, Phillip et al., 2008), however the current research 
suggests that Saudi doctors and educators stop using psychological indicators in the post-
transition phase, shifting focus almost entirely to the medical readings of the patient blood 
tests. This can have serious consequences on their interactions with patients in the post-
transition phase, as there are no mechanisms to follow up with the psychological 
motivations of the patient and their family to use the IP. This may, in turn, lead doctors 
to rely heavily or exclusively on medical examinations, which only show the problem of 
misuse after it happens. 
Thus, the only tool that doctors use to improve the quality and effectiveness of IP use is 
to blame the family and patients, however this does not identify or resolve the real reasons 
for the problem. In the post-adoption phase, there are numerous mechanisms to motivate 
patients and ensure that they are using the IP appropriately. This is important, as 
technology combined with appropriate psychological support may be a powerful 
motivator for health behaviour change (Pickup et al., 2007; Tumminia et al., 2015).  
This research is unique in addressing the importance of doctors, at least in Saudi Arabia, 
continuing to influence the perception of the current and future realities of diabetic 
children and their caregivers. In other words, the two main strategies found focus on the 
benefits of the IP, demonstrating that without the device managing the illness and 
maintaining a healthy glucose level will be much more difficult.  
6.5.2 Perceptions of the Caregivers towards IP  
Caregivers typically have different perceptions towards the IP than change agents. Other 
studies have shown that caregivers primarily perceive the IP as a tool to improve the 
lifestyle (Hirose et al., 2012, Cogan et al., 2002; Al Saleh et al, 2012), and health of their 
diabetic children (Mednick et al., 2009, Hirose et al., 2012). This research contributes to 
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this position, through the addition of two more dimensions to facilitate better 
understanding of the attitudes and perceptions of young patients towards the IP. 
Caregivers, at least in this study, generally perceive the IP to be very safe and easy to use. 
Trust and confidence in a given technology has been shown to motivate the beneficiaries 
to use it, leading to better quality of usage (Sousa et al., 2016). However, this research 
shows that too much confidence can also be harmful, because it leads to greater reliance 
on the technology to the degree that patients and their families may not be careful enough 
to ensure that they use the device correctly. 
Indeed, caregivers may have different reasons for misusing the IP, such as carelessness 
or insufficient involvement and engagement in certain aspects of the daily life of their 
children (Telo et al., 2015, Georgeanna et al., 2001, Low et al., 2005, Telo et al., 2015, 
Klingensmith et al., 2001). However, this research plainly demonstrates that negligence 
does not necessarily arise as a consequence of being a busy parent, but can also be 
attributed to factors such as the belief that the IP is easy and safe, leading to negligent use 
of the technology in the management of the IP. These perceptions can lead delegation of 
managing the IP to the diabetic child or to the other members of the family before they 
are ready, so mistakes are made in the use of the IP. 
A study in Saudi Arabia has claimed the main reason for misusing the IP in is that there 
is not enough training on the IP (Elzubier, 2002). However, the two case studies in this 
research suggest that sufficient training on the IP will not necessarily result in satisfactory 
use of the device. Moreover, although it has been claimed that the lack of parental 
knowledge of the IP device demonstrates the corresponding need for ongoing parental 
education regarding insulin pump features to improve IP usage (Mitchell et al, 2013), this 
research has not found similar results. Indeed, parents were very aware of the IP and its 
correct use. Instead, this research suggests that, at least in some cases, problems with IP 
usage can be attributed to parents feeling too comfortable in the use of the IP, leading 
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them to reduce supervision and delegate its use before the diabetic child or other family 
members are properly trained in its use.  
6.5.3 Child perception towards the IP 
Diabetic children view the IP as a tool to that seeks to improve their quality of life through 
management of diabetes. However, after the using the device and especially after being 
seen to use the technology by other people in their communities, many of these children 
begin to feel odd, restricted, or in pain. This may be partially attributed to over expectation 
of the usefulness of the medical device, which has been shown to lead to frustration after 
adoption (Franklin, 2016). Moreover, this study has shown that the IP is widely believed 
to be for the improvement of lifestyle rather than as a medical necessity, leading some 
users to remove the device, regardless of the consequences. One reason for this could be 
the fact the IP can adversely affect the body image of some women because of its size 
and obviousness in social situations (Chamberlain and Gilgen, 2015, Hains et al., 2007). 
This research found that many diabetic children in Saudi Arabia face the same problem, 
perceiving that others see the IP as a source of shame and weakness. This can result in 
children hiding their IP, as well as increasing the likelihood of the device being misused.  
The IP needs a patient to be self-disciplined, because its correct use involves many 
activities that require accurate measurements (Shalitin et al., 2010). Saudi Arabia culture 
has a tendency to be less self-disciplined than western culture (Al-Kahtani, 2007), which 
might make patients feel restricted because of the IP and therefore less likely to use the 
device properly. A feeling of restriction in the use of the IP is a drawback that has been 
acknowledged in the literature and this is clearly the case in the context of Saudi Arabia. 
6.5.4 Contradictions between different agents (the definition of contradiction) 
The concept of ‘contradiction’ is rooted in institutional logics literature, which holds that 
different professions often utilise different logics to understanding the world (Thornton 
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et al., 2012); (Hultin and Mähring, 2014). This research borrowed this concept, applying 
it on a micro-level to examine the logics of doctors, parents and diabetic children. There 
are different occupations involved here: the technical and hard logic represented by the 
doctor (change agent); the parenthood occupation, which adopts the soft and caring 
logics, in terms of safety and mercy; and the childhood occupation, which adopts lifestyle 
logics.  
This research, based on its findings, defines ‘contradiction’ as a conflict in the way that 
the change agent (doctors), sponsor of the change (parents) and the main beneficiary (the 
diabetic child) perceive, understand and define technology. This contradiction is reflected 
in the discourse by different actors. Although these contradictions are rooted in the logic 
literature, they could not be operationalised and analysed without proper understanding 
of the discourses. Therefore, it should be said that the analytic framework captured the 
discourse, which facilitates an understanding of the logics. Logics is “is the set of material 
practices and symbolic systems including assumptions, values, and beliefs by which 
individuals and organizations provide meaning to their daily activity, organize time and 
space, and reproduce their lives and experiences.” (Thornton et al, 2013). However, this 
research limits the understanding of the logics to perception and definition of the 
technology. This adaptation comes after application of the sociomateriality theory, which 
shows that technology affects how individuals perceive themselves with particular 
technology. Based on this, it can be said that people redefine technology based on their 
self-perception (Hultin and Mähring, 2014).  
Contradictions between patients and doctors with regards to in the IP have been noted in 
previous literature. (Wackerbarth et al., 2007) found that most physicians delivered 
information to enrich the knowledge of patients in the technical aspects of the IP, but gave 
little regard to their true understanding, ideas, or preferences.  ”Although healthcare is 
always trying to increase patient’s autonomy and create a harmonious relationship 
between physicians and patients, endowed with this technology some patients could 
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erroneously disregard the role of the physician”(p.6)This research has also identified the 
existence of a gap between the discourse of physicians and patients, which affects the 
relationship, in turn affecting the behaviour.  
Change agents often claim that the main issue explaining the inappropriate use of the IP 
is patients’ inability or lack of discipline in following the rules. As a consequence of this 
belief, they supply orientation and induction to stimulate the desire to use the IP correctly, 
through a focus on benefits and training to ensure that patients know how to use the 
device. Although these techniques are perceived to be useful and effective (Pickup et al., 
2014; Shalitin and Phillip, 2008), parents nevertheless still struggle, as evidence by their 
failure to use the IP appropriately. Change agents believe this is because in following the 
rules or they are careless. 
6.6 Chapter Summary 
Wearable devices are an important subdivision of assistive technologies and can have a 
profound, diverse impact on the lives of those who use them. Devices like the IP have 
been found to be defined and understood very differently, depending on the interactions 
that people have with them. One original aspect of the current research is that the IP is a 
type of wearable device that is forced on the child, who feels obligated to incorporate its 
use into their daily life. In other words, the IP is unlike other wearable devices that are 
used for merely lifestyle reasons; it is integrated into the patient body for medical and 
lifestyle reasons. Once adopted, the IP should be used carefully and correctly, otherwise 
it may not actually be beneficial to the patient, or may even potentially harm them and 
lead to withdrawal.  
The theory of reasoned action (TRA) predicts that because IP has various benefits listed 
in literature, so it can be expected that patients will use the device. However, some cases 
are exceptional because children do not make their own decisions and cannot be trusted. 
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Therefore, the new analytic framework is based on the way in which different perceptions, 
definitions, and understandings can create contradictions which in turn leads to attitudes 
and behaviours.  
Application of this framework demonstrates the existence of numerous perspectives, 
discourses, definitions and perceptions towards the IP. Doctors typically perceives it as a 
medical device, parents perceive it as a tool that will improve the safety of their children, 
and the patients are likely to have yet another perspective, defining it as a diabetic lifestyle 
tool. In this way, the patient seems to perceive that the device affects their lifestyle in 
both positive and negative ways, which may be further complicated by the influence of 
the beliefs of the child about the perceptions of others about him because of the IP. The 
mismatch in understanding and definitions of the IP potentially creates different messages 
and understandings, resulting in a negative attitude towards the device and a 
correspondingly higher change of it being used incorrectly.  
The analytic framework in this study has provided new insights into our understanding of 
the misuse of the IP. However, improvements could be made to this analytic framework 
through the integration of sampling techniques; considerations of the evolutionary nature 
of contradictions and the way they can change over the time; and improved 
generalisability of the framework. The next chapter seeks to conclude this study, critically 
examining the usefulness of the analytic framework, explicitly stating the contributions 
that have been to knowledge, outlining the limitations of this research, and mapping 
promising avenues of future research.  
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CHAPTER 7 Conclusion  
This research belongs to multi-disciplinary research community concerned with the 
adoption of wearable technologies in real-life application domains. In this project the 
investigation was focused on the Insulin Pump as an example of wearable technology that 
is more closely connected with the patient’s body than is the case with the more common 
devices such as goggles, rings, as well as more recent smart clothes. For this reason, the 
issues of technology adoption were addressed not only from technology but also from 
user perspectives.  Literature traditions were brought together, namely technology 
adoption (Technology Adoption Model – TAM and Theory of Reasoned Action – TRA 
and health belief model) and relevant psychology sociology studies dealing with user 
readiness. 
The research problem these communities share is how to explain the varying degrees of 
success in technology adoption, especially medical devices and other forms of assistive 
technologies. According to the most influential literature sources on technology adoption, 
it is difficult to predict how successful a device or a technology solution is likely to be 
with different kinds of users (for example, different age group, social status, medical 
condition, individual preferences). The main research question in this study is therefore 
“Why do patients misuse the Insulin Pump?” To answer this question, an analytical 
framework was developed to take into account the broader context of IP use, including 
diagnosed medical condition of the patient, other reasons for doctors’ prescribing IP as a 
solution, together with the type of patient, home environment, life-style and social 
constraints that may have an impact on the successful adoption of IP.  
The analytical framework was created and tested in Saudi Arabia, which presents a 
specific cultural and social environment that influence patients’ views and attitudes 
towards new technologies, and which touch upon family relationships and social 
pressures. Particular focus was on young patients - children and adolescents - whose 
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dependence on caregivers (both within the family and within the medical profession) is 
much stronger than is the case with adults. The role of caregivers with these patients is 
therefore more prominent and can significantly influence success or failure of the IP 
adoption and this was particularly significant in the post-adoption phase. This has been 
relatively neglected in the literature where the main focus of investigation has been on 
the pre-adoption phase and on creating patient motivation to adopt IP, rather than on 
maintaining motivation and ensuring successful long-term use of IP.  
Having applied the analytical framework in this particular context, the importance of the 
interactions between different people involved, medical personnel as change agents, 
family and friends as caregivers and patients themselves, not only as individuals but also 
as members of social groups appropriate for their age. The data analysis was focused on 
the discourse between these diverse agents involved and in particular on the 
contradictions that arose in the post-adoption phase that ultimately led to barriers and 
abandonment of the IP as a solution to medical problems. As supported from the 
literature, contradictions in discourse between different actors can lead to unintended and 
unexpected behaviour of the involved actors. Likewise, it is believed in this analytic 
framework, the main problem is in the contradictions in the understandings, definition 
and perspectives towards the IP is the main reason for the improper use of the IP.   
7.1  Problem description  
The IP is recognized as one of potentially successful tools to improve life styles of 
diabetic children (Reece & Williams, 2014; McAdams and Rizvi, 2016a) as discussed in 
chapter 2.4. 
However, in spite of the widespread use of the IP among diabetic children, there are cases 
where patients and caregivers struggle with it (de Vries et al., 2015; Hofer et al., 2010; 
Heinemann et al., 2016).  In the literature, possible solutions to this problem are reported 
in Chapter 2 including factors like training (Bolderman et al., 2013), improved perception 
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of benefits (Lange et al., 2014) and the belief in the IP as the solution to their medical 
problems (Grunberger et al., 2014) in Chapter 3. Although the existence of these factors 
improves the patients’ condition and life-style in some cases, there are still many patients 
who struggle with it. Therefore, this research aims to improve our understanding of the 
reasons why an unacceptably large number of patients fail to benefit from IP. This is done 
in this project by examining interaction between different actors involved and how this 
interaction influences beliefs, perceptions and attitudes of the diabetic child towards the 
IP. 
Research has been done in this area, specifically investigating doctors’ perceptions of IP 
and also studying how child patients and their families perceive the IP in Saudi Arabia 
(Al hayek et al., 2014). However, none of the research in Saudi Arabia explained how the 
differences in perceptions among the medical personnel, patients and caregivers can de-
motivate children patients and consequently lead to improper use of the IP. Indeed, 
previous research has not answered the question why diabetic patients often struggle with 
the IP even though their families understand and know very well how to use the IP 
correctly. The issue is not entirely in the technology itself but needs to be addressed from 
a people-oriented point of view as well. Indeed, this research showed that the problem is 
in the interaction and misunderstandings between the people involved in ensuring proper 
use of IP in the daily lives of its patients. These misunderstandings created an indefinite 
loop of blaming between different actors that ended in decreased motivation to use the IP 
in a proper way, even leading to psychological resistance towards it.     
7.2  Research Question: How contradictions between the different actors 
in defining and understanding the IP affect the main beneficiary 
(child) understand, define and be motivated to use the IP?  
The findings of this study suggest that the main reasons for the improper use of the IP lie 
in the lack of communication and understanding between the physician and the diabetic 
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child and the parent, which often result in the child's psychological reactance towards the 
IP. In addition, too much criticism on the part of the doctor directed at the caregivers, 
claiming that caregivers are not strict in managing the IP for their diabetic children, results 
in the child’s lack of awareness of the risks involved in misuse of the IP. The analytic 
framework developed in this study helped to establish the significance of these factors. 
In the literature, relationship weaknesses were known to be one of the reasons for the 
improper use of the wearable medical device (Appelboom et al., 2014) As discussed in 
Chapter 3.   
This research, using the analytic framework developed here, has found that the main 
reason for the lack of mutual understanding of the benefits and shortcomings of IP is that 
change agent views the IP as a technical tool, whereas the patient looks at it as something 
integrated into his body, affecting his lifestyle and his relationships with others. 
Moreover, it is known that the psychological reactance affects the patient behaviour with 
medications (Darby et al., 2014). The findings of this study show that a very important 
reason for IP failure is that the change agents keep enforcing and blaming the patient for 
imperfect use of the IP, whereas the patients feels restricted using the technology. As 
blaming escalates, the patient’s feelings of being restricted increases and ultimately 
causes the patient to react against it.  
Moreover, it is known from the literature that the caregivers are major influencers of the 
quality of the IP use by their diabetic children (Wiebe et al., 2010; Streisand et al., 2014). 
Although they are expected to be aware of the importance of IP and its usefulness 
(Blackman et al., 2014), this research has found that caregivers do not take it seriously 
because they see that one of the consequences of wearing IP in public puts their children 
at a disadvantage socially.  Doctors, on the other hand, do not appreciate these concerns; 
they keep blaming caregivers without understanding the root causes of the problem. The 
problem is mainly in mothers' feelings of sympathy and pity for their diabetic children 
and their expectations that IP will make them ’normal’ just like their peers.   
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7.3 Uniform analytical framework 
This research is organised into three phases. The first phase involved observing and 
interviewing the informants to elicit information about the problem situation. In this, 
discovery phase, what the informants said and did was recorded and used in subsequent 
analysis that aimed to capture their viewpoints, perspectives and attitudes. Three main 
sources were consulted – the informants’ discourse, explicitly expressed views and 
perceptions of IP. 
In the second phase, the focus was on identifying regularities in the informants’ practice 
and the relationships that the informants were involved in. This was the basis for the 
interpretation of what the informants meant and reasons for their behaviour. By 
understanding the view of the world of each type of informant, and combining them into 
a unified analytical framework, the complete picture of the problem situation can be 
obtained. This analytical approach is adopted from (Seo and Creed, 2002) who shows 
how different facts may be understood differently by different actors thus creating 
different kinds of contradictions and resulting behaviours. Van Parijs (1982) work has 
provided the basis for the third phase, leading to the explanation of informants’ behaviour 
and explication of the causes for that behaviour, that is, explanation of the causes, reasons, 
and motivations, as well as interpretation of the beliefs and attitudes underlying the 
informants observed behaviour. 
7.4 Contribution to knowledge 
There are three main contributions to the knowledge.  
1- A new analytic framework focused on contradictions in the discourse between 
different actors in order to define a type of technology, such as an IP, and to 
understand its impact on users. This discourse influences the differences in 
Chapter 7  Conclusion 
 
 
 
 
 
 
 
 
 
-166- 
perception among the main users, which often lead to unintended consequences.  
This research is the first to introduce an analytic approach to understand why the 
diabetic children are misusing the IP in Saudi Arabia, bearing in mind both the 
cultural and social factors influencing the take up of IP.  Special requirements for 
child patient support from family members are also considered as the family 
relationships in the Saudi Arabian culture play a particularly important part in 
influencing child patient perception of the IP. 
2- This study has also provided a new definition of contradictions which can help in 
understanding the misuse of the IP in a more insightful way. It offers novel 
definition of contradictions between actors as the conflict in the perceiving, 
understanding and defining a medical device, the conflict between the change 
agents (medical personnel), sponsor of the change (parents) and the main 
beneficiary (the diabetic child). 
3- This approach has resulted in the development of a new framework that shows 
how different contradictions lead to different diabetic patient behaviours towards 
the IP. It is found in this research that patient perception of the technology is 
determined by the main stakeholders’ view of this technology and their view of 
the patient with the IP. In other words, as discussed earlier, when the mother is 
lenient towards her child because of the inconvenience of having to wear and 
maintain the IP, the child is acting and behaving accordingly – he or she is more 
likely to misuse the IP.  
7.5 Research methods 
Since the focus is on broad social and cultural context of IP adoption, more specifically 
on the views, motives, attitudes and expectations of the three main types of agent, 
different qualitative methods were used in this empirical study - interviews, observations, 
case studies.  This research used interviews and case studies to understand the 
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contradictions between different actors in each case. The number of case studies in this 
project is limited to the main types of agent to demonstrate and validate the application 
of the analytic framework. Further case studies are likely to increase the robustness of the 
findings, as discussed in the Future Research below. However, due to the sensitivity of 
the research topic there were difficulties in finding cases with improper use of the IP since 
strict legislation prevent scientific researchers from having free access to children 
diabetics with IP and with improper use. However, the two most representative cases were 
rich in detail and helped to accomplish in-depth understanding of the problems faced by 
children patients and their families in the Saudi Arabian culture. New studies applying 
the same analytic framework in different contexts will provide stronger basis for more 
generalizable and may be more insightful findings.  
From the interviews, it seems that contradictions are evolving through time, form the pre-
adoption to the post-adoption stages of the adoption process. It could be argued that 
longitudinal case study would benefit the academic study by observing and noting the 
evolving process of the contradictions through a set period. However, this was outside 
the scope of this project, as its main aim was to identify the causes of IP misuse. In 
addition, using this method it was not possible to establish how frequent such misuse is 
and whether there are any other significant reasons for it, especially with patients of 
different age groups and belong to different cultures. These are discussed further in Future 
Research. For the purposes of this study, the research methods used have been applied to 
a real-life problem in a particular medical, social and cultural context and have effectively 
explicated the implicit views and attitudes of the agents involved, thus leading to insight 
into the hidden causes of their behaviour. 
7.6 Implications for Practice  
Based on the findings from this research, the following recommendations can be made to 
improve on the successful adoption of IP with young diabetic patients. Following these 
Chapter 7  Conclusion 
 
 
 
 
 
 
 
 
 
-168- 
recommendations in practice can in turn provide additional data that will refine the 
research outcomes of this and of similar future projects: 
 Doctors need to check the diabetic patients’ readiness systematically and 
continuously to assure, and therefore to manage, the readiness level. Readiness 
level is not only behavioural readiness but also psychological readiness. The 
findings of this research indicate that checking readiness would start by 
understanding the diabetic patients’ and their families’ views of the IP, not only 
their willingness to use it.  Readiness should not be limited to the diabetic patient 
only; but must extend to the family also. Additionally, it should be periodically 
reviewed and modified as necessary.   
 Clear understanding between different actors should be well documented and 
agreed on from the beginning of the adoption process.  
 A record should be provided for the child and the parent (caregiver) to look at when 
following up with the doctors, in order to remember the motivation that made the 
patient switch to the insulin pump.   
 Reminders for the child and caregiver should be sent by email or post about the 
proper management of IP that should be made, mentioning the consequences of the 
misuse and improper management of the IP.  
 Caregivers should attend a course on the awareness of their responsibilities, risks 
of mismanagement, in order to ensure that the families have realistic expectations 
of the IP. 
 Patients and families should be assessed on the readiness to use IP outside of the 
medical sector who prescribes the insulin pump, not relying only on the doctor and 
the diabetic educator who asses the patient and recommend the IP. This is because 
such assessment and recommendations can be a part of marketing the insulin pump 
and selling it. There should also be home visits from time to time. 
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 There can be a reminder on the actual device, to play music or talk about a 
controlled diabetes and having, or as a screen saver. Furthermore, the insulin pump 
can be designed as an accessory for the female, or it can contain video games for 
children. It can be designed to be very small that can be hidden under clothing so 
that it cannot be seen by others. 
 
7.7 Research limitation 
This research has certain methodological limitations. Limitations can be attributed to the 
final shape of the analytic framework. The analytic framework limitations are evaluated 
in section 6.4. The limitations discussed here is mainly about the final framework, in 
particular the access to the real-life cases. Because of the sensitivity of the topic, it was 
difficult to have access to patient’s records and many cases in Saudi Arabia. That is why 
the informants were from the informal network of contacts who were familiar with the 
cases of patients struggling with the IP. The number of cases were sufficient to apply the 
analytic framework in this study. In addition, as is often the case with empirical research, 
the results pertain to the specific perceptions and definitions of the patients and their 
parents towards the IP and would be difficult to be generalised without validating the 
contextual assumptions. The contextual assumptions are to do with the same 
contradictions, the same type of family background, the same level of income, the same 
accessibility to the same doctor’s mentality and way of managing insulin pump. These 
results are resultant from the use of the analytic framework which helped to understand 
these cases in depth. In order to generalise the results of the specific definitions and 
perceptions found in this research, further research, perhaps involving a quantitative 
survey to sample different patients/caregivers in different places in Saudi Arabia. Indeed, 
in the current laws, it would be virtually impossible to have access to a significant sample 
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size. This can be done only if this research is funded specifically from the health authority 
in Saudi Arabia. 
In this study, the results were validated by communicating with the families with the 
results and they expressed their satisfaction with the understandings formulated. This kind 
of validation overcomes parts of the inability to test the results from the final framework 
of the perceptions and behaviours.   
7.8 Future Research 
This research has investigated two case studies of diabetic patients aged 8 and 15. Patients 
of different age can have different views and attitudes, with the resulting differences in 
behaviour. In other words, the older the child, the less reliance on the parents in 
understanding the world  (Webb and Zimmer-Gembeck, 2014). The older the child, the 
more he or she is connected with friends and colleagues instead of their family. Therefore, 
it can be expected that the role of the mother as a main actor could be increasingly less 
significant. It could even change from that of a caregiver and decision-maker to that of a 
helper or a friend. Indeed, there is no clear evidence to suggest that this would be the case, 
but a longitudinal study can be conducted in future in order to discover how the agents’ 
roles change as the patient grows older. A future study of this kind can be focused on the 
contradictions, not only between the physician and the caregiver, the caregiver and the 
patient. It could also include interactions with friends in older age groups in order to 
discover any further contradictions that may influence the take up of IP and similar 
technologies.  
It is quite important to understand the evolving interactions between the different types 
of agent involved in IP adoption. The main determinants and understanding of the 
technology for the patient is the perceptions of ease of use and usefulness of the device, 
because these perceptions affect motivation (Giani et al., 2015). Although in the literature 
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motivation is fixed and determined by current perceptions, the research approach in this 
study argues for the possibility of different motivations in different times. Because the 
relationship between the actors are evolving over time, because their perceptions may 
change due to the experience with the technology (IP), the attitudes towards the IP may 
also change. Therefore, a longitudinal case study would throw light on the nature of 
adoption process as it evolves over time. 
Another important extension of this study would involve broadening the social and 
cultural context of the investigation. It is more than likely that in cultures outside Saudi 
Arabia would have different relationships between children and young people and the rest 
of the family, different social pressures on diabetic patients, different roles of people in 
authority such as doctors and educators. All these differences, when addressed in future 
research, will serve to refine the analytical framework developed here and thus make it 
possible to broaden the range of social and cultural contexts, build a representative sample 
of informants thus making the outcomes more scientifically reliable. 
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Code Position 
Years of 
Experience 
D.H Physician endocrinologist 2010-present 
DP.Ab Consultant paediatric endocrinologist 2002- present 
D.M Consultant physician endocrinologist 2013- present 
DP.B Paediatric endocrinologist 2009 -present 
DP. A Consultant Paediatric endocrinologist 2004- present 
DP.M Consultant Paediatric Endocrinologist 2001-present 
DP.N Consultant Paediatric endocrinologist 2013-present 
DP.Ad Consultant Peadiatric endocrinologist 1999-present 
E.E Insulin pump educator Supervisor 2011-present 
E.H Insulin pump educator 2013-present 
E.A Insulin pump educator 2014-present 
E.M Insulin pump educator 2012-present 
ES.E Diabetic Educator supervisor 2013- present 
EP.As Insulin pump educator Supervisor 2013-present 
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